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Legionella pneumophila (L.p.) ist ein gram-negatives, intrazelluläres Pathogen und eine häufige 
Ursache von schweren ambulant-erworbenen Pneumonien. L.p. repliziert im Menschen 
hauptsächlich in Alveolarmakrophagen. Durch die Sekretion von über 300 Effektorproteinen in 
das Zytosol der Wirtszelle manipuliert das Bakterium wichtige Wirtszellfunktionen wie den 
Vesikeltransport und die Genexpression. Somit ändert L.p. wichtige Funktionen der Wirtszelle, 
um seine eigene Replikation zu fördern. Eine globale Analyse der molekularen Veränderungen 
und biologischen Prozesse, die mit bakteriellen Infektionen von humanen Zellen verbunden 
sind, kann neue Einblicke in die Wirts-Pathogen-Interaktionen ermöglichen. Daher war ein Ziel 
dieser Studie, die Expressionsveränderungen verschiedener RNA-Spezies nach Infektion mit 
L.p. in primären Blutmakrophagen (BDMs) oder differenzierten THP-1-Zellen zu untersuchen. 
Diese Arbeit ist in zwei Teile gegliedert: (1) Eine funktionelle Studie, wie eine miRNA-
Manipulation die Replikation von L.p. in Makrophagen beeinflussen kann, und (2) eine globale 
Analyse von Transkriptom-Veränderungen in Wirt und Pathogen während der Infektion. (1) In 
den letzten Jahrzehnten haben sich miRNAs als wichtige Modulatoren der Immunfunktion 
etabliert. Daher sollte das miRNA-Profil von L.p.-infizierten Makrophagen identifiziert und der 
funktionelle Einfluss einer miRNA-Manipulation auf die L.p.-Replikation untersucht werden. 
Dafür wurden BDMs von gesunden Spendern mit L.p. des Stammes Corby infiziert. Die 
Sequenzierung der kleinen RNAs führte zur Identifizierung des miRNA-Profils von 
L.p.-infizierten BDMs. Es wurde eine Hochregulation von miR-146a und miR-155, sowie eine 
Herunterregulation von miR-221 und miR-125b in Makrophagen mittels qPCR validiert. Die 
miRNA-Regulation nach einer L.p.-Infektion scheint auf die transkriptionelle Veränderung von 
miRNA-Promotoren zurückzuführen zu sein, da die Acetylierungslevel und die pri-miR-
Expression mit der miRNA-Expression nach einer L.p-Infektion korrelierten. Zur funktionellen 
Charakterisierung wurden Überexpressions- und Knockdown-Experimente der miRNAs 
miR-125b, miR-221 und miR-579 durchgeführt. Diese zeigten einen Einfluss auf die bakterielle 
Replikation. Mit der Hilfe eines SILAC-Ansatzes wurde MX1 als herunterreguliertes Protein 
nach gleichzeitiger Überexpression aller drei miRNAs identifiziert. MX1 ist ein Interferon-
induziertes GTP-bindendes Protein, das für die antivirale Abwehr wichtig ist. Wie durch 
Validierungsexperimente gezeigt wurde, führte der Knockdown von MX1 zu einer erhöhten 
Replikation von L.p., die auch nach Überexpression der miRNAs beobachtet wurde. Da in silico-
Analysen keine Bindungsstellen für die miRNAs in der 3'UTR von MX1 vorhersagten, wurde 
eine Ingenuity-Pathway-Analyse durchgeführt, um konnektive Moleküle zu identifizieren. 
DDX58 (RIG I), ein Sensor für zytosolische RNA, wurde als Zielmolekül der miR-221 validiert, 
während der Tumorsuppressor TP53 mittels Luciferase-Reporter-Assay als Zielmolekül der 
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miR-125b bestätigt wurde. Eine siRNA-vermittelte Herunterregulation von TP53 als auch 
DDX58 führte zu einer verstärkten Replikation von L.p. in Makrophagen. Daher wurden DDX58 
und TP53 als verbindende Moleküle zwischen den drei miRNAs und MX1 validiert. Zusätzlich 
zeigte der oben erwähnte SILAC-Ansatz eine Herunterregulierung von LGALS8, welches 
anschließend als Zielmolekül der miR-579 identifiziert wurde. LGALS8 ist ein zytosolisches 
Lektin, das Kohlenhydrate bindet. Der Knockdown von LGALS8 erhöhte die intrazelluläre 
Replikation in Makrophagen. Zusammenfassend wurden MX1 und LGALS8 als Zielmoleküle der 
drei miRNAs (miR-125b, miR-221, miR-579) identifiziert, die zur Verminderung der L.p.-
Replikation in humanen Makrophagen beitragen. (2) Das Transkriptionsprofil von L.p.-Infektion 
in humanen Makrophagen wurde mittels dual RNA-Seq untersucht, um die Regulation von 
kodierenden und nicht-kodierenden RNAs während einer Infektion von Wirt und Pathogen 
gleichzeitig zu bestimmen. Nach Anpassung und Optimierung bestehender Protokolle wurden 
die Makrophagen mit einem GFP-exprimierenden L.p.-Stamm infiziert. Um infizierte Zellen 
(gfp+) von den nicht infizierten Zellen (gfp-) zu trennen, wurden durchflusszytometrische 
Sortierungen durchgeführt. Eine differentielle Genexpressionsanalyse wurde unter 
Verwendung von DESeq2 durchgeführt, wodurch 4.144 differentiell exprimierte humane Gene 
und 2.707 differentiell exprimierte bakterielle Gene identifiziert wurden. Die DESeq-Analyse 
der Wirtszellen zeigte differentiell exprimierte mRNAs (3.504), lncRNAs (495) und miRNAs 
(145). Davon waren 1.128 differentiell exprimierte Gene ausschließlich in den infizierten Zellen 
(gfp+ nach 8 und 16 h) signifikant reguliert. Einigen von diesen Genen wurden erfolgreich 
mittels qPCR validiert (BCL10, SOD1, IRS1, CYR61, ATG5, RND3 und JUN). Außerdem wurde die 
Regulation der Gene ZFAND2A und HSPA1 validiert, die in gfp- als auch in gfp+ Zellen eine 
Hochregulation aufwiesen. Die Analyse der bakteriellen mRNAs zeigte eine inverse Regulation 
zwischen 8 und 16 h. Dazu gehörten Gene, die am Eisenstoffwechsel, der Stressantwort, der 
Glykolyse und der Lipidbiosynthese beteiligt sind. Zusammenfassend wurden also differentiell 
exprimierte Legionellen-Gene in verschiedenen Wachstumsphasen des Infektionszyklus 
identifiziert. Die Daten des dualen Sequenzierungsansatzes, die in dieser Arbeit generiert 
wurden, sind die ersten, die ein intrazelluläres, respiratorisches Bakterium untersuchen. Mit 
Hilfe dieser Daten können die Regulationen aller kodierender und nicht-kodierender RNAs von 
Pathogen und Wirt in einem großen, umfassenden Netzwerk dargestellt werden.  
Zusammengefasst haben die Ergebnisse dieser Arbeit die Kenntnisse des Infektionsprozess von 
L.p. und seine Wirtszellen vertieft. Die Daten werden dazu beitragen das komplexe 
Zusammenspiel zwischen ihnen besser zu verstehen, indem die in silico Konstruktion eines 
RNA-Interaktions-Netzwerkes ermöglicht wird. Darüber hinaus wird die vorliegende Studie 
helfen, potenzielle neue Kandidaten für Diagnose und Therapie zu etablieren. 




Legionella pneumophila (L.p.) is a gram-negative, intracellular pathogen and a common cause 
of severe community-acquired pneumonia. In humans, L.p. replicates primarily within alveolar 
macrophages. It manipulates vital host cell functions such as vesicle trafficking and gene 
expression by the secretion of over 300 effector proteins into the host cell cytosol. Thus, L.p. 
modifies its host cell to promote its own replication. An unbiased and global analysis of the 
molecular changes and biological processes that are associated with bacterial infections of 
human cells can provide new insights into host-pathogen interactions. Therefore, one goal of 
this study was to characterize expression changes of different RNA species in response to 
infection with L.p. in human primary blood-derived macrophages (BDMs) or differentiated 
THP-1 cells. This work is structured into two parts: (1) a functional study on how miRNA 
manipulations can alter L.p. replication in macrophages and (2) an in depth analysis of 
transcriptomic events in host and pathogen during infection.  
(1) In the last few decades, miRNAs have been established as critical modulators of immune 
function. Therefore, one aim of this study was to identify the miRNA profile of L.p.-infected 
macrophages and to determine the functional impact of a miRNA manipulation on L.p. 
replication. BDMs of healthy donors were infected with L.p. strain Corby. Small RNA 
sequencing revealed the miRNA profile in BDMs following L.p. infection. An upregulation of 
miR-146a and miR-155, as well as downregulation of miR-221 and miR-125b was validated by 
qPCR in macrophages. miRNA regulation in response to infection seems to be due to 
transcriptional regulation of miRNA promoters, since the histone acetylation levels at the 
promoter and the pri-miR expression correlated with the miRNA expression upon L.p.-
infection. Overexpression and knock down experiments of miR-125b, miR-221 and miR-579 in 
combination were performed for functional characterization and showed an influence of all 
three miRNAs on bacterial replication. A SILAC approach revealed the protein MX1 as 
downregulated following simultaneous overexpression of all three miRNAs. MX1 is an 
interferon-induced GTP-binding protein important for antiviral defence. As shown by 
validation experiments, MX1 knockdown in macrophages led to an increased replication of 
L.p., as seen following overexpression of the miRNAs. Since in silico analysis predicted no 
binding sites for either miRNA in the 3’UTR of MX1, Ingenuity pathway analysis was performed 
to find the linking molecules. DDX58 (RIG-I), a sensor for cytosolic RNA, was validated as a 
target for miR-221, while the tumour suppressor TP53 was shown to be targeted by miR-125b 
via luciferase reporter assays. An siRNA-mediated knockdown of both, TP53 and DDX58, 
respectively, led to an enhanced replication of L.p. in macrophages. Thus, DDX58 and TP53 
were validated as linking molecules between the three miRNAs and MX1. Additionally, the 
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aforementioned SILAC approach revealed a downregulation of LGALS8 which was later 
validated as a target of miR-579. LGALS8 is a cytosolic lectin which binds carbohydrates and 
localizes to damaged vesicles. Knockdown of LGALS8 enhanced intracellular replication in 
macrophages. Thus, MX1 and LGALS8 were identified as targets of the three miRNAs 
(miR-125b, miR-221, miR-579) and to be responsible for the restriction of L.p. replication 
within human macrophages.  
(2) The transcriptional profile of L.p. during the course of infection in human macrophages was 
next to be established. Dual RNA-Sequencing was performed to determine the regulation of 
coding and non-coding RNA species during the course of infection of both, host and pathogen, 
simultaneously. After adaptation and optimization of existing protocols, macrophages were 
infected using a GFP-expressing L.p. strain Corby. To separate infected cells (gfp+) from the 
non-invaded bystander cells (gfp-), flow cytometry sorting was performed. Furthermore, 
Pam3CSK4 was used to generate TLR2-activated cells. RNA from all different samples, and also 
RNA from cultivated Legionella, was sequenced. Differential gene expression analysis was 
performed using DESeq2 resulting in 4,144 differentially expressed human genes (across 
multiple conditions) and 2,707 differentially expressed Legionella genes (across two time 
points). The DESeq analysis of the separated RNA fractions from host cells revealed 
differentially expressed mRNAs (3,504), lncRNAs (495), and miRNAs (145). 1,128 differentially 
expressed genes were exclusively significantly regulated in invaded cells (gfp+ at 8 and 16 h). 
Some of these were validated via qPCR including BCL10, SOD1, IRS1, CYR61, ATG5, RND3 and 
JUN. In addition, the simultaneous upregulation of the genes ZFAND2A and HSPA1 in the 
bystander and in Legionella-invaded cells was validated. The analysis of the bacterial mRNAs 
revealed a switch of gene usage, i.e. inverse regulation at 8 and 16 h post infection. This switch 
included genes which are involved in iron metabolism, stress response, glycolysis and lipid 
biosynthesis. Hence, differentially expressed genes within different growth phases of the 
infection cycle were identified. This dataset is the first of its kind to cover a respiratory 
pathogen. The dual RNA-Sequencing performed in this study provides data to encapsulate the 
RNA landscape of coding and non-coding RNAs in pathogen and host. 
In summary, the results have deepened our insight into the infection process and the 
molecular interaction of L.p. and its host cells and will help to understand the complex 
interplay between host and pathogen by allowing for the in silico re-construction of an RNA 
interaction network. Furthermore, the present study will help to establish potential new 
candidates for diagnosis and therapy. 
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1.1 Lower respiratory tract infections 
Lower respiratory tract infections are among the leading causes of death worldwide. In 2015, 
they accounted for 3.2 million deaths (WHO 2017). Five conditions primarily contribute to the 
respiratory disease burden, including lung cancer, chronic obstructive pulmonary disease 
(COPD), asthma, tuberculosis and acute respiratory infections. The world Health Organization 
(WHO) estimates that these lung diseases accounted for one-tenth of the disability-adjusted 
life-years (DALYs) lost worldwide in 2008. Besides their influence worldwide, respiratory 
infections are, most notably, the leading cause of death in developing countries (Ferkol and 
Schraufnagel 2014). 
 
 Pneumonia as respiratory disease 1.1.1
One form of acute respiratory infection that affects primarily the small air sacs of the lung 
(alveoli) is pneumonia. Pneumonia is one of the leading causes of death in children worldwide 
and responsible for 16% of all deaths of children under five years old. In 2015, pneumonia 
killed 920,136 children under the age of five. It is most prevalent in South Asia and sub-
Saharan Africa, but other regions are also affected (WHO 2017). Indeed, pneumonia kills far 
more children than human immunodeficiency virus or malaria (Wardlaw 2006).  
 
Figure 1.1: Pneumonia as an acute respiratory infection. The infection primarily affects the small air 
sacs (alveoli) of the lung which are then filled with pus and fluid. Therefore, the gas exchange is limited 
resulting in painful breathing, productive or dry cough, chest pain and fever. In comparison, within 
healthy alveoli, the oxygen uptake into the blood is functional. Adapted from: https://smart.servier.com. 
 
During pneumonia, the alveoli are filled with pus and fluid, leading to painful breathing and 
limited oxygen uptake into the blood (WHO 2017). Other symptoms of pneumonia are 
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productive or dry cough, chest pain and fever (Turkington and Ashby 2007). To confirm 
diagnosis, chest X-ray and laboratory tests (blood tests, culture of the sputum) are used 
(Wardlaw 2006). Pneumonia can be life-threatening, but otherwise healthy people can recover 
within one to three weeks (AmericanLungAssociation 2017). The infection spreads via 
coughing, sneezing, touching or inhaling contaminated air droplets. It can be prevented by 
immunization, adequate nutrition, and by addressing environmental factors (WHO 2017). The 
disease is classified by the location of acquisition as community-acquired, or health care 
associated pneumonia (NHLBI 2011).  
Pneumonia can be caused by different pathogens, including bacteria, viruses, fungi, parasites, 
or various chemicals (WHO 2017). More than 30 different causes are known. Therefore, 
understanding the cause of pneumonia is important to find the appropriate therapy. For 
example, bacterial pneumonia can be treated with antibiotics, but only one third of children 
with pneumonia receive the appropriate antibiotics (AmericanLungAssociation 2017).  
The most common cause of a bacterial pneumonia is Streptococcus pneumoniae, affecting over 
900,000 Americans every year. However, another important bacterium causing pneumonia is 
Legionella pneumophila (L.p.). According to estimates, 4% of ambulant pneumonia cases are 
caused by Legionella in Germany (Robert-Koch-Institut 2012). In 2016, the surveillance atlas of 
infectious disease recorded 7,069 reported cases of Legionnaires’ disease in the EU ((ECDC) 
2018). 
 
 Impact of Legionellosis as pneumonic form of infection 1.1.2
Legionellosis describes the pneumonic and the non-pneumonic form of infection with the 
genus Legionella from water or potting mix (WHO 2017).  
The non-pneumonic form of legionellosis, also called Pontiac fever, is an acute, self-limiting, 
influenza-like illness. It lasts usually 2-5 days and has an incubation period varying from a few 
up to 48 hours. This disease is not life-threatening and associated with symptoms including 
fever, chills, headache, malaise and muscle pain (myalgia) (WHO 2017). 
In contrast, the pneumonic form of legionellosis is also known as Legionnaires’ disease. It is 
characterized as progressive pneumonia with respiratory failure accompanied by multi-organ 
failure and a death rate of 5 – 30%. The incubation period lasts from 2 to 10 days. Symptoms 
of this disease are fever, loss of appetite, headache, malaise and lethargy and is often 
associated with an initial mild cough (WHO 2017).  
The exact incidence of Legionnaires’ disease is not yet known, according to differences in 
awareness levels, diagnostic methods, and reporting of the disease in different countries. 
Generally, it accounts for 2 - 9% of cases of community acquired pneumonia (Stout and Yu 
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1997). In the USA, the reported incidence of Legionnaires’ disease showed an increase of 192% 
from year 2000 to 2009 (MMWR 2011). Primarily elderly and immuno-compromised people 
get infected. Furthermore, incidence of the disease seems to be season-dependent, since 62% 
of all cases occur during summer and early autumn. This fact might be due to better growth 
and survival conditions for the bacterium including higher humidity (Cunha, Connolly et al. 
2015). Moreover, most of the cases were travel-associated and only 4% of cases were 
attributed to a known outbreak or possible cluster of Legionnaires’ disease (Garcia-Vidal, 
Labori et al. 2013). 
For correct treatment of Legionnaires’ disease, it first needs to be diagnosed. The Bacteria can 
be detected by both, culture and non-culture techniques (Cunha, Burillo et al. 2016). One 
possibility is the urinary antigen detection test. It is the fastest diagnostic technique and 
recognizes components of the cell wall lipopolysaccharide of Legionella serogroup 1 in urine. 
The test sensitivity is 56 – 99%. Thus, this test does not detect approximately 40% of 
Legionnaires’ disease cases (Helbig, Uldum et al. 2003; Shimada, Noguchi et al. 2009; Jarraud, 
Descours et al. 2013). The gold standard for detecting Legionnaires’ disease is still to sample 
culture of the lower respiratory tract, since it allows the diagnosis of all Legionella spp., 
outbreak investigation, and further epidemiological studies, or even antimicrobial 
susceptibility testing (Jarraud, Descours et al. 2013; Pierre, Baron et al. 2017). However, also 
other techniques are used for detection, including several microscopy methods or nucleic acid 
amplification-based methods (Murdoch, Podmore et al. 2013; Ratcliff 2013). The advantages of 
these PCR-based techniques are the detection of other serogroups and species and a higher 
sensitivity (about 30%) compared to culture-methods, which leads to improved diagnoses 
(Murdoch, Podmore et al. 2013; Ratcliff 2013). Nevertheless, Legionnaires’ disease is 
underdiagnosed and underreported. In 97% of cases, diagnosis was made by means of urinary 
antigen testing, and only 5% were confirmed by culture. Since the urinary antigen test can only 
detect Legionella serogroup 1, the test should be used in conjunction with other diagnostic 
tests as many other species and serogroups are pathogenic (Pierre, Baron et al. 2017). 
Therefore, better diagnostic tests are needed for detection of all L.p. serotypes and species. 
(Cunha, Burillo et al. 2016).  
Given the fact that Legionella are intracellular pathogens and invasion is necessary to cause 
infection, antibiotics should accumulate and be bioactive inside the host cells (Cunha, Burillo et 
al. 2016). As a first-line of therapy to treat legionellosis, macrolides are used. These are 
glycosides and inhibit protein biosynthesis of gram-positive and gram-negative bacteria 
including Legionella. In severe cases, Rifampicin is also given (Longo D.L. 2012). Rifampicin 
blocks the DNA-dependent RNA polymerase, thus specifically preventing bacterial 
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transcription. The duration of therapy should be at least 14 days and in immune-compromised 
people, three weeks. Macrolides such as Azithromycin and Clarithromycin are effective and 
show fast anti-bacterial capacities in vitro. Both are often used to treat infections of the 
respiratory tract and disturb the protein biosynthesis of bacteria. Their application is especially 
recommended for immuno-compromised people (Longo D.L. 2012).  
 
1.2 The genus Legionella 
The genus Legionella consists of 58 different species, three subspecies (Rizzardi, Winiecka-
Krusnell et al. 2015) and has more than 80 serogroups. All Legionella species were isolated 
from aqueous environments, such as Legionella pneumophila (L.p.), Legionella longbeachae or 
Legionella bozemanii.  
Legionella are ubiquitous in aquatic habitats at temperatures between 25°C and 55°C (optimal 
at 35°C) (WHO 2017). In nature, the pathogen survives as an intracellular parasite of amoeba, 
ciliated protozoa, or slime moulds (Fields, Benson et al. 2002). Legionella infects amoeba 
including Hartmannella, Acanthamoeba and Naegleria which can be found in naturally 
occurring biofilms (Rowbotham 1986; Fields 1996; Fields, Benson et al. 2002; Abdel-Nour, 
Duncan et al. 2013). Legionella also inhabits human-made environments, including water 
pipes, air-conditioning systems, cooling towers, fountains and spa baths (Fraser, Deubner et al. 
1979; Sethi and Brandis 1983; Spitalny, Vogt et al. 1984). In nature, low abundances of 
Legionella are found in aquatic habitats, while it inhabits human-made aquatic environments 
in higher numbers (Eisenreich and Heuner 2016).  
Some species and serogroups are more virulent than others and can cause infections in 
humans. The majority of human infections are caused by Legionella pneumophila serogroup 1 
(Fields 1996; Yu, Plouffe et al. 2002). Legionella pneumophila is also the most common 
causative agent of Legionnaires’ disease (WHO 2017).  
 
 Legionella pneumophila 1.2.1
Legionella pneumophila is a rod-shaped bacterium with strict growth requirements for iron 
and cysteine. It is a non-encapsulated, aerobic bacillus with a single polar flagellum. The size of 
the pathogen is approximately 2 µm in length and 0.3 – 0.9 µm in width (Lederberg 2000). As a 
gram-negative bacterium, it is surrounded by a cell wall consisting of a double set of covering 
membranes. The inner membrane encloses the bacterial cytoplasm, whereas the outer 
membrane covers the inner membrane and consists of phospholipids, lipopolysaccharides 
(LPS) and also carries proteins (Beveridge 1999). 
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The first recognized occurrence of this pathogen was in 1976 in the Bellevue-Stratford Hotel in 
Philadelphia. During that time a convention for veterans of the American legion was hosted by 
the hotel and 182 of 4400 persons became acutely ill, often associated with pneumonia. 
Overall, the 182 cases resulted in 29 deaths and the hospitalization of 147 people (Fraser, Tsai 
et al. 1977). One year later, the causative agent could be isolated from lung tissue of a fatality 
and subsequently identified as a gram-negative bacterium. Therefore, it was termed Legionella 
pneumophila, which reflects both its victims and the newly described Legionnaires’ disease 
(Brenner, Steigerwalt et al. 1979). 
The general route of infection in humans is via the inhalation of contaminated aerosols 
(Arnow, Chou et al. 1982; Cunha, Burillo et al. 2016). Another less common mode is for 
example direct contact with surgical wounds (Johnson, Yu et al. 1985; Marrie, Haldane et al. 
1991). Humans are accidental dead-end hosts for Legionella and therefore, the transmission 
from human to human is generally not observed, but there may be exceptions. One case has 
been described where a probable person-to-person transmission of L.p. serogroup 1 occurred 
in Portugal in 2014 (Borges, Nunes et al. 2016; Correia, Ferreira et al. 2016). However, aerosol 
producing systems such as cooling towers, hot tubs, industrial equipment, domestic plumbing 
systems, thermal spas, water outlets, respiratory devices and nebulisers, or nasogastric tubes 
in hospitals leading to the spread of the pathogen and are often associated with outbreaks of 
Legionnaires’ disease in humans (Cunha, Burillo et al. 2016; WHO 2017). For example, hospital-
acquired Legionnaires’ disease has been connected to the presence of Legionella in the water 
supply (Stout, Yu et al. 1982). Studies have shown that Legionella spp. was detectable in hot 
water distribution systems in 12 – 70% of hospitals (Lin, Stout et al. 1998). A further risk for 
disease acquisition is augmented exposure to the source harbouring Legionella which 
comprises the frequency and duration of exposure (Mandell, Bennett et al. 2010). 
Furthermore, the likelihood of an infection depends on the virulence of the bacteria, the 
concentration, the effectiveness of dissemination, and the aerosol type (Cunha, Burillo et al. 
2016). After transmission to the human lung, bacteria are infecting alveolar macrophages. 
Legionella replicate within macrophages, leading to inflammation and pneumonia (Newton, 
Ang et al. 2010; Copenhaver, Casson et al. 2014). In Germany, the last big outbreak occurred in 
Warstein in summer 2013 with 78 laboratory-confirmed cases, including two fatalities (Maisa, 
Brockmann et al. 2015). Legionella pneumophila serogroup 1 could be identified to be 
responsible for the epidemic. The sources harbouring the epidemic strain were cooling towers 
of different companies, the waste water treatment plants of the city and one company as well 
as water samples of the river and its branches (Petzold, Ehricht et al. 2017). This represented 
the biggest Legionella pneumophila outbreak in Germany to date. 
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 The Legionella intracellular life cycle 1.2.2
The innate ability of Legionella to multiply within different protozoa has equipped the 
pathogen with the capacity to replicate in human alveolar macrophages. As L.p. has the ability 
to infect amoeba and macrophages, combined with the fact that only one case of human-to-
human transmission has been described, has led to the hypothesis that the interaction of L.p. 
with amoeba has equipped the bacteria with the factors allowing replication within human 
macrophages (Newsome, Baker et al. 1985; Cianciotto and Fields 1992; Franco, Shuman et al. 
2009; Al-Quadan, Price et al. 2012). Thus, Legionella uses amoeba as ‘training grounds’ for 
replication in human macrophages (Molmeret, Horn et al. 2005). Both, free-living amoeba and 
human macrophages are eukaryotic cells which share conserved molecular pathways targeted 
by L.p. (Molmeret, Horn et al. 2005; Al-Quadan, Price et al. 2012; Richards, Von Dwingelo et al. 
2013).  
L.p. exhibits at least a biphasic life-cycle (Rowbotham 1986; Byrne and Swanson 1998; 
Garduno, Garduno et al. 2002; Molofsky and Swanson 2004). The appearance of further life 
stages or forms were also discussed (Robertson, Abdelhady et al. 2014). Briefly, L.p. alternates 
between a transmissive (virulent) and replicative (avirulent) form. In the replicative form, L.p. 
multiplies within the Legionella containing vacuole (LCV) inside the host or in media and is 
non-motile and non-cytotoxic. It stays in this form as long as sufficient nutrients and living 
space are available. When nutrients become scarce, L.p. differentiates into the transmissive 
form. In protozoa, it changes into a flagellated spore-like mature infectious form (MIF) that is 
stress-resistant and almost metabolically dormant (Rowbotham 1986; Byrne and Swanson 
1998; Heuner, Brand et al. 1999; Garduno, Garduno et al. 2002; Hammer, Tateda et al. 2002; 
Greub and Raoult 2003; Molofsky and Swanson 2004; Abdelhady and Garduno 2013). Thus, 
differences in morphology, motility, pathogen metabolism and gene expression controlled by 
regulatory systems are detectable between the two life stages (Molofsky and Swanson 2004). 
The lifecycle of Legionella in protozoa was first described by Timothy Rowbotham who could 
show that L.p. is able to infect amoeba (Rowbotham 1983). The infection cycle starts with the 
adhesion of the bacterium to the host cell. It is followed by cell entry as one of the most 
important steps, which requires the flagellum, pili and bacterial surface proteins, such as major 
outer membrane proteins, heat shock proteins, and the mip protein (Cunha, Burillo et al. 
2016). The mip gene was the first detected gene associated with macrophage infectivity of L.p. 
(Engleberg, Carter et al. 1989). The method of internalization by eukaryotic cells is still not 
completely understood. Several competing theories differ on whether it is a host-directed 
response or driven by the pathogen. In general, internalization of the bacteria depends on the 
host cell type and bacterial strain. Phagocytes usually take up bacteria by conventional 
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phagocytosis (Newton, Ang et al. 2010). The less common coiling phagocytosis has been 
observed for the uptake of L.p. in mammalian cells and amoeba (Horwitz 1984; Bozue and 
Johnson 1996). Another form of internalization such as macropinocytosis was found in bone 
marrow-derived macrophages (Watarai, Derre et al. 2001). Further mechanisms of uptake 
include the zipper-like conventional phagocytosis or the opsonin-dependent phagocytosis 
(Reynolds and Newball 1974; Rechnitzer and Blom 1989). The ability of L.p. to infect non-
professional phagocytes such as HeLa epithelial cells suggests the hypothesis of an uptake that 
is cell-dependent (Dreyfus 1987; McCusker, Braaten et al. 1991).  
In the second step of the infection process, internalized L.p. employs its type IV B secretion 
systems (T4BSS) to form the LCV in which the bacterium differentiates into the replicative form 
for efficient replication (Isberg, O'Connor et al. 2009). Legionella possess two protein secretion 
systems: Lsp type II secretion system (T2SS) and Dot/Icm type IV secretion system (T4SS). Both 
play major roles in the pathogenesis of Legionella (Cianciotto 2013; Kubori and Nagai 2016). In 
T2SS, protein substrates are first translocated across the inner membrane. When T2SS pilus-
like apparatus is active, the proteins exit the bacterial cell through a specific outer membrane 
pore (Nivaskumar and Francetic 2014). It was shown that the T2SS secretes over 25 proteins, 
including 18 confirmed enzymes and novel proteins, which seem to be unique for Legionella 
(DebRoy, Dao et al. 2006; Tyson, Pearce et al. 2013). Via the Dot/Icm type IV secretion system 
(T4SS), L.p. secretes over 330 effector proteins to promote the formation of the LCV and its 
own replication. Many bacterial pathogens use dedicated translocation systems to deliver 
arsenals of effector proteins to their hosts, but L.p. maintains the largest arsenal of effectors.  
Once inside the host cytosol, these effectors modulate eukaryotic cell biology to acquire 
nutrients, block microbial degradation, subvert host defences, and enable pathogen 
transmission to other hosts (Ensminger 2016). Therefore, the T4BSS is crucial for replication of 
L.p. within amoeba and macrophages. The Dot/Icm secretion system is a multiprotein 
apparatus. It is encoded by the dot/icm (dot: defective in organelle trafficking; icm: 
intracellular multiplication) genes which are highly conserved among all Legionella species 
(Berger and Isberg 1993; Brand, Sadosky et al. 1994). About 10% of the genome of L.p. code 
for these effector proteins (Al-Quadan, Price et al. 2012) and many of them possess 
eukaryotic-like domains. Thus, L.p. is able to modulate host cell function by interaction with 
host proteins and organelles (Cazalet, Rusniok et al. 2004; de Felipe, Glover et al. 2008; Nora, 
Lomma et al. 2009; Hubber and Roy 2010; Rolando and Buchrieser 2012). The mutant strain 
dotA, which has no functional T4SS, lacks the capacity to replicate within the host and the 
ability to escape from the phagosome-lysosome fusion, a hallmark feature of Legionella 
infections (Berger, Merriam et al. 1994; Tilney, Harb et al. 2001).  




Figure 1.2: Biphasic life cycle of Legionella pneumophila. 1.) Legionella pneumophila (L.p.) adheres to 
the host cell and is taken up within the phagosome. 2.) L.p. secretes over 330 effector proteins into the 
host cell cytosol via the T4BSS to establish the LCV. L.p. recruits ER vesicles and mitochondria to the LCV 
and replicates safely within the LCV (replicative phase). 3.) When nutrients became limited, the 
bacterium differentiates into the flagellated transmissive form. 4.) L.p. is released into the host cell 
cytosol which results in the egress of the bacteria. 5.) A new infection cycle starts with the initiation of 
infection of neighbouring host cells. ER, endoplasmic reticulum; LCV, Legionella containing vacuole; RP, 
replicative phase; TP, transmissive phase; T4BSS, type 4 b secretion system. Adapted from: Eisenreich 
and Heuner, FEBS Letters, 2016. 
 
The LCV is negative for canonical markers of the endocytic pathways such as Rab5 for early 
endosomes, Rab7 for late endosomes and Lamp-1 for lysosomes (Roy, Berger et al. 1998; 
Clemens, Lee et al. 2000). Thus, a LCV does not undergo acidification and maintains a pH ~6.1 
and prevents fusion with the lysosome (Horwitz 1983b; Horwitz 1983a; Horwitz and Maxfield 
1984). The escape from phagosome lysosome fusion is a hallmark of Legionella pathogenesis. 
Since mutant strains lacking this capacity are not able to multiply within human macrophages, 
it is essential for virulence (Horwitz 1987). Through the injection of effector proteins by the 
T4SS, the LCV is surrounded by mitochondria, ribosomes and smooth vacuoles derived from 
the endoplasmatic reticulum (ER). Thus, membrane thickness of LCV changes to resemble that 
of the ER within the first 15 minutes post infection (Horwitz 1983b; Tilney, Harb et al. 2001). 
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Furthermore, small GTPases such as Rab1, Sar1 and ADP ribosylation factor 1 (Arf1) are 
targeted by bacterial effector proteins and are subsequently recruited to the LCV. These are 
fused to the LCV and critical for ER-to-Golgi trafficking. At four hours post infection, ER-derived 
structures as well as mitochondria start to disappear from the LCV and ribosomes are recruited 
to the LCV resulting in a rough ER-like vacuole.  
In the third step of the infection procedure, L.p. inhibits the bactericidal activity of the 
phagocyte and converts the phagosome into a safe intracellular niche for its replication (Escoll, 
Rolando et al. 2013). After replication within the LCV, when nutrients become limited, L.p. 
differentiates into the flagellated transmissive form (Garduno, Garduno et al. 2002). 
Afterwards, L.p. eventually ruptures the LCV membrane by pore formation and membrane lysis 
(Kirby, Vogel et al. 1998; Alli, Gao et al. 2000). The release into the host cell cytosol is 
hypothesized to cause disintegration of the plasma membrane and structural and functional 
disruption of cytoplasmic organelles. This results in host cell osmotic lysis and subsequently in 
the egress of the bacteria into the extracellular milieu. Then, a new infection cycle can start 
with the initiation of infection of neighbouring host cells.  
 
1.3 Immunity 
The immune system faces daily exposure to millions of potential pathogens, such as bacteria 
or viruses. The transmission of these pathogens can occur through direct contact, ingestion, 
and inhalation. In order to cope with those pathogens and to protect the host against 
microbial infections mammals have developed a highly specific immune system consisting of 
an innate and an adaptive immune system, which cooperate.  
A single bacterium can produce almost 20 million progeny in a single day with a doubling time 
of one hour. Thus, to fight infections, the innate immune system is needed for initial 
protection and fast immune response (Alberts 2002). The adaptive immune system activates 
innate effector mechanisms in an antigen-specific manner. This immune response remembers 
previous contacts with specific pathogens and destroys them upon re-infection (Alberts 2002; 
Medzhitov 2007). The adaptive immune response comprises the activation and expansion of 
specific clones of B and T cells. Therefore, the adaptive immune response against a new 
pathogen can take a week before it is effective. Furthermore, the adaptive immune system 
requires the stimulation and activation of the innate immune system through antigen 
presenting cells such as macrophages (Medzhitov 2007). Therefore, the innate immune 
response is important for both, the fast defence against pathogens and the activation of the 
adaptive immune system.  
 
   Introduction 
10 
 
 Innate Immunity 1.3.1
The innate immune system represents the first line of defence and is not specific to particular 
pathogens (Alberts 2002). It is an older evolutionarily defence strategy comprising conserved 
regulatory mechanisms and found in multiple organisms such as plants, fungi, insects, and 
primitive multicellular organisms (Murphy, Travers et al. 2012). The innate immune system 
consists of a humoral as well as a cellular section that recognizes conserved features of 
pathogens and is quickly activated to destroy invaders.  
The humoral part is mainly represented by the complement system which marks the 
pathogens for destruction. It consists of about 20 interacting soluble proteins mainly 
originating in the liver and primarily produced by hepatocytes. The plasma proteins are 
circulating in the blood and extracellular fluid and are inactive until the invasion of a pathogen. 
They were originally identified by their ability to “complement” the action of antibodies to 
clear pathogens (Alberts 2002). In short, the complement system helps to identify bacteria, 
activates cells and promotes the clearance of opsonized antigens or dead cells.  
In contrast, the cellular part of the innate immune system possesses different cell types from 
the hematopoietic lineage that originates in the bone marrow (Alberts 2002). Those innate 
leukocytes include natural killer cells, eosinophils, basophils, mast cells and the phagocytic 
cells such as macrophages, neutrophils, and dendritic cells (Murphy, Travers et al. 2012). The 
cells from the innate immune system need to differentiate self from non-self. Therefore, the 
innate immune system relies on the recognition of molecules that are absent in the host, but 
common to many pathogens. These so called PAMPs stimulate two types of innate immune 
responses, the inflammatory response by the secretion of cytokines, and phagocytosis by 
macrophages and neutrophils. Both responses are very quick, act within minutes and occur 
even if the host has never been previously exposed to this kind of pathogen (Alberts 2002). In 
summary, the major functions of the innate immune system are the opsonisation of pathogens 
for phagocytosis through the complement system, the recruitment of immune cells to sites of 
infection through production of chemotactic factors such as cytokines, and the identification 
and elimination of pathogens that might cause infection (Alberts 2002; Murphy, Travers et al. 
2012).  
 
 Pathogen recognition 1.3.2
Since innate immune recognition is based on the detection of molecular structures that are 
unique to microorganisms, innate leukocytes express pattern recognition receptors (PRRs) 
(Medzhitov 2007; Murphy, Travers et al. 2012). These PRRs have broad pathogen specificity 
and are able to bind to a large number of pathogen-associated molecular patterns (PAMPs) 
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which have common structural motifs or patterns. PAMPs are often molecules that are 
invariant among microorganisms of a given class, are products of pathways that are unique to 
microorganisms or have essential roles in microbial physiology. Bacterial PAMPs are for 
example components of the cell wall, such as lipopolysaccharide, peptidoglycan, lipoteichoic 
acids and cell-wall lipoproteins. The detection of viral components via the innate immune 
system is different, because all viral components are synthesized within host cells. Therefore, 
the main targets of immune recognition are viral nucleic acids. The differentiation of self and 
external nucleic acids is based on structural modifications which are unique to viral RNA and 
DNA (Medzhitov 2007).  
The PRRs include several distinct classes such as Toll-like receptors (TLRs), NOD-like receptors 
(NLRs) and cytosolic nucleic acid sensors. The best described and investigated class are the 
TLRs. They are type I transmembrane proteins containing an extracellular domain with leucine-
rich repeats (LRRs) and a cytoplasmic tail with a conserved region called the Toll/IL-1 receptor 
(TIR) domain (Gay, Gangloff et al. 2006). TLRs are evolutionarily conserved receptors and 
received their name from their similarity to the toll gene, first identified in Drosophila in 1985. 
These receptors were found to be important during the defence against microbial infection 
(Hansson and Edfeldt 2005). In humans, 11 different TLRs are described, whereas in mice 13 
different TLRs are known (Mahla, Reddy et al. 2013). TLRs are transmembrane proteins which 
are located on the membranes of innate leukocytes including dendritic cells, macrophages and 
natural killer cells. However, cells of the adaptive immune system (T and B lymphocytes) and 
non-immune cells (epithelial cells, endothelial cells, fibroblasts) also express several TLRs 
(Delneste, Beauvillain et al. 2007). During the immune response TLRs activate tissue-resident 
macrophages to produce pro-inflammatory cytokines such as tumour-necrosis factor (TNF), 
interleukin-1β (IL-1β) and interleukin-6 (IL-6). Those secreted cytokines trigger the local and 
systemic inflammatory response leading to the recruitment of leukocytes to the site of 
infection and the prevention of pathogen spreading. Furthermore, IL-1ß and IL-6 activate 
hepatocytes to produce acute-phase proteins which activate the complement system and 
opsonize pathogens for phagocytosis by macrophages and neutrophils. Additionally, TLRs 
directly trigger an inflammatory response of macrophages by inducing the production of 
antimicrobial proteins and peptides for pathogen defence. However, all exact functions of TLRs 
in antimicrobial defence are not examined, yet, but in general, TLRs elicit inflammatory and 
antimicrobial responses upon activation by their specific ligands (Medzhitov 2007).  
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 Macrophages as first line of defence 1.3.3
One major function of the innate immune system is the activation of professional phagocytes 
to eliminate invading pathogens or particles. Professional phagocytes are distinguished from 
non-professional phagocytes according to how effective they are at phagocytosis. Professional 
phagocytic cells express a multitude of receptors on their surfaces for the recognition of 
signals that are not normally found in healthy tissues, such as TLRs. Those cells are, besides 
macrophages, monocytes and DCs, along with neutrophils and mast cells (Mantovani, 
Rabinovitch et al. 1972). Macrophages mainly arise from myeloid precursors located in the 
bone marrow and are the most efficient phagocytes. The precursors are released into 
circulation as monocytes. Their role is to replenish the pool of tissue-resident macrophages 
and DCs in steady state and in response to inflammation. The spleen serves as reservoir for 
immature monocytes. After migration of the monocytes, they differentiate into macrophages 
or dendritic cells (Geissmann, Manz et al. 2010). Macrophages are able to migrate outside of 
the vascular system to sites of pathogen invasion. The binding of bacterial molecules to surface 
receptors triggers phagocytosis and the destruction of pathogens. Briefly, tissue-resident 
macrophages are the first line of defence against extrinsic invaders and coordinate leukocyte 
penetration in innate immunity. Phagocytic macrophages maintain the equilibrium between 
antigen removal by phagocytosis and degradation of microbes, apoptotic cells, and neoplastic 
cells (Gordon 2003). 
Two hallmarks of macrophages are diversity and plasticity. Two phenotypes exist for 
macrophage polarization, which can be activated in a variety of different ways: Classically 
activated M1 and alternatively activated M2 macrophages. Numerous pathways of signal 
transduction, transcriptional and post-transcriptional networks of regulation are involved in 
the polarization process of macrophages. Classically activated macrophages (M1) have 
antimicrobial and tumoricidal activities and release pro-inflammatory cytokines which retard 
cellular proliferation surrounding the tissue leading to tissue damage. In contrast, alternatively 
activated macrophages (M2) secrete anti-inflammatory cytokines leading to wound healing 
and tissue repair. M2 macrophages are linked to immunosuppression, tumorigenesis and 
elimination of parasites. These macrophages are further sub-categorized into M2a, M2b, M2c 
and M2d based upon gene expression profile (Arora, Dev et al. 2017). The nomenclature of 
polarized macrophage populations is still a matter under discussion. Murray and colleagues 
claim that researchers should describe stimulation scenarios and adopt a nomenclature linked 
to the activation standards and avoid M2a, M2b and so forth (Murray, Allen et al. 2014). 
Nevertheless, overshooting imbalance in M1/M2 activation may have detrimental effects 
which can result in disease or inflammation (Wang, Liang et al. 2014).  
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Phenotypic differentiation depends on a variety of different stimuli including the tissue 
microenvironment, microbes, or their products. Macrophages can be stimulated to M1 
macrophages by the release of IFN-γ. Furthermore, a combination of IFN-γ with microbial 
stimuli like lipopolysaccharide (LPS) or other cytokines such as granulocyte-macrophage colony 
stimulating factor (GM-CSF) and TNF-α lead to the M1 phenotype of macrophages (Martinez 
and Gordon 2014; Murray, Allen et al. 2014).  
A Legionella infection of human macrophages results in an M1-like phenotype. The recognition 
of L.p. in human macrophages is described in the following section.  
 
 Sensing of Legionella pneumophila in macrophages 1.3.4
The innate immune system recognizes L.p. by different PRRs such as TLRs, NLRs and cytosolic 
acid sensors (Massis and Zamboni 2011; Cunha and Zamboni 2014; Naujoks, Lippmann et al. 
2017).  
TLRs are expressed on the membranes of innate leukocytes for the recognition of pathogen 
structures. TLR2 is activated by lipopeptides and lipoproteins, which are cell wall components 
of Legionella. Furthermore, lipidA signals via TLR2 to induce the expression of CD14. Other co-
receptors influencing agonist-TLR2 interaction, are CD36 and integrins (van 
Bergenhenegouwen, Plantinga et al. 2013). The LPS of Legionella is mainly recognized by TLR2 
(Akamine, Higa et al. 2005; Shim, Kim et al. 2009). The atypically LPS structure of Legionella is 
unique and supports adherence to the membrane of target cells including alveolar 
macrophages. Moreover, it differs from the LPS structure of other bacteria such as Salmonella 
typhimurium (Zahringer, Knirel et al. 1995). A recent study suggests that Legionella might be 
able to partly evade TLR2-mediated recognition in humans via its type 2 secretion system 
(T2SS) (Mallama, McCoy-Simandle et al. 2017). Nevertheless, this receptor is critical to the 
outcome of L.p. infections in mice as previously demonstrated. Mice deficient in the tlr2 gene 
showed impaired cytokine production and an increased susceptibility to bacterial replication in 
the lungs (Hawn, Smith et al. 2006). Aside from this, TLR5 senses flagellin of Legionella and 
plays an important role in Legionella infection in humans (Hawn, Berrington et al. 2007). Since 
a stop codon polymorphism in the gene of TLR5 has been shown to be linked with 
susceptibility to Legionnaires’ disease (Hawn, Verbon et al. 2003). Endosomal TLR9 is activated 
by bacterial DNA in the phagosome (Newton, Perkins et al. 2007). Mice lacking TLR9 produced 
less cytokines after Legionella infection. Therefore, these mice were more permissive of 
Legionella replication in the lungs (Newton, Perkins et al. 2007). Generally, all mentioned TLRs 
lead to activation of the adapter molecule myeloid differentiation primary response protein 88 
(MyD88) which mediates the downstream NFκB-dependent production of pro-inflammatory 
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mediators, such as TNF-α and various other cytokines (Archer and Roy 2006; Archer, 
Alexopoulou et al. 2009).  
In addition to the TLR-mediated recognition of Legionella, NOD1 and NOD2 are activated by 
Legionella cell wall peptidoglycan leading to activation of NFκB, mediated by receptor 
interacting protein-2 (RIP2). Knockout studies with mice deficient in both NLRs NOD1 and 
NOD2 or deficient in RIP2 revealed impaired neutrophil recruitment and reduced bacterial 
clearance during lung infection (Frutuoso, Hori et al. 2010). Moreover, the NLRs NAIP5 and 
NLRC4 form a multiprotein complex called the inflammasome (NAIP5/NLRC4 inflammasome), 
which recognizes intracellular flagellin delivered by the T4SS of Legionella (Ren, Zamboni et al. 
2006; Lightfield, Persson et al. 2008; Lightfield, Persson et al. 2011; Pereira, Morgantetti et al. 
2011; Kortmann, Brubaker et al. 2015). This inflammasome-complex contributes to caspase-1 
activation to regulate production of IL-1β and IL-18, and to restrict L.p. growth in human 
macrophages and mice. The restriction of Legionella growth also relies on gasdermin D-
dependent cell death called pyroptosis due to pore formation and on the induction of the 
fusion of LCV and lysosome (Molofsky, Byrne et al. 2006; Ren, Zamboni et al. 2006; Shi, Zhao et 
al. 2015). This observation is confirmed by a study showing that the non-flagellated Legionella 
species L. longbeachae fails to trigger pyroptosis and is not restricted by the NAIP5/NLRC4 
inflammasome (Pereira, Marques et al. 2011).  
Another crucial pathway for sensing Legionella is the detection of bacterial nucleic acids in the 
cytosol. Legionella-DNA is recognized by the DNA sensor cyclic GMP-AMP synthase (cGAS), 
which directly binds DNA. The binding mediates the production of the second messenger cyclic 
2′3′-GMP-AMP (2′3′-cGAMP), which in turn activates STING-dependent signalling (Sun, Wu et 
al. 2013; Watson, Bell et al. 2015). In contrast, intracellular Legionella-RNA is detected by the 
cytosolic RNA sensors RIG-I (retinoic acid-inducible gene I) which is encoded in humans by the 
DDX58 gene. RIG-I is part of the RIG-I-like receptor family, which also includes MDA5 
(Melanoma Differentiation-Associated protein 5). Both, RIG-I and MDA5, are involved in the 
activation of MAVS (Mitochondrial antiviral-signalling protein), also known as IPS-1 (Hou, Sun 
et al. 2011). Thus, STING-dependent signalling and activation of MAVS leads to the activation 
of the transcription factor interferon regulatory factor 3 (IRF3). IRF3 is phosphorylated by the 
serine/threonine-protein kinase TBK1 triggering the secretion of type I interferons (IFNs) 
including IFN-α and IFN-β (Opitz, Vinzing et al. 2006; Stetson and Medzhitov 2006; Lippmann, 
Muller et al. 2011). Type I IFNs in turn strongly activate macrophage-intrinsic defence 
mechanisms and, together with IFNγ, induce antibacterial clearance in vivo (Lippmann, Muller 
et al. 2011; Naujoks, Tabeling et al. 2016).  
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Furthermore, cytosolic DNA is also sensed by the AIM2 inflammasome composed by the 
cytosolic helicase AIM2. It directly binds the Legionella-DNA and uses the adaptor protein ASC 
to trigger the activation of caspase-1 leading to pyroptosis and production of IL-1α and IL-1β 




Figure 1.3: Overview of the innate immune sensing of Legionella in macrophages. L.p. is recognized by 
TLR2 and TLR5 on the cell surface and by TRL9 in the phagosome. All TLRs displayed activate NFκB via 
MyD88 to induce production of pro-inflammatory mediators. Additionally, NOD1/NOD2, RIG-I and 
MDA5, cGAS, AIM inflammasome and NAIP5/NLRC4 sense bacterial peptidoglycan, RNA, DNA and 
flagellin, which are localized in the host cell cytosol through the T4SS. NAIP5/NLRC4 and AIM form an 
inflammasome leading to the activation of Caspase-1 and thus to the production of IL-1β and IL-18 and 
pyroptosis. NOD1 and NOD2 signal via RIP2 to stimulate the expression of NFκB-dependent pro-
inflammatory genes. The DNA sensor cGAS induces the expression of type I IFNs including IFN-α and 
INF-β via STING, TBK1 and IRF3 signalling. Moreover, the RNA-sensor RIG-I and MDA5 as well as their 
adapter molecule MDA5 might contribute to the production of type I IFNs via TBK1 and IRF3. Adapted 
from: Massis and Zamboni, frontiers in Microbiology, 2011) 
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1.4 Non-coding RNAs of eukaryotes 
Non-coding RNAs (ncRNAs) are RNA molecules that are not translated into proteins. Although 
98.5% of the human genome is comprised of non-protein coding DNA sequences, most of the 
genome is transcribed into RNA (Birney, Stamatoyannopoulos et al. 2007; Lander 2011). The 
exact number of non-coding RNAs is unknown, but according to bioinformatics and 
transcriptomics analyses the predicted number is more than several thousands (Birney, 
Stamatoyannopoulos et al. 2007; Washietl, Pedersen et al. 2007; Morris 2012).  
The majority of studies so far have focused on the function of proteins, but comparably less is 
known about the function of ncRNAs (Carninci, Kasukawa et al. 2005; Kapranov, Cheng et al. 
2007). Although many ncRNAs were considered to be non-functional (junk RNA), studies have 
shown that ncRNAs play important roles in the regulation of gene expression  
(Palazzo and Lee 2015). Different classes of non-coding RNAs contribute to many cellular 
processes such as gene expression regulation, cell differentiation, RNA maturation, protein 
synthesis and development (Chen, Satpathy et al. 2017). ncRNAs can be separated into two 
groups: (1) classical housekeeping RNAs which are constitutively expressed and play critical 
roles in protein biosynthesis including ribosomal RNAs (rRNAs), transfer RNAs (tRNAs), small 
nuclear RNAs (snRNAs) and small nucleolar RNAs (snoRNAs); and (2) regulatory RNAs that 
comprise small regulatory RNAs such as microRNAs (miRNAs), silencer RNAs (siRNAs), piwi-
interacting RNAs (piRNAs) and long non-coding RNA (lncRNAs) (Wu, Su et al. 2016). In the 
following sections, the major functions of long non-coding RNAs and miRNAs will be 
highlighted.  
 
 Long non-coding RNAs 1.4.1
LncRNAs are transcripts with a length greater than 200 nucleotides which do not encode a 
protein (Iyer, Niknafs et al. 2015). In mammals, lncRNAs are mainly transcribed by RNA 
polymerase (RNAP) II or III and are capped, polyadenylated and spliced in the same manner as 
that of mRNAs (Struhl 2007; Bierhoff, Schmitz et al. 2010; Rinn and Chang 2012). No defining 
biochemical features can be exclusively ascribed to lncRNAs (Mercer and Mattick 2013). 
lncRNAs were first described as a transcript class during the large-scale sequencing of full-
length cDNA libraries in mice (Okazaki, Furuno et al. 2002). It could be shown that humans also 
express lncRNAs. Genome wide transcriptome studies in humans have led to the discovery and 
annotation of nearly 50,000 lncRNA genes (Iyer, Niknafs et al. 2015). Most annotated lncRNAs 
are expressed at lower levels than mRNAs and are cell type specific (Atianand, Caffrey et al. 
2017). Thus, RNA sequencing data of multiple developmental stages and tissue types are 
necessary to achieve comprehensive annotations (Cabili, Trapnell et al. 2011; Derrien, Johnson 
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et al. 2012). According to literature, lncRNAs can be classified based on their genomic location 
with respect to nearby proteins or based on their function. 
According to their genomic location, lncRNAs can be separated into long intergenic noncoding 
RNAs (lincRNAs), intronic lncRNAs, natural antisense transcripts (NATs), sense lncRNAs, and 
bidirectional lncRNAs. With the exception of lincRNAs, the other classes often show some 
degree of overlap with nearby protein-coding genes (Wu, Su et al. 2016; Atianand, Caffrey et 
al. 2017). LincRNAs are located in the intergenic region between two protein-coding genes, 
while intronic lncRNAs are transcribed within the introns of protein-coding genes. Therefore, 
they contain no sequence complementarity to the mature, spliced mRNA of the protein-coding 
gene. In contrast, NATs are transcribed from the complementary strand of a protein-coding 
gene and contain one or more regions of sequence complementary to the mRNA of the 
protein-coding gene (Atianand, Caffrey et al. 2017). Such antisense lncRNAs are particularly 
common, and up to 72% of genomic loci in mice show evidence of generation of antisense 
lncRNAs (Werner, Carlile et al. 2009). Moreover, bidirectional lncRNAs are located within 1 kb 
of promoters of protein-coding genes and they are transcribed from the opposite direction. 
According to their function, lncRNAs can be classified into cis- and trans-acting lncRNAs. A cis-
acting lncRNA targets the neighboring locus and its effect is restricted to the chromosome 
from which it is transcribed. In contrast, trans-acting lncRNAs affect genes on other 
chromosomes. It is still a matter of debate how lncRNAs act preferentially. A prevalence of 
cis-regulatory lncRNAs would explain the relatively low expression levels of many lncRNAs and 
their generally limited sequence conservation (Ulitsky and Bartel 2013). Furthermore, only 
about 3% of human lncRNAs have expression profiles strongly correlated with those of their 
neighboring genes. Strong negative correlations are exceedingly rare, which argues against 
widespread cis regulation by lncRNAs (Derrien, Johnson et al. 2012).  
Generally, LncRNAs were initially thought to be non-functional and even transcriptional noise, 
but recently it became clear that many lncRNAs are important for several cellular processes. 
LncRNAs can carry out scaffolding functions by the formation of RNA-protein complexes or 
subcellular structures. An example of a lncRNA with scaffolding functions is the lncRNA TERC 
(Telomerase RNA component). TERC serves as a template for telomere replication by 
telomerase and acts as a molecular scaffold for the polymerase enzyme around the RNA 
(Lingner, Hughes et al. 1997). Furthermore, lncRNAs can influence protein activity and 
modulate their localization. The lncRNA NRON (non-coding repressor of NFAT) was found to 
repress the nuclear factor of activated T-cells (NFAT). NFAT is a Ca2+-regulated transcription 
factor that controls gene expression in many cell types. NRON binds NFAT, thereby limiting the 
nuclear-cytoplasmic trafficking of NFAT which results in the repression of NFAT target gene 
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expression (Sharma, Findlay et al. 2011). In addition, lncRNAs can regulate the expression of 
genes through a variety of mechanisms including epigenetic modifications, transcription and 
post-transcriptional processing (Mercer, Dinger et al. 2009; Kornienko, Guenzl et al. 2013). It 
was shown that lncRNAs are involved in epigenetic regulation by recruiting chromatin-
remodeling complexes to specific locations in the genome. Thus, HOTAIR (HOX transcript 
antisense RNA) guides the PRC2 complexes (polycomb repressive complex 2) to the HOXD 
cluster, thereby repressing transcription in trans (Rinn, Kertesz et al. 2007). Moreover, the 
well-known lncRNA XIST coats the X chromosome in cis and also recruits the PRC2 complex. 
This induces the formation of heterochromatin, which ultimately leads to X-chromosome 
inactivation (Brockdorff 2011; Pontier and Gribnau 2011). LncRNAs also play a role in 
transcriptional regulation. In eukaryotes, RNAP II transcribes protein-coding genes into mRNA 
in collaboration with general transcription factors. Therefore, some lncRNAs regulate the 
transcription by directly affecting the loading and activity of RNAP II or general transcription 
factors (Espinoza, Allen et al. 2004). Another way for lncRNAs to regulate mRNA transcription 
is to modulate the activity of a particular transcription factor by acting as a co-factor or 
inhibitor. The lncRNA Evf2 acts as a co-activator of the transcription factor DLX2, resulting in an 
induced gene expression of DLX5 and DLX6 (Feng, Bi et al. 2006). Additionally, lncRNAs can 
regulate the post-transcriptional processing of mRNAs, including mRNA editing, splicing, 
transport, translation and degradation (Wu, Su et al. 2016). As an example, NAT Zeb2 can bind 
the Zeb2 mRNA through complementary base-pairing and thereby prevent the splicing 
processing of the intron. This results in the upregulation of the Zeb2-protein without an 
alteration on transcriptional level (Beltran, Puig et al. 2008).  
In general, lncRNAs play an important role in many different cell types, since they coordinate 
many processes in cell and tissue development (Hu, Alvarez-Dominguez et al. 2012). LncRNAs 
regulate the development of cardiomyocytes, stem cells, epithelial cells, erythrocytes and 
adipocytes and are also involved in the development and differentiation of several different 
immune cell lineages (Guttman, Donaghey et al. 2011; Hu, Yuan et al. 2011; Grote, Wittler et 
al. 2013; Kretz, Siprashvili et al. 2013; Sun, Goff et al. 2013; Alvarez-Dominguez, Hu et al. 
2014).  
In contrast to miRNAs or proteins, the function of lncRNAs can only partly be inferred from 
sequence or structure and they use a variety of mechanisms to regulate processes. Thus, the 
biological function of any lncRNA needs to be determined on a case-by-case basis.  
 




miRNAs are endogenous, non-coding, single-stranded RNA molecules with a length of 20 - 24 
nucleotides that negatively regulate gene regulation at a post-transcriptional level (Bartel 
2004). Initially, miRNAs have been discovered in the nematode Caenorhabditis elegans 
(C. elegans) in 1993. It was observed that the small regulatory RNA lin-4 was important for the 
developmental transition in early larval stage progression of C. elegans by targeting lin-14 
mRNA. Therefore, lin-4 was the first identified miRNA with a length of 22 nucleotides (Lee, 
Feinbaum et al. 1993). Although the identification of unknown miRNAs in different species is 
still ongoing work, already known miRNAs have shown striking sequence conservation across 
species and phyla. This observation hints towards similarities in function among them (Das, 
Garnica et al. 2016). miRNAs are expressed in a tissue-specific or developmental-stage-specific 
manner, thereby contributing to cell-type-specific protein-expression profiles (Krol, Loedige et 
al. 2010). Intriguingly, miRNAs can be found in bodily fluids including serum, plasma, urine, 
saliva and milk (Weber, Baxter et al. 2010). In humans, over 2,500 matured miRNAs (based on 
miRBase.org, released August 2010, Last Update: November 2010) have been identified so far 
and about 60% of all protein-coding genes are predicted to be regulated by them (Friedman, 
Farh et al. 2009). Bioinformatics predictions of miRNA targets have provided an important tool 
to explore the functions of miRNAs. However, the overall success rate of such predictions 
remains to be determined by experimental validation (He and Hannon 2004).  
 
1.4.2.1 Biogenesis and function 
miRNA genes can be transcribed either from independent miRNA genes or are embedded 
within introns, and occasionally exons of other genes (Carthew and Sontheimer 2009). Two 
pathways of the miRNA biogenesis are possible: the canonical and the non-canonical pathway.  
In the canonical pathway, miRNA genes are transcribed into long primary miRNA transcripts 
(pri-miRNAs) by RNA polymerase II and occasionally by RNA polymerase III (Cai, Hagedorn et al. 
2004; Lee, Kim et al. 2004; Borchert, Lanier et al. 2006). The sequence of pri-miRNAs can be 
several kilobases in size and they can contain stem loops of several mature miRNAs, which give 
rise to one miRNA cluster. The dsRNA binding protein DGCR8 (DiGeorge critical region 8) 
recognizes the hairpin structure of the pri-miRNA and brings it in close proximity to the 
RNAse III enzyme Drosha (Krol, Loedige et al. 2010). Both form the nuclear microprocessor 
complex leading to the cleavage of the pri-miR into hairpin shaped structures called pre-miRNA 
with a length of approximately 70 nucleotides (Lee, Ahn et al. 2003). In the non-canonical 
pathway, miRNA precursors are located in mRNA introns and are spliced out and therefore 
bypass the microprocessor complex (Schamberger, Sarkadi et al. 2012). In both pathways, the 
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pre-miRNA is exported from the nucleus into the cytoplasm by exportin-5 in a Ran-GTP 
dependent manner (Yi, Qin et al. 2003; Lund, Guttinger et al. 2004). The pre-miRNA is only 
bound by exportin-5 if the 3’ overhang that derives from Drosha cleavage is present. Thus, the 
export is selective for correctly processed RNAs (Zeng and Cullen 2004). In the cytoplasm, the 
pre-miRNA is recognized and its terminal loop is cut off by the RNAse Dicer in complex with the 
double-stranded RNA binding protein TRBP (transactivation-responsive (TAR) RNA-binding 
protein). Therefore, a ~20 bp-mature miRNA/miRNA duplex is produced that dissociates from 
Dicer and TRBP (Hutvagner, McLachlan et al. 2001). The miRNA/miRNA duplex is processed 
and unwound by the activity of several helicases, assisted by Argonaute 2 (Ago2) (Winter, Jung 
et al. 2009). Thereby, the guide strand stays associated with Ago2 in the miRNA induced 
silencing complex (miRISC), while the remaining strand (passenger strand) is degraded. In most 
cases, there is a preference for which strand is incorporated into miRISC due to factors such as 
thermodynamic stability. Typically, the strand with the lower thermodynamic stability at its 5’ 
base pair is incorporated into miRISC (Schwarz, Hutvagner et al. 2003). The miRISC guides the 
miRNA to its target mRNA. Thereby, binding of miRNA and mRNA in the RISC can lead to 
translational repression, mRNA deadenylation and mRNA degradation. Thus, miRNA binding is 
a mechanism for post-transcriptional regulation of gene expression (Winter, Jung et al. 2009). 
In detail, miRNAs bind to complementary sequences in the 3’ untranslated region (3’UTR) of 
mRNA transcripts. However, they do not require perfect complementarity for binding. Only the 
nucleotides 2-7 of the miRNA, also known as seed region, have to perfectly match a sequence 
of the 3’UTR for binding (Lewis, Shih et al. 2003). miRNA-mediated gene regulation relies on 
two mechanisms. Multiplicity describes the phenomenon that one miRNA can bind hundreds 
of different target mRNA. If one mRNA is targeted by several miRNAs that act together, it is 
called as synergy (Krek, Grun et al. 2005). In general, miRNAs reduce protein levels of their 
mRNA targets, but this might not always be the case. Since miRNA-binding also occurs in the 5’ 
untranslated region (5’UTR) of target mRNAs, exons or DNA elements, translation and 
transcription can be enhanced, respectively (Lytle, Yario et al. 2007; Vasudevan, Tong et al. 
2007; Place, Li et al. 2008; Fang and Rajewsky 2011; Lin, Liu et al. 2011).  
 




Figure 1.4: Simplified schematic of the canonical pathway of miRNA processing. RNA polymerase II/III 
(RNA Pol II/III) generates the primary miRNA transcript (pri-miRNA). The pri-miRNA is cleaved by the 
microprocessor complex Drosha-DGCR8 in the nucleus. The resulting hairpin, pre-miRNA, is exported 
into the cytoplasm by exportin-5 in a Ran-GTP dependent manner. Dicer cleaves the terminal loop of the 
pre-miRNA with the aid of the dsRNA binding protein TRBP resulting in the miRNA-duplex. The guide 
strand of the miRNA-duplex is incorporated into the Ago2 containing miRISC complex whereas the 
passenger strand is degraded. miRNA-guided binding of miRISC to specific target mRNAs through base-
pair complementarity within the miRNA seed region mediates translational repression, mRNA target 
cleavage or mRNA deadenylation. Adapted from: Winter et al, Nature Cell, 2009) 
 
1.4.2.2 microRNAs in the innate immune system 
miRNAs can have many different targets because only the seed region needs to be 
complementary to mediate its function. Therefore, miRNAs can have a variety of different 
functions. miRNAs are important regulators of cell differentiation and function and mediate a 
variety of processes including controlling innate and adaptive immunity. miRNA regulation has 
been studied in a wide range of leukocytes and in the immune response of non-leukocytes. 
Indeed, the activation of innate immune cells including macrophages, dendritic cells and 
natural killer cells is partly controlled by miRNAs (Montagner, Orlandi et al. 2013; Smyth, 
Boardman et al. 2015; Essandoh, Li et al. 2016). More precisely, miRNAs are for example 
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involved in the polarization process of macrophages. A number of studies have been 
performed to determine the miRNA expression profiles in M1 and M2 polarized human and 
murine macrophages. These studies revealed that miR-9, miR-127, miR-155, and miR-125b 
promote M1 polarization, while miR-124, miR-223, miR-34a, let-7c, miR-132, miR-146a, and 
miR-125a-5p induce M2 polarization by targeting various transcription factors and adaptor 
proteins (Zhang, Zhang et al. 2013; Cobos Jimenez, Bradley et al. 2014). M1 and M2 
phenotypes play distinctive roles in cell growth and progression of inflammation-related 
diseases. Thus, miRNAs which are relevant for the polarization process of macrophages may 
have therapeutic potential in the treatment of inflammation-related diseases such as sepsis, 
obesity, cancer, and multiple sclerosis (Essandoh, Li et al. 2016). Moreover, miRNAs contribute 
to a balanced immune response between elimination of pathogens and immune dysregulation 
as seen in sepsis or chronic inflammation. The best illustrated example is provided by their 
regulation of TLR signalling. TLR-signalling leads to the induction of miRNAs which in turn 
target elements of TLR signalling pathways such as signalling proteins, regulatory molecules, 
transcription factors or cytokines. Therefore, the role of miRNAs as fine tuners is fulfilled by 
their function in complex feedforward and feedback loops (Drury, O'Connor et al. 2017). 
Besides that, the most studied miRNAs, miR-146a and miR-155, are important regulators of 
inflammation. In response to pathogens, both miRNAs are upregulated, but show opposing 
effects. miR-155 is induced by TLR2, TLR3, TLR4 and TLR9 signalling in many cell types and 
generally functions as a pro-inflammatory miRNA. miR-155 targets factors which negatively 
regulate inflammation (Wang, Hou et al. 2010; Thounaojam, Kundu et al. 2014). To prevent 
exaggerated inflammation, the miR-155 expression is controlled by IL-10 which inhibits its 
transcription (McCoy, Sheedy et al. 2010). By contrast, miR-146a negatively regulates TLR 
signalling through a negative feedback loop by targeting IRAK1 and TRAF6. miR-146a was 
originally identified in a screen which aimed at identifying miRNAs induced by LPS stimulation 
and is expressed widely throughout the hematopoietic system (Taganov, Boldin et al. 2006). In 
general, its expression appears to be low in precursors and resting cells and increases with 
maturation and activation (Boldin, Taganov et al. 2011; Rusca, Deho et al. 2012). Knockout 
studies in mice have clearly displayed the importance of miR-146a in the regulation of the 
immune response. Mice deficient in miR-146a are hyperresponsiveness to LPS, they develop 
an immune-proliferative disorder characterized by splenomegaly, lymphadenopathy, 
premature death and a very significant induction of myeloproliferation (Rusca, Deho et al. 
2012). In summary, miR-155 enhances inflammation, whereas miR-146 inhibits inflammation 
(Taganov, Boldin et al. 2006; O'Connell, Chaudhuri et al. 2009).  
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In addition to the role of miR-155 in inducing immune responses, a study has shown that 
miR-155 also regulates mRNA targets involved in pro-inflammatory transcriptional processes 
as seen for miR-146a. Therefore, it is suggested that miR-155 acts as a broad limiter of pro-
inflammatory gene expression once the miR-146-dependent barrier to LPS triggered 
inflammation has been breached (Schulte, Westermann et al. 2013). Thus, miR-155 post-
transcriptionally inhibits negative regulators of inflammation, such as SHIP-1, SOCS-1 or PIK3CA 
(Gottwein, Mukherjee et al. 2007; Lu, Thai et al. 2009; O'Connell, Chaudhuri et al. 2009; 
Thounaojam, Kundu et al. 2014), pro-inflammatory signalling components, such as TAB2, IKKε 
or FOS (Gottwein, Mukherjee et al. 2007; Lu, Weidmer et al. 2008; Ceppi, Pereira et al. 2009), 
and mediators of programmed cell death (Koch, Mollenkopf et al. 2012).  
Furthermore, an involvement of miRNAs in endotoxin tolerance (LPS tolerance) has been 
demonstrated (Quinn, Wang et al. 2012). Endotoxin tolerance is a controlled immune response 
to prevent tissue damage, overwhelming sepsis and mortality, and refers to a phenomenon 
that cells show a reduced responsiveness towards repeated endotoxin stimulation (Greisman, 
Young et al. 1969). Thus, miRNAs play a role in switching from a strong, early pro-inflammatory 
response to the resolution of the inflammatory process (O'Neill, Sheedy et al. 2011). Studies by 
el Gazzar and McCall have demonstrated that not only miR-146a and miR-155 are regulating 
the TLR4 signalling pathway. Moreover, miR-221, miR-579 and miR-125b are increased 
significantly in LPS-tolerized cells compared to naive cells. The study revealed that miR-221 
accelerates TNF-α degradation, whereas miR-125b and miR-579 block its translation. The 
effect of these miRNAs on the TNF-α 3’UTR is mediated via recruitment of specific RNA-binding 
proteins, which act as mRNA destabilizers and translational inhibitors, respectively. In 
conclusion, the miRNAs are upregulated to inhibit TNF-α mRNA to prevent an exaggerated 
immune response to a second stimulus (El Gazzar and McCall 2010). Other miRNAs are also 
involved in endotoxin tolerance by controlling TLR4 signalling. For instance, let-7e was shown 
to negatively target TLR4 and reduced levels of miR-98 are increasing IL-10 secretion. Both, 
downregulation of miR-98 and increased levels of let-7e, contribute to LPS hyporesponsiveness 
(Androulidaki, Iliopoulos et al. 2009; Liu, Chen et al. 2011).  
The expression of miRNAs is highly regulated. miRNA-mediated control of mRNAs levels is very 
fast, but not as rapid as the effects of proteosomal degradation. However, it allows a strong 
initial immune response that is gradually dampened down. Therefore, their function as 
immunomodulators is well placed. (O'Neill, Sheedy et al. 2011).  
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1.4.2.3 microRNAs in infectious diseases 
miRNAs play crucial roles in the regulation of many cellular processes such as proliferation, 
metabolic pathways, immune response and development (Bartel 2004; Kloosterman and 
Plasterk 2006; Taganov, Boldin et al. 2007; Deiuliis 2016). Expression of miRNAs at normal 
levels maintains homeostasis in eukaryotes (Das, Garnica et al. 2016). Therefore, expression 
changes of miRNAs may have drastic effects. It can result in serious diseases in humans 
including cancer, kidney failure, cardiac disease, diabetes and liver cirrhosis (Kloosterman and 
Plasterk 2006; Rome 2013; Finch, Marquardt et al. 2014; Trionfini, Benigni et al. 2015; 
Santovito, Egea et al. 2016). Besides that, miRNAs are also important during several infectious 
diseases. The miRNA expression profile is altered when pathogens infect host cells which was 
firstly monitored in viral infection (Cullen 2011). Moreover, bacterial pathogens also alter host 
miRNAs which has already been studied and well described in infections with different kind of 
bacteria, such as Helicobacter pylori, Listeria monocytogenes, Salmonella enteria serovar 
Thyphimurium and Mycobacterium tuberculosis (Eulalio, Schulte et al. 2012; Harapan, Fitra et 
al. 2013; Staedel and Darfeuille 2013; Maudet, Mano et al. 2014a). However, the miRNA 
expression profile is not only altered in response to an infection as part of the host response to 
limit bacterial replication. Since miRNAs play an important role in the regulation of the innate 
and adaptive immune response, it is not surprising that pathogens have evolved to exploit host 
miRNAs to modulate the immune response (Drury, O'Connor et al. 2017). It has already been 
deciphered that host cellular miRNAs are manipulated by pathogens, such as viruses and many 
intracellular bacteria, to promote their own survival (Das, Garnica et al. 2016; Drury, O'Connor 
et al. 2017). For instance, HIV-1 induces upregulation of miR-34a which targets phosphatase 1 
nuclear-targeting subunit (PNUTS) to promote its replication (Swaminathan, Murray et al. 
2013). Furthermore, Epstein-Barr virus latent membrane protein 1 induces miR-146a 
expression to negatively regulate the interferon response and promote its survival (Cameron, 
Yin et al. 2008). In hepatocytes, the genome of hepatitis C virus (HCV) is stabilized by the 
binding of host miR-122. This binding protects HCV from degradation by innate antiviral 
endonucleases (Jopling, Yi et al. 2005). This shows that a pathogen can also be dependent on 
endogenous expression of host miRNAs that promote their survival or replication which results 
in tissue tropism. As mentioned before, intracellular bacteria also appear to manipulate host 
cell miRNA expression to downregulate inflammatory cytokines, factors and pathways that 
promote autophagy and cell apoptosis (Drury, O'Connor et al. 2017). For instance, miR-26a is 
downregulated in macrophages by Mycobacterim tuberculosis (M. tuberculosis). Therefore, the 
target of miR-26a, Krüpple-like factor 4 (KLF4), is repressed which usually promotes 
macrophage polarization towards an anti-inflammatory M2 phenotype. In M2 macrophages, 
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bactericidal mechanisms are repressed, which leads to an increased replication of 
M. tuberculosis (Sahu, Kumar et al. 2017). Additionally, miR-146a expression was shown to be 
induced after Mycobacterium bovis infection. miR-146a suppresses the inducible nitric oxide 
(NO) synthase (iNOS) expression and NO generation by targeting TRAF6, thus promoting 
mycobacterial survival in macrophages (Li, Wang et al. 2016). Moreover, in vitro studies 
indicate that Salmonella modulates host miRNAs in epithelial cells as well as macrophages. A 
downregulation of let-7a was detected in RAW264.7, HeLa cells and macrophages, and miR-21, 
miR-146 and miR-155 were upregulated in RAW264.7 in response to a Salmonella infection 
(Schulte, Eulalio et al. 2011). All of these miRNAs were associated with pro- and 
anti-inflammatory responses, but not with invasion or replication of Salmonella. In 2014, a 
study described how Salmonella exploit host miRNAs. Maudet and colleagues identified a 
Salmonella-mediated downregulation of the miR-15 family in HeLa cells using a library of 
miRNA mimics. Cyclin D1 protein is targeted by the family and associated with cell cycle 
progression. Therefore, cells remain in G1/S phase that favors the intracellular replication of 
Salmonella (Maudet, Mano et al. 2014b). Additionally, the miRNAs miR-30c and miR-30e are 
also involved in intracellular replication of Salmonella (Verma, Mohapatra et al. 2015).  
Given that miRNAs mediate the host response to infection, miRNA dysregulation could 
contribute to susceptibility to disease and immunopathology. Therefore, understanding how 
dysregulation of miRNAs can contribute to disease progression may provide new therapeutic 
targets or prognostic indicators. Disease-related miRNAs have already been detected in bodily 
fluids and were used as biomarkers or as targets for therapeutics (Guay and Regazzi 2013; 
Mulrane, Klinger et al. 2014; Pal, Jaiswar et al. 2015; Hayes and Chayama 2016).  
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1.5 Objective of the study 
In the last few decades, non-coding RNAs have been found to be important regulators of gene 
expression at the post-transcriptional level by binding to target transcripts or by mediating 
gene regulation. The goal of this study was to understand the influence of an infection with 
L.p. on non-coding RNAs in human macrophages to understand the closely connected host-
pathogen processes from the angle of putative trans-species regulatory RNA networks. The 
novelty herein is the specific focus on transcriptome events in host and pathogen 
simultaneously. This work is structured into two parts: (1) a functional study on how 
Legionella-infections influence the miRNA response of the host and (2) an in depth analysis of 
transcriptomic events in host and pathogen during infection. 
(1) Many physiological cellular processes, including immune responses to infections, are 
regulated at the post-transcriptional level by miRNAs. As an intracellular bacterium, L.p. can 
survive and replicate in phagocytic cells and modulate the defence of the host cell in a very 
sophisticated way. Therefore, the hypothesis arose that L.p. could alter the miRNA expression 
of the host to its own benefit. Since a global analysis of host miRNA expression changes upon 
Legionella infection of human macrophages had never been established before, high 
throughput sequencing of small RNAs was used to determine the miRNA profile of L.p.-
infected human macrophages. This study aims to assess the influence of miRNA expression 
changes on the course of infection with L.p. in human macrophages and their functional 
consequences. Furthermore, the present work also inspects the mechanism behind a miRNA 
dysregulation in response to infection.  
(2) The transcriptional profile of L.p. during the course of infection in human macrophages is 
yet to be investigated. Additionally, the altered gene expression of Legionella infected 
macrophages has only been performed in a mixed population of infected and non-infected 
cells. Therefore, the second part of the study aims to uncover the most important 
transcriptional events in both, host cell and bacterium, during the course of infection. To 
elucidate the transcriptional profile of the host and pathogen simultaneously, we used a dual 
RNA-Seq approach. This method allows the definition of the RNA landscape including coding 
and non-coding RNAs of pathogen and host, in great depth and with high accuracy. One 
important step of this work was the establishment of the method and the first analysis and 
validation experiments.  
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2 Materials and Methods 
 
2.1 Materials 
 Instruments and equipment 2.1.1
Table 2.1: List of instruments and equipment 
Instruments Type Company 
analytical column Acclaim PepMap RSLC, 
packed with 2.6 μm C18 
particles of 150 Å pore size 
Thermo Fisher Scientific 
Waltham, MA, USA 
Automated cell counter TC10™ BioRad Laboratories  
Hercules, USA 
Bioanalyzer 2100 Bioanalyzer Instrument Agilent Technologies 
Santa Clara, USA 
Bioluminescence and 
Chemoluminescence Imager 
ChemoCam Imager 3.2 INTAS Science lmaging 
Göttingen,Germany 
Camera AxioCam MRm Zeiss 
Oberkochen, Germany 
Cell Counting Chamber Neubauer Counting Chamber Paul Marienfeld GmbH & Co. KG  
Lauda-Königshofen, Germany 
Cell culture bench SAFE 2020 Thermo Fisher scientific  
Schwerte, Germany 
Centrifuge HERAEUS Multifuge X3R Thermo Fisher scientific 
Schwerte, Germany 
Centrifuge Gentrifuge 5424R Eppendorf 
Hamburg, Germany 
Centrifuge Sprout® Mini-Gentrifuge Heathrow Scientific ® LLC 
lllinois, USA 
Centrifuge Heraeus Fresco L7 Thermo Fisher scientific 
Schwerte, Germany 
co2 Incubator HERAcell 240i Thermo Fisher scientific 
Schwerte, Germany 
Dispenser Multipette® plus Eppendorf 
Hamburg, Germany 
Dispenser Multipette® Xstream Eppendorf 
Hamburg, Germany 
FACS Guava easyCyte ™ Merck Millipore TM 
Billerica, USA 
FACS-Sorter FACS Aria III Cell Sorter Miltenyi Biotec GmbH 
Bergisch Gladbach, Germany  
Fluorometer Qubit® 2.0 Fluorometer Thermo Fisher scientific 
Schwerte, Germany 
Gel comb 10 Well, 14 Well Peqlab 
Erlangen, Germany 
Gel documentation apparatus Gel-x lmager INTAS Science lmaging 
Göttingen,Germany 
Gel electrophoresis apparatus PerfectBiue Gel System Peqlab 
Erlangen, Germany 
Gel preparation equipment Multiple Gel Casting Peqlab 
Erlangen, Germany 
Gel preparation equipment Gel Trays Peqlab 
Erlangen, Germany 
Hybridization Oven / UV HL-2000 HybriLinker UVP 
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Crosslinker Cambridge, UK 




MaxQ 600 Thermo Fisher scientific 
Schwerte, Germany 
Labaratory roller mixer SRT6D Stuart ® 
Marseille, France 
Labaratory shaker See-Saw rocker SSL4 Stuart ® 
Marseille, France 
Liquid nitrogen storage tanks Cryo Plus 2 Thermo Fisher scientific 
Schwerte, Germany 
low flow liquid chromatography 
system 
UltiMate™ 3000 RSLCnano 
System 
Dionex/Thermo Fisher Scientific 
Idstein, Germany 
Macs multi stand magnet quadroMacs Miltenyi Biotec GmbH 
Bergisch Gladbach, Germany 
Magnetic & Heating Stirrer RCT Standard IKA 
Staufen, Germany 




Merck Millipore TM 
Billerica, USA 




Merck Millipore TM 
Billerica, USA 
Mass spectrometer Q Exactive mass 
spectrometer 
Thermo Fisher Scientific 
Waltham, MA, USA 
Microscope AXIO Vert a1 Zeiss 
Oberkochen, Germany 
Microscope PrimoVert Zeiss 
Oberkochen, Germany 
Microwave Inverter SHARP 
Hamburg, Germany 
PCR Cycler PeqSTAR 2x Gradient Peqlab 
Erlangen, Germany 




Pipetboy Accu-jet pro BRAND GMBH&CO KG 
Wertheim, Germany 
Pipette (0.1 - 10001JI)  Gilson 
Middelton, USA 
Plate reader Tecan Infinite M200 PRO Thermo Fisher scientific  
Schwerte, Germany 
Power supplies PeqpowerE300 200/300V Peqlab 
Erlangen, Germany 
Precision Scales  Denver Instruments 
Göttingen, Germany 
Real Time PCR System ViiA7 TM Life Technologies ™ 
Darmstadt, Germany 
Real Time PCR System QuantStudio3 Thermo Fisher scientific 
Schwerte, Germany 
Spectrophotometer NanoDrop 2000c Thermo Fisher scientific Schwerte, 
Germany 
Steam sterilizer Varioklav® HP Medizintechnick GmbH 
Oberschleißheim, Germany 
Surgical preparation set  Fine Science Tools 
Heidelberg, Germany 
Thermomixer (1.5 mL; 2 mL) Thermomixer Comfort Eppendorf 
Hamburg, Germany 
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trap column Acclaim™ PepMap™ 100 C18-
LC-column 
Thermo Fisher Scientific 
Waltham, MA, USA 
TriVersa NanoMate source  Advion, Ltd. 
Harlow, UK 
Ultrasonic homogenizer SONOPULS HD 2070 BANDELIN electronic GmbH & Co. KG 
Berlin, Germany 
Vacuum pump AC 04 VACUUBRAND GMBH + CO KG 
Wertheim, Germany 
Vortex VortexGenie2 Scientific lndustries 
New York, USA 
Vortex IKA®MS3 Agilent Technologies 
Santa Clara, USA 
Vortex Vortex V-1 plus Peqlab 
Erlangen, Germany 
Water bath  GFL® 
Burgwedel, Germany 
 
 Consumables and plasticware 2.1.2
Table 2.2: List of consumable and plasticware 
Subject Name Company 
µ slide for microscopy µ-Slide (chambered 
coverslip) with 8 wells 
ibidi 
Planegg / Martinsried 
1 mL Norm-Jet syringe  Henke-Sass Wolf GmBH 
Tuttlingen, Germany 
100 mL containers, polypropylene  SARSTEDT AG & Co. 
Nümbrecht, Germany 
15 - 50 mL tube Falcon SARSTEDT AG & Co. 
Nümbrecht, Germany 
6-well plate, 12-well plate, 24-well 
plate, 96-well plate 
CELLSTAR® Cell culture 
plate 
Greiner Bio-One GmbH 
Frickenhausen, Germany 
96-well plate (white) for luciferase-
Assay 
Cell Grade Brand plates BRAND GMBH + CO KG 
Wertheim, Germany 
96-well plate for ELISA  Thermo Fisher scientific 
Schwerte, Germany 
96-well plate for LDH Mikrotestplatte SARSTEDT AG & Co. 
Nümbrecht, Germany 
Canula  BD Biosciences 
Heidelberg, Germany 
Cap tube for cultivation of bacteria 14 mL PP tube Greiner Bio-One GmbH 
Frickenhausen, Germany 
Cell culture dish  Greiner Bio-One GmbH 
Frickenhausen, Germany 
Cell culture flask (T25; T75) TC Flask SARSTEDT AG & Co. 
Nümbrecht, Germany 
Cell scraper (25 - 50 cm)  SARSTEDT AG & Co. 
Nümbrecht, Germany 
Cotton buds Cotton buds, Rotilabo Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Coverslips (11 - 18 mm)  Thermo Fisher scientific 
Schwerte, Germany 
Cryo-tubes  SARSTEDT AG & Co. 
Nümbrecht, Germany 
Cuvette (polystyrene)  SARSTEDT AG & Co. 
Nümbrecht, Germany 
Disposal Bags  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Dissecting set  Fine Science Tools GmbH 
Heidelberg, Germany 
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DNA Chip  Agilent Technologies 
Santa Clara, USA 




High sensitivity Chip  Agilent Technologies 
Santa Clara, USA 
Inoculation spreader  SARSTEDT AG & Co. 
Nümbrecht, Germany 
Inoculation tube Loop Soft 10 µL VWR International GmbH 
Darmstadt, Germany 




Lintfree tissues Delicate task wipes Kimberly-Ciark Professional® 
Roswell, USA 
Magnetic columns MACS LS Columns Miltenyi Biotec GmbH 
Bergisch Gladbach, Germany 
Microscope slides (76 x 26 mm)  Thermo Fisher scientific 
Schwerte, Germany 
Nitrocellulose Blotting membrane Amersham Protran, 0.2 µm GE Healthcare Life Science Hyclone 
laboratories 
Logan, USA 
NuPAGE4-12% acrylamide Bis-Tris 
Midi Gel 
 Novex Life Technologies  
Darmstadt, Germany 
Optical adhesive film microAmp® Life Technologies™ 
Darmstadt, Germany 
Parafilm PARAFILM® M VWR International GmbH 
Darmstadt, Germany 
Pasteur pipette  Glaswarenfabrik Karl Hecht 
GmbH &Co KG - "Assistent" 
Sondheim, Germany 
PVDF membrane Immobilon-PSQ transfer 
Membran, 0.2 µm 
Merck Millipore TM 
Billerica, USA 
qPCR 96- weil plates (0.1 mL)  Life Technologies™ 
Darmstadt, Germany 
RNA Nano Chip  Agilent Technologies 
Santa Clara, USA 
Serological pipette (5 mL - 25 mL)  SARSTEDT AG & Co. 
Nümbrecht, Germany 
Steril filtration filters (0.2 µm) Filtrepur S SARSTEDT AG & Co. 
Nümbrecht, Germany 
Surgical diposable scalpel  B. Braun Melsungen AG 
Melsungen, Germany 
Tips (0.5 mL – 25 mL) Combitips advanced® Eppendorf 
Hamburg, Germany 
Tips (10 µL - 1000 µL) Safe Seal-Tips ®professional Biozym Scientific GmbH 
Hessisch Oldendorf, Germany 
Tips (10 µL - 1000 µL)  Gilson 
Middelton, USA 
Tips (10 µL - 1000 µL) Diamond ® Gilson 
Middelton, USA 
Tips (10 µL - 1000 µL) TOWERPACK™ Gilson 
Middelton, USA 
Tips (5 mL - 50 mL) Tips for PIPETMAN® Gilson 
Middelton, USA 
Tubes  Eppendorf 
Hamburg, Germany 
Tubes (0.5 - 2.0 mL) Safelock Tubes Eppendorf 
Hamburg, Germany 
Tubes (1.8 mL) CryoPure Tubes SARSTEDT AG & Co. 
Nümbrecht, Germany 
Tubes (2 mL) Phaselock Gel 5Prime GmbH 
Hilden, Germany 
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Ultra- low attachment Cluster plate 
(6-well, 10 cm-dish) 
Costar® Corning lnc. Amsterdam, Netherlands 




Table 2.3: List of chemicals 
Chemical Name Company 
2-Mercaptoethanol  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
4.6-Diamin-2-Phenylindol (DAPI)  ATT Bioquest 
Sunnyvale, USA 
AB-Serum  Sigma-Aldrich 
St. Louis, USA 
ACES  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 





St. Louis, USA 
Acid phenol chloroform  Ambion by life technologies 
Carlsbad, USA 
Acrylamide Acrylamide (Rotiphoresis Gel 30, 
37.5:1) 
Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Agar Agar (Kobe I)  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Agarose Biozym LE Agarose Biozym Scientific GmbH 
Hessisch Oldendorf, 
Germany 
Ammonium bicarbonate  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 





St. Louis, USA 
Ampicilin Sodium Salt  Sigma-Aldrich 
St. Louis, USA 
Aqua-PCI Roti® Aqua-
Phenol/Chloroform/Isoamyl alcohol 
Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Bradford Assay  BioRad Laboratories  
Hercules, USA 
BSA Albumin Fraktion V Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Calcium chloride  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Charcoal activated  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Chloramphenicol  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Chloroform Trichloromethane Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 




Coomassie Brilliant Blue  Merck Millipore TM 
Billerica, USA 
CutSmart® Buffer  New England Biolabs 
Ipswich, USA 
DL-Dithiothreitol  Fermentas,  
Thermo Fisher Scientific 




DMSO Dimethyl sulfoxide Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
ECL Reagent ECL Prime Western Blotting 
Detection Reagent 
GE Healthcare Life Science 
Hyclone laboratories 
Logan, USA  
EDTA  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Ethanol Ethanol absolute Sigma-Aldrich 
St. Louis, USA 
Ethidium bromide  Invitrogen Thermo Fisher 
scientific 
Carlsbad, USA 
Ethylene Diamine Tetra-Acetic Acid 
(EDTA) 
 Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Fetal Calf Serum (FCS) FBS Superior Biochrom GmbH 
Berlin, Germany 
Ficoll  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
GelRed nucleic acid stain GelRed™ Biotium 
Scarborough, Canada 
Gentamicin  gibco™ life technologies 
Thermo Fisher Scientific 
Carlsbad, USA 
Glutamaxx  gibco™ life technologies 
Thermo Fisher Scientific 
Carlsbad, USA 
Glycerol  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 





Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
HPLC-grade water  J. T. Baker,  
Center Valley, PA, USA 
Human Serum off-the-clot, Type AB  Lonza GmbH 
Basel, Switzerland 
Iodoacetamide   Sigma-Aldrich 
St. Louis, USA 
Iron (III) nitrate nonahydrate  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Isopropanol  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Kanamycin sulphate  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Labeled Arginine 13C arginine Sigma-Aldrich 
St. Louis, USA 
Labeled lysine 13C lysine Sigma-Aldrich 
St. Louis, USA 
LB Agar LB Agar (Lennox) Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
LB Broth LB Broth (Lennox) Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
L-Cysteine  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Lipofectamine 2000  Invitrogen Thermo Fisher 
scientific 
Carlsbad, USA 
Liquid Nitrogen  Linde 
Düsseldorf, Germany 
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Loading Dye 6x Mass Ruler Thermo Fisher scientific 
Schwerte,Germany 
Methanol  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Mowiol 4-88  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Nonidet P40 Nonidet P40 BioChemica (Substitute) AppliChem 
Darmstadt, Germany 
NuPAGE™ LDS Sample Buffer (4X) Sample Buffer Novex Life Technologies  
Darmstadt, Germany 
NuPAGE™ Sample Reducing Agent 
(10X) 
Reducing agent Novex Life Technologies  
Darmstadt, Germany 
NuPAGE™ Transfer Buffer (20X) Transfer Buffer Novex Life Technologies  
Darmstadt, Germany 
Paraformaldehyde  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
PBS (1x) Phosphate Buffered Saline (1x) Healthcare Life Science 
Logan, USA 
Pen/Strep Penicillin/Streptomycin Biochrom GmbH 
Berlin, Germany 
phosphoric acid  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Potassium chloride  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Powdered milk  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 






  Invitrogen  
Thermo Fisher scientific 
Carlsbad, USA 
SOB Broth  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Sodium Acetate  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Sodium Azide  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Sodium Chloride  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Sodium Dodecyl Sulfate Pellets SDS Pellets Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 




 Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Thiourea  Sigma-Aldrich 
St. Louis, USA 
Tri (hydroxymethyl) aminomethane 
(TRIS) 
 Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
TRIS hydrochloride  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Triton X100  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Trizol TRI Reagent® Sigma-Aldrich 
St. Louis, USA 
TWEEN 20  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
Ultra Pure water  Biochrom GmbH 
Berlin, Germany 
Urea Urea, Bioscience Grade Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
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Yeast extract  Carl Roth GmbH & Co. KG 
Karlsruhe, Germany 
 Enzymes 2.1.4
Table 2.4: List of enzymes 
Enzyme Company 
NotI 
New England Biolabs 
Ipswich, USA 
RNasin® Ribonuclease Inhibitor 
Promega 
Mannheim, Germany 
T4 DNA Ligase 
New England Biolabs 
Ipswich, USA 
T4 RNA Ligase, truncated 
Epicentre 
Madison, USA 
Trypsin Gold, Mass Spectrometry Grade 
Promega 
Madison, USA 
Trypsin-EDTA 0.05% (1x) 
gibco™ life technologies 
Thermo Fisher Scientific Carlsbad, USA 
XhoI 
New England Biolabs 
Ipswich, USA 
 
 Stimulants and cytokines 2.1.5
Table 2.5: List of stimulants and cytokines 
Name  Company 
Flagellin Fla-ST (100µg) 
Invitrogen Thermo Fisher scientific 
Carlsbad, USA 




IL-1β (human) Interleukin 1 beta 
Sigma-Aldrich 
St. Louis, USA 
LPS Lipopolysaccharide 
Sigma-Aldrich 
St. Louis, USA 
Pam3CSK4  






St. Louis, USA 
 
 Kits 2.1.6
Table 2.6: List of Kits 
Kits Name Company 
Accuracy & fluorescence detection Kit Guava easy Check Kit 
Millipore 
Darmstadt, Germany 
Cloning Kit StrataClone Blunt PCR 
Cloning Kit 
Agilent Technologies 
Santa Clara, USA 




DNA Polymerase Kit  Taqman Polymerase 
Thermo Fisher Scientific 
Schwerte, Germany 
DNA, RNA and protein purification Nucleo Spin® Gel and PCR 
clean up 
Macherey-Nagel GmbH & Co. KG 
Düren, Germany 
DNase digestion Promega™ RQ1 RNase-Free 
Promega 
Mannheim, Germany 




ELISA Kit for human Interleukin 8 DuoSet®ELISA Kit for human 
Interleukin 8 
R&D Systems Inc.  
Minneapolis, USA 
Luciferase Assay Kit DualGlo® Luciferase Assay 
System Kit Promega 
Promega 
Mannheim, Germany 
MicroRNA Reverse Transcription Kit TaqMan® MicroRNA Reverse 
Transcription Kit 
Thermo Fisher Scientific 
Schwerte, Germany 
miRNA library preparation Kit TruSeq Small RNA Library 
Preparation Kits - Set A 
Illumina Inc. 
San Diego, USA 
Multiplex Assay Kit Milliplex High sensitivity 
human cytokine Kit 
Merck Millipore TM 
Billerica, USA 
Phusion DNA Polymerase Phusion® High-Fidelity DNA 
Polymerase  
New England Biolabs 
Ipswich, USA 
Plasmid Midi Kit  
 
Nucleobond®  Xtra Midi Plus 
EF 
Macherey-Nagel GmbH & Co. KG 
Düren, Germany 
Plasmid Mini Kit  Nucleo Spin® Plasmid Quick 
Pure 
Macherey-Nagel GmbH & Co. KG 
Düren, Germany 
Protein Detection Kit Pierce BCA Protein Assay Kit 
Thermo Fisher Scientific 
Schwerte, Germany 
qPCR Master Mix Fast SYBR® Green Master Mix 
Thermo Fisher Scientific 
Schwerte, Germany 
qPCR Master Mix TaqMan® Fast Advanced 
Master Mix 
Thermo Fisher Scientific 
Schwerte, Germany 
Reverse Transcription Kit High Capacity cDNA Reverse 
Transcription Kit 
Thermo Fisher Scientific 
Schwerte, Germany 
RNA isolation mirvana™ miRNA Isolation Kit 




Table 2.7: List of primary antibodies 
Specificity Source class Conjugate Company Ordering number Application 
Actin goat IgG - Santa Cruz 
Biotechnology, Inc. 
Santa Cruz, USA 
sc-1616 Western Blot 







IgG rabbit IgG - Santa Cruz 
Biotechnology, Inc. 
Santa Cruz, USA 
sc-66931 Immunofluorescence, 
cytometric analysis 






TP53 mouse IgG2a - Abcam plc 
Cambridge, United 
Kingdom 
ab1101 Western Blot 
Tubulin mouse IgG2a - Santa Cruz 
Biotechnology, Inc. 
Santa Cruz, USA 
sc-5286 Western Blot 
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Table 2.8: List of secondary antibodies 

























Anti-goat donkey IgG HRP Santa Cruz 
Biotechnology, Inc. 
Santa Cruz, USA 
sc-2020 Western Blot 
Anti-
mouse 
goat IgG HRP Santa Cruz 
Biotechnology, Inc. 
Santa Cruz, USA 
sc-2005 Western Blot 
Anti-rabbit mouse IgG HRP Cell Signaling 
Technology 
Leiden, Netherlands 
5127S Western Blot 
 
 Oligonucleotides 2.1.8
Table 2.9: Custom oligonucleotides for mRNA target detection 
gene List name Custom oligonucleotides for mRNA target detection application 
hATG5 OBS-1406 Fwd: CAACTTGTTTCACGCTATATCAGG qPCR 
OBS-1407 Rev: CACTTTGTCAGTTACCAACGTCA qPCR 
hBCL10 OBS-530 Fwd: GTGAAGAAGGACGCCTTAGAAA qPCR 
OBS-531 Rev: TCAACAAGGGTGTCCAGACCT qPCR 
hCXCL8 OBS-0017 Fwd: ACTGAGAGTGATTGAGAGTGGAC qPCR 
OBS-0018 Rev: AACCCTCTGCACCCAGTTTTC qPCR 
hCYR61 OBS-1402 Fwd: GGCTCCCTGTTTTTGGAATGG qPCR 
OBS-1403 Rev: TTTGAGCACTGGGACCATGA qPCR 
hDDX58 OBS-1542 Fwd: ATCCCAGTGTATGAACAGCAG qPCR 
OBS-1543 Rev: GCCTGTAACTCTATACCCATGTC qPCR 
hHSPA1A OBS-1394 Fwd: TAACCCCATCATCAGCGGAC qPCR 
OBS-1395 Rev: AACAGCAATCTTGGAAAGGCCC qPCR 
hIL1β OBS-0134 Fwd: AGC TCG CCA GTG AAA TGA TGG qPCR 
OBS-0135 Rev: CAG GTC CTG GAA GGA GCA CTT C qPCR 
hIRS1 OBS-1282 Fwd: CAGCTCACCTTCTGTCAGG qPCR 
OBS-1283 Rev: AGGTCCATCTTCATGTACTCC qPCR 
hJUN OBS-1414 Fwd: GAGCTGGAGCGCCTGATAAT qPCR 
OBS-1415 Rev: CCCTCCTGCTCATCTGTCAC qPCR 
hLGALS8 OBS-1382 Fwd: TTGAGATCGTGATTATGGTGCT qPCR 
OBS-1383 Rev: ATCCTGTGGCCATAGAGCAG qPCR 
hMX1 
 
OBS-731 Fwd: AAGAGCTCCGTGTTGGAGG qPCR 
OBS-732 Rev: TGGTAACTGACCTTGCCTCTC qPCR 





OBS-1366 Fwd: GGGCTTTGGAATTCTGTGGC qPCR 
OBS-1367 Rev: CCTTGGAATGGTGGCTGGAT qPCR 
hRND3 
 
OBS-1430 Fwd: GAAACAAAGCAGTCGGCTCG qPCR 
OBS-1431 Rev: ATTTTCTCTCTGAAACGCGGC qPCR 
hRPS18 
 
OBS-0107 Fwd: GCGGCGGAAAATAGCCTTTG qPCR 
OBS-0108 Rev: GATCACACGTTCCACCTCATC qPCR 
hSOD1 
 
OBS-1432 Fwd: CACTGGTGGTCCATGAAAAAGC qPCR 
OBS-1433 Rev: ACACCACAAGCCAAACGACT qPCR 
hSOD2 
 
OBS-275 Fwd: ATGTTGAGCCGGGCAGTGTG qPCR 
OBS-276 Rev: GCGCGTTGATGTGAGGTTCC qPCR 
hTP53 
 
OBS-1500 Fwd: GGGCTTCTTGCATTCTGG qPCR 
OBS-1501 Rev: CCTCCGTCATGTGCTGTG qPCR 
hZFAND2A 
 
OBS-1400 Fwd: CTACGGAGGAGGACACCTGA qPCR 
OBS-1401 Rev: TTAAGTGTCACCTGGCTCTCG qPCR 
LINC00278 
 
OBS-873 Fwd: AGCCAGGAGTGAAGACGACAG qPCR 
OBS-874 Rev: AGGTCCTGTAGCACACTGTTCC qPCR 
LINC00346 
 
OBS-875 Fwd: TCATGGAGTGAGTGCGGAAGAC qPCR 
OBS-876 Rev: TGGATCTGATGACACTGCAGC qPCR 
 
Table 2.10: Cloning primers for insert amplification and restriction site integration. Restriction sites for 
NotI and XhoI are underlined 
name List name Custom oligonucleotides for 3’UTR amplification application 
DDX58_fwd3’UTR _3XhoI OBS-1791 GTTTCTCGAGtatcaggtcctcaatcttcagc cloning 3´UTR 
DDX58_rev_short_NotI OBS-1793 GTTTGCGGCCGCgctgaccactgtagagtggatac cloning 3´UTR 
TP53_fwd_short_XhoI OBS-1789 GTTTCTCGAGgatgatctggatccaccaagac cloning 3´UTR 
TP53_rev_NotI OBS-1790 GTTTGCGGCCGCcctcagacacacaggtggc cloning 3´UTR 
 
Table 2.11: Commercial Taqman Probes for miRNA detection 
Probe mature miRNA sequence (5´- 3´) Assay-ID Company 
hsa-miR-125a-3p ACAGGUGAGGUUCUUGGGAGCC 02199 Thermo Fisher Scientific 
Schwerte, Germany 
hsa-miR-125b-5p UCCCUGAGACCCUAACUUGUGA 00449 Thermo Fisher Scientific 
Schwerte, Germany 
hsa-miR-130b-5p ACUCUUUCCCUGUUGCACUAC 02114 Thermo Fisher Scientific 
Schwerte, Germany 
hsa-miR-146a-5p UGAGAACUGAAUUCCAUGGGUU 00468 Thermo Fisher Scientific 
Schwerte, Germany 
hsa-miR-155-5p UUAAUGCUAAUCGUGAUAGGGGU 002623 Thermo Fisher Scientific 
Schwerte, Germany 
hsa-miR-221-3p AGCUACAUUGUCUGCUGGGUUUC 000524 Thermo Fisher Scientific 
Schwerte, Germany 
hsa-miR-222-3p  AGCUACAUCUGGCUACUGGGU 002276 Thermo Fisher Scientific 
Schwerte, Germany 
hsa-miR-26a-2-3p CCUAUUCUUGAUUACUUGUUUC 002115 Thermo Fisher Scientific 
Schwerte, Germany 
hsa-miR-27a-5p AGGGCUUAGCUGCUUGUGAGCA 002445 Thermo Fisher Scientific 
Schwerte, Germany 
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hsa-miR-29b-1-5p GCUGGUUUCAUAUGGUGGUUUAGA 002165 Thermo Fisher Scientific 
Schwerte, Germany 




001006 Thermo Fisher Scientific 
Schwerte, Germany 
 
Table 2.12: Commercial oligonucleotides for detection of primary miRNAs (pri-miRNAs) 
name Assay-ID Company 
hsa-miR-125b Hs03303224_pri Thermo Fisher Scientific Schwerte, Germany 
hsa-miR-146a Hs03303259_pri Thermo Fisher Scientific Schwerte, Germany 
hsa-miR-155 Hs03303349_pri Thermo Fisher Scientific Schwerte, Germany 
hsa-mir-16-2 Hs03303046_pri Thermo Fisher Scientific Schwerte, Germany 
hsa-miR-221 Hs03303007_pri Thermo Fisher Scientific Schwerte, Germany 
hsa-miR-579 Hs03304404_pri Thermo Fisher Scientific Schwerte, Germany 
 
 siRNA pools 2.1.9
Table 2.13. List of siRNA pools 
name ordering 
number 
Ensembl identifiers company 
Silencer™ Select Negative Control No. 1 
siRNA 
4390843 ´- Thermo Fisher Scientific  
Schwerte, Germany 
SMARTpool: ON-TARGETplus DDX58 siRNA L-012511-
00-0005 
ENSG00000107201  GE Healthcare Europe GmbH  
Freiburg, Germany 
SMARTpool: ON-TARGETplus LGALS8 siRNA L-010607-
00-0005 
ENSG00000116977  GE Healthcare Europe GmbH  
Freiburg, Germany 
SMARTpool: ON-TARGETplus MX1 siRNA L-011735-
00-0005 
ENSG00000157601  GE Healthcare Europe GmbH  
Freiburg, Germany 
SMARTpool: ON-TARGETplus RPL13A siRNA L-013601-
00-0005 
ENSG00000142541  GE Healthcare Europe GmbH  
Freiburg, Germany 
SMARTpool: ON-TARGETplus TP53 siRNA L-003329-
00-0005 
ENSG00000141510  GE Healthcare Europe GmbH  
Freiburg, Germany 
 
 Synthetic miRNAs 2.1.10
Table 2.14: List of miRNA mimics 
name Assay-ID company 
mirVana® miRNA mimic miR-125b-5p MC10148 Thermo Fisher Scientific  
Schwerte, Germany 
mirVana® miRNA mimic miR-221-3p MC10337 Thermo Fisher Scientific  
Schwerte, Germany 
mirVana® miRNA mimic miR-579 MC12340 Thermo Fisher Scientific  
Schwerte, Germany 
mirVana™ miRNA Mimic, Negative Control #1 4464058 Thermo Fisher Scientific  
Schwerte, Germany 
 
Table 2.15: List of miRNA inhibitors 
name Assay-ID company 
mirVana® miRNA inhibitor miR-125b-5p MH10148 Thermo Fisher Scientific Schwerte, Germany 
mirVana® miRNA inhibitor miR-221-3p MH10337 Thermo Fisher Scientific Schwerte, Germany 
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mirVana® miRNA inhibitor miR-579-3p MH12340 Thermo Fisher Scientific Schwerte, Germany 
mirVana™ miRNA Inhibitor, Negative Control #1 4464076 Thermo Fisher Scientific Schwerte, Germany 
 
 Plasmids 2.1.11
Table 2.16: List of plasmids 
Vector company 
pSC-A-amp/kan Agilent Technologies 
Santa Clara, USA 
psiCHECK2 Vector  Promega 
Mannheim, Germany 
pUCIDT Integrated DNA Technologies, Inc. 
Skokie, USA 
 
 Media and buffers 2.1.12
Table 2.17: List of media and buffers 
Medium Name Company 
DMEM Dulbecco’s Modified Eagle 
Medium 
gibco™ life technologies 
Thermo Fisher Scientific Carlsbad, 
USA 
OptiMEM Opti-MEM® (1x) Reduced 
Serum Medium 
gibco™ life technologies 
Thermo Fisher Scientific Carlsbad, 
USA 
PBS Phosphate Buffered Saline 
(1x) 
GE Healthcare Life Science Hyclone laboratories 
Logan, USA 
RPMI RPMI Medium 1640 (1x) gibco™ life technologies Thermo Fisher Scientific 
Carlsbad, USA 
RPMI + supplements RPMI Medium 1640 (1x) 
[+] 4.5 g/L D-Glucose 
[+] 2.383 g/L HEPES Buffer 
[+] L-Glutamine 
[+] 1.5 g/L Sodium Bicarbonate 
[+] 110 mg/L Sodium Pyruvate 
gibco™ life technologies Thermo Fisher Scientific 
Carlsbad, USA 
SILAC DMEM  Dulbecco’s Modified Eagle 
Medium 
Thermo Fisher scientific 
Schwerte, Germany 
 
 Cell lines 2.1.13
Table 2.18: List of cell lines 
Cultivated cells origin cultivation 
Blood-derived 
macrophages 
Isolated from Buffy-coats 1% Glutamaxx 
HEK293 ATCC 10% FCS 
In DMEM 
THP-1 cells ATCC 10% FCS 
in RPMI 1640 + supplements 
 
 Bacteria 2.1.14
Table 2.19: List of bacterial strains 
Bacterial strain source 
Legionella pneumophila (Corby) gfp (#69) provided by the Robert Koch Institut (Berlin, Germany) 
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Legionella pneumophila (Corby) wt (#20) provided by the Robert Koch Institut (Berlin, Germany) 
Supercompetent E. Coli DH5a New England Biolabs (Ipswich, USA) 
 
 Prepared buffers and solutions 2.1.15
Table 2.20: List of prepared buffers and solutions 
name composition 
BCYE agar 10 g ACES 
10 g Yeast extract 
2.5 g Charcoal (activated) 
15 g Agar 
ad 1 L in H2O to pH 6.9 
after autoclavation: 
0.4 g L-cysteine 
0.25 g ferric nitrate 
Buffer A 2% (v/v) acetonitrile 
0.1% (v/v) acetic acid 
in HPLC-grade H2O 
ELISA coating buffer 7.13 g Natriumhydrogencarbonat 
1.59 g Natriumcarbonat 
ad 1 L H2O 
to pH 9.5 with 10 N NaOH 
ELISA dilution buffer 10% v/v FCS 
in 1x PBS 
ELISA wash buffer 0.05% v/v Tween  
in 1x PBS 
FACS blocking buffer 10% v/v FCS 
0.5% v/v Tween 
in PBS 
FACS Fixation buffer 4% v/v PFA 
in PBS 
FACS Permeabilisation buffer 0.5% v/v Tween 
in PBS 
FACS Wash Buffer 5% v/v FCS 
in PBS 
Laemmli Buffer 13.15 % v/v Stacking Buffer 
21.05 % v/v 10 % SDS 
10.5 % v/v Glycerol 
5.75 % v/v 1 % Bromphenol Blue 
LB Agar 3.5 % w/v LB Agar 
in H2O 
LB Medium 2 % w/v LB Broth 
in H2O. 
Lysis Buffer 0.6 M Tris-HCl pH 6,8 
25X Proteaseinhibitor Cocktail 
20% v/v NP40 
Ad 1 mL in Phosphoprotein Wash Buffer 
MACS Buffer 0.5% v/v FCS 
0.2 mM EDTA 
in PBS 
Phosphoprotein Wash Buffer 2.5 mM Na3VO4  
125 mM NaF 
18.75 mM Na4P2O7 
in PBS 
RIPA Buffer 10 mM Tris, pH 7.5 
150 mM NaCl 
1% v/v NP-40 
1% v/v Desoxycholat 
1 mM EDTA 
SOB medium 30.7 g SOB 
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ad 1 mL in H2O 
TAE buffer (50X) 242 g Tris-Base 
57.1 mL Ethanoic acid 
100 mL EDTA (0.5 M) 
ad 1 L in H2O 
TBS buffer (10x) 10 mM Tris 
0.9% (w/v)  
90 g NaCl  
ad 1 L H2O 
to pH 7.4 with 37% (v/v) HCl 
TBST-T 100 mL 10X TBS buffer 
0.1% (v/v) Tween-20 
ad 1 L in H2O 
UT-Buffer 8 M Urea 
2 M Thiourea 
in H2O 
Western Blot Blocking Solution 10% (w/v) milk 
5% (w/v) BSA 
in 1X TBS-T 
Western Blot Resolving Gel 10 % 4.94 mL ddH2O  
7.56 mL Tris-HCl pH 8.8  
6.68 mL Acrylamide/Bisacrylamide  
500 µL 10% (v/v) Glycerol  
200 µL 10% (w/v) SDS  
100 µL 10% (w/v) APS  
20 µL TEMED  
Western Blot Running Buffer for SDS-PAGE (10X)  250 mM Tris 
1.92 M Glycin 
in H2O 
Western Blot Running Buffer for SDS-PAGE (1X) 100 mL Western Blot Running Buffer for SDS-PAGE 
0.1% SDS 
ad 1 L H2O 
Western Blot Stacking Gel 5 % 5.68 mL ddH2O 
2.5 mL Tris-HCl pH 6,8  
1.66 mL Acrylamid/Bisacrylamid  
100 µL 10% (w/v) SDS 
50 µL 10% (w/v) APS 
10 µL TEMED 
Western Blot Wet Blot Buffer (10X) pH 8.3 250 mM Tris 
1.92 M Glycin 
ad 1 L H2O 
to pH 7.4 with 37% (v/v) HCl 
Western Blot Wet blot running buffer (1X) 200 mL 10X Wet-Blot Puffer  
20% (v/v) Methanol 
0.1% (w/v) SDS 
ad 2 L H2O 
 
 Computational resources 2.1.16
Table 2.21: List of computational resources 
Software Version 
Adobe Photoshop CS 5.1 
Agilent 2100 Expert Software B.02.08.SI648 (SR1) 
Clonemanager 9 
FlowJo v. 7.6.5 2.0 
GENtle  
GraphPad Prism 6 




LabImage 1D  
Microsoft Office 2010  
NEB Cutter  
Quant Studio design and analysis  
ViiA7 RUO 1.2 
Windows 7 Professional 
 
 List of websites 2.1.17










 Cell culture 2.2.1
2.2.1.1 Preparation and cultivation of primary human monocytes 
Monocytes were isolated from donor buffy coats provided by the Centre for Transfusion 
Medicine and Haemotherapy in Giessen, Germany. All donors gave informed written consent 
for use of their blood samples for scientific purposes. The blood sample was carefully stacked 
onto a cushion of Ficoll solution. The two layers were centrifuged for 25 minutes at 800 x g 
with minimal acceleration and deceleration. The centrifugation yielded a distinct leukocyte 
layer. Leukocytes were aspirated, resuspended in ambient temperature PBS and washed twice. 
The pellet was taken up in MACS Buffer. An appropriate amount of cells was incubated with 
anti-CD14 magnetic microbeads for 20 minutes at 4°C. Labeled cells were magnetically 
retained in a MACS LS column and eluted after depletion of unlabeled leukocytes. Over 90% of 
the prepared cells were CD14-positive as tested by FACS analysis. After counting, 8 - 12 x 106 
cells were seeded in ultra-low attachment 10cm-plates. Cells were left to adhere for two hours 
in RPMI medium without supplements. Afterwards, adhesion of cells was validated by 
microscopy, and 1% (v/v) of human AB serum was added. Monocytes were cultivated for 6 
days at 37°C and 5% CO2 without media replacement. Maturation to macrophages was 
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confirmed by microscopy. For subsequent experiments, macrophages were replated (section 
2.2.1.2) for transfections (section 2.2.1.7.1) or infections with Legionella pneumophila (section 
2.2.1.5.2).  
 
2.2.1.2 Replate of primary human monocytes 
After 6 days of cultivation, cells were detached and seeded in cell culture plates to obtain the 
accurate cell number for experimentation. Therefore, cells were incubated with warm PBS for 
10 minutes and detached from the low attachment plate by careful rinsing. Macrophages were 
centrifuged for 10 minutes at RT with 250 x g and the cell pellet was dissolved in RPMI medium 
without supplements to obtain the desired cell concentration. Finally, cells were seeded for 
infection with L.p. or used for transfection experiments with siRNA. 
 
2.2.1.3 THP-1 cell culture and PMA  
THP-1 cells are immortalized isolates of a one year old infant male with leukemia and used as a 
model for human monocytes (Tsuchiya, Yamabe et al. 1980). The cell line was purchased from 
the American Type Culture Collection (ATCC). The human monocytic suspension cell line was 
cultured in RPMI medium + 10% (v/v) fetal calf serum (FCS) in T75 tissue culture flasks at a 
density of 2 – 10 x 106 cells/mL. Cells were split regularly to maintain the appropriate density. 
Cells were discarded upon exceeding the 16th passage, and the culture was re-launched from 
a frozen stock aliquot. THP-1 cells were passaged and frozen as suggested by ATCC (ATCC®TIB-
202TM). To obtain adherent macrophage-like cells, THP-1 monocytes were stimulated with 
20 nM Phorbol-12-myristat-13-acetat (PMA) for 24 h. Upon differentiation to macrophages, 
morphology changes and PMA induced a growth arrest via upregulation of cyclin-dependent 
kinase inhibitor 1 (p21) (Traore, Trush et al. 2005). Subsequently, media was renewed and 
differentiated THP-1 cells were used for further experiments. 
 
2.2.1.4 HEK-293T cell culture 
Human embryonic kidney cells 293T (HEK-293T) display an adherent epithelial morphology. 
The cell line was cultured in DMEM + 10% (v/v) FCS in T75 tissue culture flasks at 37°C and 5% 
CO2 and split regularly to maintain 70 - 90% confluency. Cells were discarded upon exceeding 
the 22nd passage, and the culture was re-launched from a frozen stock aliquot. Cells were 
detached by swilling with media and then diluted for further cultivation. The HEK-293T cells 
were only used for the luciferase-based reporter assay (section 2.2.4.9). 
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2.2.1.5 Determination of macrophage bactericidal capacity 
2.2.1.5.1 Preparing infection cultures for Legionella pneumophila 
Infection experiments were performed with the Corby strain of Legionella pneumophila (L.p.). 
The wildtype strain (#20) or the GFP-expressing strain (#69) of L.p. (Table 2.19) was used. 
Bacteria from frozen glycerol stock were streaked on a BCYE agar plate and incubated for 2 
days at 37°C with 5% CO2. This culture was stored at 4°C and used for up to one week. For 
infection, bacteria were taken from this stored culture with a sterile cotton swab and streaked 
on a new BCYE agar plate. This plate was incubated for 3 days at 37°C with 5% CO2 and was 
used on day 3 to prepare the infection solution. The selection of the kanamycin-resistent gfp-
expressing strain (#69) was achieved by the cultivation on BCYE agar plates containing 
20 µg/mL kanamycin. 
2.2.1.5.2 Infection of macrophages with Legionella pneumophila  
Only differentiated macrophages were infected with Legionella pneumophila. Bacteria were 
scraped from the prepared infection culture and resuspended in PBS to an OD600 of 1 which 
equals 2 x 109 bacteria or colony forming units (CFUs) per mL. Serial dilutions were performed 
in PBS (infection solution). The ratio of bacteria to cells is defined as the multiplicity of 
infection (MOI). In order to achieve the desired multiplicity of infection (MOI), the required 
volume of infection solution was diluted in medium (RPMI + 10% (v/v) FCS) and carefully added 
to the macrophages. The MOI and infection time was set as indicated in the respective 
experiments. 
For determination of the precise MOI, 50 µL of the dilutions from the infection solution were 
streaked on BCYE agar plates and incubated for 3 days at 37°C. After incubation, colony 
forming units (CFUs) were counted and the precise MOI was calculated (CFU/mL= counted 
colonies x dilution factor). 
2.2.1.5.3 Colony forming unit (CFU) assay 
In order to assess replication of L.p. in human macrophages, CFU assays were performed. The 
assays were always performed in transfected and differentiated BDMs or THP-1 cells, as 
described in section 2.2.1.7. To obtain reliable results for one independent experiment, 
technical triplicates of each treatment and time points were performed. 24, 48 and 72 h post 
infection with L.p., macrophages were lysed by addition of saponin (1% final concentration) 
and incubated for 10 minutes at 37°C. Cell lysis was confirmed by microscopy. Lysates were 
transferred into a new tube and serially diluted in a range from 1:10 to 1:1,000,000 in PBS. 
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Dilutions were streaked on BCYE agar plates and incubated for three days at 37°C and 5% CO2. 
Individual colonies were counted and total bacterial load was calculated.  
2.2.1.5.4 Determination of infection efficiency by flow cytometry 
In order to identify infection efficiencies of THP-1 cells with Legionella pneumophila, flow 
cytometry was used. PMA-differentiated THP-1 cells were infected with a GFP-expressing 
strain at MOI 10 according to section 2.2.1.5.2.  
After the indicated infection time, cells were washed once with PBS and incubated for 
4 minutes at 37°C with Trypsin/EDTA for detaching. Subsequently, cells were centrifuged for 8 
minutes at room temperature at 300 x g. The pellet was resuspended in PBS with 5% (v/v) FCS 
and measured on the Guava® easyCyte flow cytometer (Merck Millipore). The data were 
analysed using FlowJo v. 7.6.5.. 
 
2.2.1.6 Stimulation of human macrophages 
For the dual RNA-Seq approach (section 2.2.3), a synthetic control for TLR2-activating 
Legionella LPS was needed. Therefore, THP-1 cells were stimulated with the TLR2 agonist 
Pam3CSK4 (Pam3) for 8 and 16 h, respectively. Pam3 stimulation and infection with L.p. was 
performed simultaneously. The bacterial lipoprotein analog Pam3 was added at a final 
concentration of 100 ng/mL. 
 
2.2.1.7 Transfection of human macrophages 
2.2.1.7.1 Transfection of BDMs with siRNAs 
Blood-derived macrophages were transfected with an siRNA-pool against specific targets 
(Dharmacon). Transfection was achieved by cultivating cells in medium containing 
Lipofectamine 2000 and Optimem in a 1:50 ratio plus the respective siRNA-pool at a final 
concentration depending on the specific siRNA (table 2.23). 4 x 105 cells were transfected in a 
volume of 1 mL (100 µL mixed transfection solution + 900 µL cell suspension). Cells were 
centrifuged for 2 h at 37°C for 2,000 rpm to achieve maximal transfection efficiency. After 
centrifugation, 1% (v/v) human AB-Serum was added to the cells. After 24 h of incubation, 
medium was renewed and cells were used for further experiments (e.g. infections with L.p. 
section 2.2.1.5.2). Knockdown of mRNA mediated by siRNA was validated by qPCR (section 
2.2.2.5.1) or Western Blot (section 2.2.5.2). 
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2.2.1.7.2 Transfection of THP-1 cells with siRNAs 
Monocytic THP-1 cells (not differentiated) were transfected with an siRNA-pool against specific 
mRNAs (Dharmacon). Transfection was achieved by cultivating the cells in medium containing 
Lipofectamine 2000 and Optimem in a 1.5:100 ratio plus the respective siRNA-pool in a final 
concentration depending on the specific siRNA (table 2.23). 5 x 105 cells were transfected in a 
volume of 1 mL (100 µL mixed transfection solution + 900 µL cell suspension). After 24 h, 
THP-1 cells were stimulated with 20 nM PMA, as previously described (section 2.2.1.3) and 
incubated for an additional 24 h. Thereafter, medium was renewed and cells were used for 
further experiments. Knockdown of mRNA mediated by the siRNA-pool was validated via qPCR 
(section 2.2.2.5.1) or Western Blot (section 2.2.5.2). 
 
Table 2.23: Transfected amount of siRNA 
siRNA targets amount of siRNA 
DDX58 20 nM 
LGALS8 30 nM 
MX1 50 nM 
TP53 30 nM 
 
2.2.1.7.3 Transfection of macrophages with synthetic miRNAs 
Undifferentiated, monocytic THP-1 cells were transfected with double-stranded miRNA 
precursors. Transfection was achieved by cultivating the cells in medium containing siPort 
NeoFX and Optimem in 3:100 ratio plus the respective miRNA precursors in a final 
concentration of 30 nM. 1 x 105 cells were transfected in a volume of 1 mL (100 µL mixed 
transfection solution + 900 µL cell suspension). After 24 h, THP-1 cells were stimulated with 
20 nM PMA, as previously described (section 2.2.1.3) and incubated for an additional 24 h. 
Thereafter, medium was renewed and cells were used for further experiments. Overexpression 
of the given miRNA was verified by qPCR (section 2.2.2.5.3). 
 
 Investigation of the global macrophage RNA profile upon infection 2.2.2
2.2.2.1 RNA Isolation 
In order to estimate changes on the transcriptional level upon infection, RNA expression was 
analyzed. To this end, cell culture medium was removed. 500 µL TRIZOL® Reagent was added 
to the cells followed by an incubation for 5 min. The suspension was then transferred to an 
tube and 100 µL chloroform was added. The mixture was vigorously shaken for 1 minute. After 
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3 minutes of incubation, samples were centrifuged at 16,000 x g for 15 minutes at 4°C to 
separate into an aqueous and an organic layer. The aqueous phase, containing the RNA, was 
transferred into a new tube. RNA precipitation was achieved by the addition of 250 µL 
isopropanol to the aqueous phase. Additionally, 1 µL of GlycoBlue™ was added to conjugate 
and visualize precipitated RNA. Precipitation was performed either overnight at -20°C or for 30 
minutes at RT followed by a centrifugation step at 16,000 x g for 15 minutes at 4 °C. The 
supernatant was carefully removed and RNA pellets were washed twice with 500 µL of 75% 
(v/v) ethanol at 4°C for 5 minutes with 12,000 x g. The remaining pellet was air-dried and 
resuspended in 15 µL sterile nuclease free water. Potential RNA secondary structures were 
dissolved by incubating at 58°C for 5 minutes. RNA was stored at -20°C or kept on ice to 
prevent degradation. The concentration was determined by the Spectrophotometer Nanodrop 
(Thermo Fisher scientific) or Qubit Fluorometer (Thermo Fisher scientific) if higher sensitivity 
was required. 
 
2.2.2.2 DNase digestion of RNA 
In order to remove potential DNA contamination from the RNA preparation, DNase digestion 
was performed with DNase I from Roche according to manufacturer´s instructions. The 
following reaction mix was applied for 1 µg RNA. 
 
Table 2.24: Mastermix for DNase digestion of RNA 
component Final concentration 
Total RNA 1 µg 
10X incubation buffer 2 µL 
DNase I recombinant, RNase-free 1 Unit 
Ultrapure water Ad 20 µL 
 
The reaction mix was incubated at 37°C for 15 - 20 minutes. Thereafter, the volume was filled 
up to 200 µL and an equal volume aqua- Phenol, Chloroform und Isoamylalkohol (aqua-PCI) 
was added for RNA precipitation. The mixture was vigorously shaken and centrifuged at 
16,000 x g for 15 minutes at 4°C. The upper phase was transferred and precipitation with 
isopropanol was performed as described (section 2.2.2.1). 
 
2.2.2.3 Determination of RNA integrity by gel electrophoresis 
In order to test the quality of all RNA samples before sequencing, RNA integrity was verified on 
a Bioanalyzer 2100 (Agilent) according to the manufacturer´s protocol. The ratio of intact 18s 
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and 28s rRNA was used to calculate an RNA integrity number (RIN). The ration should be 2.1:1, 
deviations from that indicate RNA degradation. A RIN of 10 reflects perfect RNA quality, while 
a RIN of 5 means partial degradation. Based on this guideline, RINs > 8 were considered to 
indicate sufficient RNA quality and useful for further analysis. 
 
2.2.2.4 miRNA analysis by Illumina small RNA sequencing 
The miRNome of L.p.-infected BDMs was determined by Illumina TruSeq small RNA 
sequencing. BDMs of three different donors were infected with L.p. at an MOI of 0.25 for 24 
and 48 h or left untreated as control. RNA was isolated using TRIZOL® (section 2.2.2.1) and the 
quality was examined on a Bioanalyzer 2100 (Agilent). Samples with sufficient RNA quality 
were used for Illumina library preparation according to the manufacturer´s instructions.  
Briefly, 3’ and 5’ adapters were ligated to 1 µg total RNA with T4 RNA ligase (Epicentre). 
Following the reverse transcription of the RNA into cDNA, PCR amplification was performed. 
To distinguish the prepared samples, different index primers were added. Afterwards, samples 
with unique indices were pooled into two libraries and cDNA was loaded on a PAA-gel. The 
fraction with a size of 145 – 160 bp was cut from the gel to enrich for small RNAs. This fraction 
contained the cDNA transcribed from mature miRNAs generated from 22 nt RNA fragments. 
Following elution of the cDNA, the final libraries were concentrated by ethanol precipitation. 
Finally, prepared libraries were validated by a Bioanalyzer run and sent for sequencing.  
Sequencing was performed in the lab of Wei Chen in the Max Delbrück Center for Molecular 
Medicine (MDC) in Berlin. Sequencing was performed in a multiplexed run of 1x51 cycle +7 
(index) on an Illumina HiSeq2000 (Illumina). 
Bioinformatics analysis of the high-throughput data was carried out by Prof. Dr. Annalisa 
Marsico (Freie Universität Berlin, Germany).  
 
2.2.2.5 Quantitative real-time PCR analysis 
The quantitative real-time PCR (qPCR) is a laboratory method to monitor transcriptional 
expression changes. It is based on reverse transcription followed by a polymerase chain 
reaction (PCR). It is used to quantify the amplification of a targeted DNA molecule during the 
PCR in real-time (Weis, Tan et al. 1992). In this study, qPCR was used to determine expression 
changes of mRNAs, miRNAs and primary miRNAs (pri-miRNAs).  
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2.2.2.5.1 mRNA – reverse transcription and quantification 
Total RNA was transcribed into cDNA via the High Capacity reverse transcription kit (Thermo 
Fisher Scientific). According to the manufacturer's protocol, 200 – 2,000 ng RNA were used for 
the transcription via random hexamer primers. The reaction was set to a final volume of 20 µL 
with ultrapure water. 
 
Table 2.25: Mastermix for the reverse transcription of mRNAs 
Component Volume for 20 µL reaction 
10X RT buffer 2 µL 
10X Random Primers 0.8 µL 
100 mM dNTPs 2 µL 
50 U/µL multiscribe reverse transcriptase  1 µL 
RNA (250 – 2000 ng) X µL 
Ultrapure water Ad 20 µL 
 
The following thermal cycling program was applied: 
Table 2.26: mRNA reverse transcription thermo protocol 
Cycle step Temperature Time 
annealing 25°C 10 minutes 
elongation 37°C 2 hours 
deactivation 85°C 5 minutes 
hold 8°C ∞ 
 
The obtained cDNA was diluted to a final concentration of 5 ng/µL and subsequently 
quantified on a ViiA7 Real-Time PCR System (Thermo Fisher Scientific) using the SYBR Green 
detection method. This dye intercalates into double stranded DNA thereby allows detection of 
the amplified product. The following mastermix with specific primers (table 2.9) was used to 
detect expression changes of target genes.  
 
Table 2.27: Mastermix for mRNA quantification by quantitative real time PCR 
Component Volume for 20 µL reaction 
2X FAST SYBRR Green Master Mix 10 µL 
10 µM Primer forward 0.4 µL 
10 µM Primer reverse 0.4 µL 
cDNA (7.5 ng final) 1.5 µL 
Ultrapure water Ad 20 µL 
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The following program was used for cDNA amplification: 
Table 2.28: High capacity reverse transcription thermo protocol 
 Cycle step Temperature Time 
 denaturation 95°C 20 seconds 
 
40 cycles 
primer binding/elongation 60°C 20 seconds 
denaturation 95°C 15 seconds 
 cycling end 60°C 1 minute 
 melting curve 60 - 95°C 0.05 °C/s gradually 
  95°C 15 s 
 
The cycle threshold (Ct) was determined by the ViiA7 software (Thermo Fisher Scientific). The 
Ct value indicates the number of cycles at which the fluorescent signal is higher than the 
background. The higher the cDNA amount in the sample, the sooner the threshold cycle is 
reached, and the lower the Ct value. Ct values of the target genes were normalized to the 
constant Ct value of an endogenous reference gene yielding the ∆CT and used to determine 
differences in expression between samples. The ribosomal 18S-RNA (RPS18) represented the 
endogenous reference gene for mRNAs. Expression analysis was performed with the 2(-∆CT) 
method suggested by Livak et al. (Livak and Schmittgen 2001): 
∆Ct = Ct target gene - Ct reference gene 
ΔΔCt = ΔCt (treated/infected sample) - ΔCt (control/uninfected sample) 
- (ΔΔCt) = log2-fold change 
2(-ΔΔCt) = linear x-fold change 
The log2-fold change was used to display the qPCR results.  
 
2.2.2.5.2 miRNA – reverse transcription and quantification 
In order to detect miRNA expression changes, 350 – 1,000 ng of total RNA were transcribed 
into cDNA using the Taqman microRNA reverse transcription kit (Thermo Fisher Scientific). A 
multiplex reaction with specific RT-primer and the RT-primer for the endogenous control was 
applied to reverse transcribe several miRNAs in one reaction. Reverse transcription was 
performed according to manufacturer's protocol. 
 
Table 2.29: Mastermix for the reverse transcription of miRNAs 
Component Volume for 15 µL reaction 
10X RT buffer 1.5 µL 
RT primerpool (0.05X each) 6 µL 
100 mM dNTPs 0.3 µL 
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50 U/µL multiscribe reverse transcriptase  3 µL 
RNA (350 – 1000 ng) X µL 
Ultrapure water Ad 15 µL 
 
The following thermal cycling program was applied: 
Table 2.30: miRNA reverse transcription thermo protocol 
Cycle step Temperature Time 
annealing 16°C 30 minutes 
elongation 42°C 30 minutes 
deactivation 85°C 5 minutes 
hold 8°C ∞ 
 
The obtained cDNA was usually diluted at a final concentration of 6.66 ng/µL with one 
exception. For detection of the miR-125b, cDNA was applied undiluted for quantification on 
the ViiA7 Real-Time PCR System. The detection of the amplified product was performed by 
sequence-specific TaqMan probes. The resulting reactionmix with the addition of specific 
Taqman probes was used to detect expression changes. Reaction volume was set to 20 µL with 
ultrapure water.  
 
Table 2.31: Mastermix for miRNA quantification by quantitative real time PCR 
Component Volume for 20 µL reaction 
2X TaqMan® Fast Advanced Master Mix 10 µL 
TaqMan primer 1 µL 
cDNA (10 ng final) 1.5 µL 
Ultrapure water Ad 20 µL 
 
The same program for cDNA amplification was used as for the reverse transcribed mRNA (table 
2.28). The signal of each specific miRNA was normalized to the small nuclear noncoding RNA 
RNU48. Since it is constantly expressed in normal tissues and cell lines, it was used as an 
endogenous control (Gordanpour, Nam et al. 2012; Manikandan, Deva Magendhra Rao et al. 
2015; Crossland, Norden et al. 2016). The log2-fold change was calculated as previously 
described.  
2.2.2.5.3 pir-miRNA – reverse transcription and quantification 
For the detection of primary miRNAs (pri-miRNA), the TaqMan® Pri-miRNA Assay Kit was used. 
Reverse transcription was performed as previously described for mRNA transcription (section 
2.2.2.5.2). Since the primers of the TaqMan® Pri-miRNA Assay will detect genomic DNA, a 
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DNase digestion of the isolated RNA was performed before reverse transcription (described in 
section 2.2.2.2). 
For the quantification of cDNA the same reaction mix and thermoprofile as used for the 
detection of mRNA expression was applied (table 2.28).  
 
 Dual RNA-seq 2.2.3
Dual RNA-seq refers to the application of the high-throughput RNA sequencing technique to a 
dual system composed of host cells, here infected with Legionella, allowing the host and the 
pathogen transcriptome to be analysed in parallel at different time points during the course of 
infection. This technique was performed in accordance with the procedure established for 
Salmonella infection of human epithelial cells (Westermann, Forstner et al. 2016). The 
technique has been adapted and applied for the first time to Legionella infection of human 
macrophages. In the following, the steps of the procedure are described in detail. 
 
 
Figure 2.1: Simplified Scheme of the dual RNA-Seq approach. Macrophages (host cells) are infected 
with a GFP-expressing strain of Legionella pneumophila (pathogen) in vitro. After a certain infection 
time, Legionella-invaded cells (gfp+) are separated from non-infected bystander cells (gfp-) via FACS-
sorting. Afterwards, RNA is isolated and processed for sequencing. The separation of host and pathogen 
is taking place in silico via the mapping of the reads against the two different reference genomes. 
Finally, the expression profiles of both, host and pathogen are determined. 
 
2.2.3.1 Stimulation and Legionella-infection of THP-1 cells 
THP-1 cells were differentiated in with 20 nM PMA for 24 h (section 2.2.1.3). After medium 
change, cells were infected with a GFP-expressing strain of Legionella pneumophila at an MOI 
of 10 or stimulated with 100 ng/mL Pam3CSK4 for 8 and 16 h. After the addition of bacteria, 
cells were centrifuged for 10 minutes at 500 x g to synchronize the infection process. At the 
same time, control bacteria from the infection solution (L.p. T0) were centrifuged for 5 
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minutes at 4°C with 3,500 x g. Three tubes with 2 x 109 bacteria each were incubated in 1 mL 
RNAprotectTM solution for 30 minutes. After incubation, 400 µL PBS was added and centrifuged 
for 5 minutes at 4°C with 6,000 x g followed by two PBS washing steps. Afterwards, bacterial 
pellets were frozen in liquid nitrogen and stored at -80°C. 
At 2 h post infection, THP-1 cells were washed twice with PBS and medium containing 
25 µg/mL Gentamycin was added to selectively inactivate extracellular Legionella, thus 
synchronizing the infection and preventing reinfection. 
 
2.2.3.2 Fluorescence activated cell sorting (FACS) of Legionella infected macrophages 
At 8 and 16 h post infection or stimulation, THP-1 cells were washed once with PBS and 
subsequently detached using Trypsin/EDTA for 4 minutes at 37°C. Cells were centrifuged for 10 
minutes at 300 x g. Cell pellets were resuspended in PBS and cell concentration was 
determined. Cells were kept on ice and infected macrophages (GFP-positive fraction) were 
separated from the non-invaded bystander cells (GFP-negative fraction) by cytometric sorting 
on a BD Aria III (BD Bioscience) machine. Sorting was performed in the Flow Cytometry Core 
Facility, Marburg, with the assistance of Dr. Hartmann Raifer. Uninfected THP-1 cells (ctr) were 
also sorted to obtain an appropriate control. At least 4 x 105 cells were sorted into 4 mL 
RNAprotectTM solution to maintain RNA integrity. After Sorting, cells in RNAprotectTM solution 
were centrifuged for 10 minutes at 4,500 x g and 4°C. Cell pellets were washed twice. Finally, 
pellets were frozen in liquid nitrogen and stored at -80°C until RNA was isolated.  
In order to assess the sort purity, a post sort analysis was performed where a sub-population 
of the sorted cells was re-analysed. Secondly, 9 x 105 sorted cells (gfp- and gfp+) were lysed 
with 1% (v/v) saponin, diluted in PBS and streaked on a BCYE agar plate. Bacterial colonies 
were counted and CFU/mL was calculated. 
 
2.2.3.3 RNA Isolation (miRVana) 
Total RNA was isolated using the mirVana™ miRNA Isolation Kit. According to manufacturer's 
protocol, thawed pellets were completely lysed in lysis/binding buffer. After organic extraction 
and washing steps, total RNA was eluted in 100 µL ultrapure water. RNA quality was verified 
using Bioanalyzer 2100 (Agilent) (section 2.2.2.3). 
 




Total RNA was sent for commercial sequencing to Vertis Biotechnologie AG (Freising, 
Germany). RNA was depleted for bacterial ribosomal RNA (rRNA), eukaryotic cytoplasmic rRNA 
and mitochondrial rRNA using Ribo-Zero Gold rRNA Removal Kit (Epidemiology) (Illumina). No 
polyA enrichment was performed to preserve all different RNA species for sequencing, 
including circular RNAs. Random-primed libraries without cutoff above 50 bp were prepared 
from biological triplicates and sequenced on an Illumina Illumina NextSeq 500 system with a 
75 bp read length. Sequencing the miRNA fraction required additional steps. First, the small 
RNA fraction (<200 bp) was purified from the total RNA and concentrated using RNeasy 
MinElute Cleanup kit (Qiagen). Secondly, the miRNAs were isolated by nuclear acid 
fractionation (Caliper LabChip XT) by help of an internal size marker. Afterwards, the samples 
were processed and sequenced as previously described.  
 
2.2.3.5 Bioinformatics analysis 
The bioinformatics analysis was performed by Prof. Annalisa Marsico (Freie Universität Berlin, 
Germany) and Dr. Brian Caffrey (MPI MolGen Berlin, Germany) (section 2.2.7.1).  
 
 Functional microRNA evaluation by luciferase-based reporter constructs 2.2.4
For studying miRNA-mRNA interaction, luciferase assays were performed. Firstly, the vector 
plasmids were constructed by cloning the 3’UTR fragment into the psiCHECK-2 plasmid. 
Secondly, HEK 293T cells were transfected with cloned vector constructs and the miRNA 
mimics followed by the bioluminescence detection.  
 




Figure 2.2: The psiCHECK2 vector. The plasmid carries a sequence which encodes for firefly luciferase 
(hluc+) and for Renilla reniformis luciferase (hRluc). Located within the hRluc sequence is a multiple 
cloning site which was used for the insertion of the respective mRNA 3’UTR sequence (wildtype or 
mutated). For selection purposes, the vector carries an ampicillin resistance gene (Amp
r
). The vector 
was designed by Promega. 
 
2.2.4.1 Construction of the vector constructs 
2.2.4.1.1 PCR for fragment amplification 
Polymerase chain reaction (PCR) is a laboratory technique that is used for the amplification of 
a DNA segment. This method generates thousands to millions of copies of a particular DNA 
sequence by the use of specific primers (Bartlett and Stirling 2003). In this study, PCR was used 
to generate and amplify the 3’UTR fragments of DDX58 and TP53. The fragments were 
amplified from an uninfected cDNA sample of THP-1 cells with the use of specific primers 
(table 2.10). The forward primer possessed a restriction site for XhoI (CTCGAG), while the 
reverse primer carried a restriction site for NotI (GCGGCCGC). To verify the absence of NotI 
and XhoI restriction sites in the 3’UTR fragment, the amplified sequence was screened by 
Clone Manager (Scientific & Educational Software). PCR was performed with the Phusion® 
High-Fidelity DNA Polymerase PCR Kit (NEB). PCR was performed according to manufacturer's 
protocol.  
 
Table 2.32: Mastermix for fragment amplification via PCR with phusion polymerase 
Component Volume for a 50 µL Reaction 
5X Phusion HF Buffer 10 µL 
10 mM dNTPs 1 µL 
10 µM Primer forward 1 µL 
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10 µM Primer reverse 1 µL 
Phusion DNA Polymerase 0.5 µL 
MgCl2 1 µL 
PCR Enhancer 5 µL 
Template DNA (500 ng) x µL 
Nuclease-free water Ad 50 µL 
 
The elongation time and the annealing temperature were adjusted according to fragment size 
and primer sequence, respectively. A gradient PCR with the indicated cycler program (table 
2.33) was performed on a temperature PCR Cycler PeqSTAR 2x Gradient (Peqlab) to determine 
the optimal annealing temperature.  
 
The following PCR program was applied:  
Table 2.33: Thermo protocol for the phusion polymerase PCR  
 Cycle step Temperature Time 
 initial denaturation 98°C 1 minute 
 
25 cycles 
denaturation 98°C 5 seconds 
primer binding X°C 15 seconds 
elongation 72°C 60 seconds/1kb 
 final extension 72°C 10 minutes 
 hold 4°C ∞ 
 
Only the wildtype versions of the 3’UTR of DDX58 and TP53 were amplified with the 
aforementioned primers. The DNA sequence of the mutated version of TP53 3’UTR was 
ordered as DNA fragment and directly cloned into the pSC-A-amp/kan PCR Cloning Vector. The 
plasmid pUCIDT, carrying the mutated sequence of DDX58 3’UTR and the wildtype and 
mutated version of LGALS8 3’UTR, was also purchased. Thus, the ordered plasmid was directly 
transformed into competent E.coli (Top 10) for amplification (section 2.2.4.6) and 
subsequently cloned into the psiCHECK-2 vector.  
 
2.2.4.1.2 Stratagene cloning  
The StrataClone PCR Cloning Kit is used for the quick cloning of PCR products. It has a high 
cloning efficiency and the blue-white screening allows for the quick detection of the colonies 
harboring the vector with the fragment of interest. In order to obtain higher amounts of the 
3’UTR fragment, the amplified fragment was firstly cloned into the pSC-A-amp/kan PCR 
Cloning Vector by the use of the StrataClone PCR Cloning Kit (Agilent). Therefore, the PCR 
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components were removed by column purification (NucleoSpin Extract II Kit). The method was 
performed according to the manufacturer´s protocol. Briefly, the fragment was ligated into the 
StrataClone Vector that contains two DNA arms, each charged with topoisomerase I on one 
end and a loxP containing recognition sequence on the other end. Taq-amplified PCR products 
contain 3’ adenosine overhangs. Thus, the fragment was efficiently ligated to vector arms 
through A-U base-pairing followed by topoisomerase I-mediated strand ligation. Subsequently, 
the ligated linear molecule was cloned into a competent Escherishia coli (E. coli) engineered to 
transiently express Cre recombinase. A circular vector is generated by the Cre-mediated 
recombination between the vector loxP sites. Transformed cells were grown on media 
containing ampicillin. Since the resulting vector possesses a lacZ´ α-complementation cassette, 
transformed colonies were selected by blue-white screening. The white colonies harbored the 
vector with the inserted fragment. 
 
Figure 2.3: Map for the StrataClone PCR Cloning Vector pSC-A-amp/kan. Within the rlacZ’ sequence is a 
multiple cloning site located which was used for the insertion of the amplified PCR product. The lacZ´ α-
complementation cassette can be used for blue-white screening. For selection purposes, the vector 
carries an ampicillin and a kanamycin resistance gene. The insert is located within the multiple cloning 
sequences (MCS) of the vector and different primer binding sites and enzyme restriction sites are 
indicated in the sequence below. The vector was designed by Agilent. 
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2.2.4.1.3 Colony PCR 
In order to more quickly screen for colonies with correct integration of the insert of interest, 
colony PCR was performed. Therefore, single colonies were picked and resuspended in the PCR 
reaction mix containing the DNA-polymerase of Thermus aquaticus (Taq polymerase) (Chien, 
Edgar et al. 1976; Saiki, Gelfand et al. 1988). Amplification was achieved by addition of specific 
primers that flanking the insert (adjusted to the used vector construct).  
 
Table 2.34: Mastermix for colony-PCR with Taq polymerase 
Component Volume for a 25 µL Reaction  
10X Taq Buffer 2.5 µL 
10 mM dNTPs 0.5 µL 
10 µM Primer forward 0.5 µL 
10 µM Primer reverse 0.5 µL 
MgCl2 1 µL 
Taq polymerase 0.2 µL 
Nuclease-free water 19.8 µL 
Picked colony  
 
Table 2.35: Primer pairs used for screening of correct integration of the insert of interest 
Vector construct Primer fwd sequence Primer rev sequence 
pSC-A-amp/kan OBS-1294 TATCCACTGTGGAATTCGCC OBS-1295 AGCCCAATGTGGAATTCGC 
pUCIDT OBS-0113 GTAAAACGACGGCCAGTG OBS-0076 GGAAACAGCTATGACCATGA 
psiCHECK-2 OBS-0522 CAAGAGCTTCGTGGAGCG OBS-0523 CGCGAGGTCCGAAGACTC 
 
Depending on the fragment size and primer sequences, elongation time and annealing 
temperature were adjusted, respectively. 
 
Table 2.36: Thermo protocol for the colony PCR with Taq polymerase 
 Cycle step Temperature Time 
 initial denaturation 95°C 5 minutes 
 
35 cycles 
denaturation 95°C 30 seconds 
primer binding X°C 30 seconds 
elongation 72°C 60 seconds/1kb 
 final extension 72°C 5 minutes 
 hold 4°C ∞ 
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2.2.4.2 Agarose gel electrophoresis 
For separation of DNA fragments with different lengths, an agarose gel electrophoresis was 
performed. The DNA fragments are separated by applying an electric field. Since DNA is 
negatively charged, the DNA moves to the positively charged pole through the agarose matrix. 
Based on the sieve effect, smaller fragments migrate faster than longer fragments. Therefore, 
the separation of the DNA fragments depends on the fragment length (Bjornsti and Megonigal 
1999). For all experiments, 1.5% or 2% agarose gels with 1X TAE-Buffer and 1X GelRed (Biotium 
Inc) were used. For determination of fragment size, one lane was loaded with a DNA ladder. 
Depending on the expected fragment size, the DNA standard Gene Ruler 1 kb or the 
FastRulerTM Low Range DNA ladder (Thermo Fisher Scientific) was used. The electrophoresis 
was run in 1X TAE-Buffer at 120 V. DNA was visualized by a Gel documentation apparatus with 
UV-light (INTAS).  
For gel extraction, the agarose gel was run at 80 V and stopped as soon as the DNA fragment 
of interest was sufficiently separated from the other bands. The UV exposure time was kept at 
a minimum to avoid damaging of the DNA fragments.  
 
2.2.4.3 Gel extraction 
DNA fragments of interest were cut from the agarose gel with a scalpel. DNA extraction was 
performed with the NucleoSpin Gel and PCR Cleanup Kit (Machery-Nagel) according to the 
manufacturer's protocol. The concentration of the purified DNA was determined by the 
Spectrophotometer Nanodrop (Thermo Fisher scientific).  
 
2.2.4.4 Restriction digest 
After PCR amplification, PCR components were removed by column purification with 
NucleoSpin Gel and PCR Cleanup Kit (Machery-Nagel). In order to clone amplified DNA 
fragments into the psiCHECK-2 vector, the amplified DNA fragments and the empty psiCHECK-2 
vector were digested with NotI (NEB) and XhoI (NEB). The reaction was set up as 
recommended by the manufacturer instructions (https://nebcloner.neb.com/#!/redigest).  
 
Table 2.37: Mastermix for double digest of DNA 
Component Volume for a 25 µL Reaction 
DNA (1 µg) X µL 
10 X NEBuffer 3.1 5 µL 
XhoI 1 µL 
Materials and Methods 
60 
 
NotI 1 µL 
Nuclease-free water Ad 50 µL 
 
Digestion was performed for 15 minutes at 37°C. Restriction enzymes were deactivated at 65°C 
for 20 minutes. Digested fragments were isolated using gel electrophoresis followed by gel 
extraction and column purification (section 2.2.4.3).  
 
2.2.4.5 Ligation  
The purified and digested DNA fragments were ligated into linearized psiCHECK-2 plasmid. 
Therefore, 100 ng of digested plasmid and 20 ng of accordingly digested insert were incubated 
at room temperature for 10 minutes with 1 µL T4 ligase (NEB) at a final volume of 20 µL. 
Subsequently, the enzyme was heat inactivated at 65°C for 10 minutes. Afterwards, the ligated 
vector was transformed into competent E. coli (Top10) (section 2.2.4.6). 
 
2.2.4.6 Transformation of vector constructs in E. coli 
The generated or custom-made vector constructs were transformed into a chemically 
competent E. coli strain (Top10) for amplification. The required amount of competent cells was 
thawed on ice for 10 minutes. Afterwards, 5 µL of ligation reaction or 1 µL of empty plasmid 
was added to 50 µL competent cells. The solution was incubated on ice for 30 minutes. 
Subsequently, cells were incubated at 42°C for 45 seconds. Immediately after the heat shock 
step, cells were placed on ice for 2 minutes. The 5-fold volume of SOC medium was added. 
Cells were incubated for 30 minutes at 37°C and shaken vigorously (250 rpm). The suspension 
with the transformed bacteria were plated on pre-warmed LB agar plates containing 
appropriate antibiotics. Plates were incubated over night at 37°C.  
 
2.2.4.7 Plasmid extraction 
Single colonies were picked and inoculated in liquid LB-media containing the appropriate 
antibiotics. Cultures were grown overnight at 37°C. Isolation of the plasmid was performed 
with the plasmid mini kit (Nucleo Spin® Plasmid Quick Pure, Macherey Nagel), or with the 
plasmid midi kit (Nucleobond® Xtra Midi Plus EF from Macherey Nagel) followed by the 
manufacturer´s instruction. Extracted plasmids were stored at -20°C. 
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2.2.4.8 Sequencing of generated vector constructs 
Cloned and mutated vector constructs were sent for sequencing to validate accuracy of the 
sequence. The Sanger Sequencing was executed by sequencing service of LMU Munich or by 
the company Microsynth Seqlab (Göttingen). Sample preparation was performed according to 
company instructions. The obtained sequences were tested for their accuracy by Clone 
Manager (Scientific & Educational Software). 
 
2.2.4.9 Transfection of HEK-293T 
HEK-293T cells were reverse transfected with Lipofectamine2000 (Thermo Fisher Scientific) 
and Optimem in a 1:50 ratio. Cells were simultaneously transfected at a final concentration of 
2.5 pmol miRNA mimic and 200 ng generated vector construct (psiCHECK-2 with specific 
3’UTR) per 100 µL. As control, a scramble mimic was transfected. The empty vector 
(psiCHECK-2) was transfected in combination with the miRNA mimics to exclude non-specific 
signals achieved by miRNA overexpression. In this study, mimics for miR-125b, miR-221 and 
miR-579 were used. If all three miRNAs (miRNA-pool) were added, transfection was performed 
at a final concentration of 2.5 pmol (each mimic 0.833 pmol). The prepared transfection mix 
was incubated for 10 minutes at room temperature and then added to the cells. Subsequently, 
cells were cultured for 72 h at 37°C with 5% CO2. Then, bioluminescence detection was 
performed. 
 
2.2.4.10 Quantification of microRNA efficiency by bioluminescence 
Reporter gene constructs are used to study and quantify expression changes of a target gene 
which is fused to the reporter gene. The psiCHECK-2 vector contains two reporter genes. The 
Renilla luciferase is used as primary reporter gene. The sequence of interest (3’UTR of DDX58, 
TP53 and LGALS8) is cloned into the region located downstream of the Renilla translational 
stop codon. The co-transfection of a miRNA mimic results in cleavage and subsequent 
degradation of the transcript, if the miRNA binds to the sequence of interest (Fig. 2.4). 
Therefore, a decrease in Renilla activity indicates that the miRNA binds to the cloned sequence 
of interest. The second reporter gene is the Firefly luciferase and allows for the normalization 
of Renilla luciferase expression and a distinction between specific and global effects. 
Therefore, a decrease of both luminescences indicates a global impact on the cell population 
mediated by cell death or inhibition of cell growth. Thus, this reporter assay leads to 
reproducible results and enables the monitoring of the influence of a miRNA on the 3’UTR by 
measuring the bioluminescence.  
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The Dual-Glo® Luciferase Assay System Kit (Promega) was used to measure the interaction 
between miRNA and 3’UTR. The constructed vectors with 3´UTR of DDX58, TP53 and LGALS8 
(wildtype and mutated versions) were used. All steps were performed according to 
manufacturer´s instructions. Firefly luminescence was determined 10-15 minutes after 
substrate addition with the Tecan Infinite M200 PRO plate reader (Thermo Fisher Scientific) 
with 1 s integration time. The ratio of Renilla- and Firefly-luminescence was calculated and 
further normalized to the empty vector lacking the specific 3´UTR.  
 
 
Figure 2.4: Simplified scheme of the mechanism of action of the quantification of miRNA efficiency by 
bioluminescence. Within the Renilla reniformis luciferase (hRluc) sequence is a multiple cloning site 
located which was used for the insertion of the respective mRNA 3’UTR sequence (sequence of interest). 
This vector is transfected into HEK-293T cells and a fusion of the Renilla luciferase gene and the gene of 
interest is transcribed. The miRNA mimic is co-transfected simultaneously. If a specific miRNA binds to 
3’UTR of the target mRNA and initiates the RNAi process, the Renilla luciferase fused with target gene 
will be cleaved and subsequently degraded, leading to a decreased Renilla luciferase signal. Adapted 
from: Promega, Technical Bulletin for siCHECKTM Vectors, Version 6/09. 
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 Biochemical methods 2.2.5
2.2.5.1 Lactate dehydrogenase release (LDH) measurement  
In order to determine cytotoxicity in cultured cells, LDH release in harvested supernatants was 
measured by Cytotoxicity Detection kit of Roche. The procedure was performed as instructed 
by the manufacturer. Supernatants of THP-1 cells and BDMs were diluted 1:10. Measurements 
were performed in technical duplicates with the Tecan Infinite M200 PRO plate reader 
(Thermo Fisher Scientific). 
 
2.2.5.2 Semi quantitative protein analysis by Western Blot 
After indicated incubation time, cells were washed with PBS and lysed in RIPA buffer (without 
SDS). Lysed cells were centrifuged at maximum speed for 20 minutes at 4°C to remove cell 
debris. Protein concentration was determined by bicinchoninic acid assay (BCA assay). 
Measurements were carried out with the PierceTM BCA Protein Assay Kit. All steps were 
performed according to manufacturer´s instructions. Optical density was measured in the 
Tecan Infinite M200 PRO plate reader (Thermo Fisher Scientific) at a wavelength of 595 nm, 
and protein concentration was calculated.  
Samples were taken up in Laemmli-buffer at 1:5 ratio and denatured for 5 minutes at 95°C. For 
protein separation, 10% SDS gels were used, and 20 to 30 µg of protein were loaded per lane 
and a marker lane was included as reference. For focusing the proteins in the stacking gel, 80 V 
was applied. Thereafter, voltage was increased to 120 V for transmigration of the proteins into 
the resolving gel.  
Proteins were transferred to a nitrocellulose membrane with the use of a tank blot for 1 h at 
100 V. 
Afterwards, the membrane was blocked over night at 4°C in a mixture of 10% milkpowder 
solution with 3% Bovine serum albumin (BSA). Primary antibody (α-MX1-antibody) was added 
at a 1:1,000 dilution and incubated for 2 hours at room temperature on a tumbling shaker. 
Unbound protein was removed by several washing steps in TBS-T. HRP-conjugated secondary 
antibody was given for additional 2 hours at room temperature on a tumbling shaker. After 
removal of excess antibody by washing, protein signal was detected on the Bioluminescence 
and Chemoluminescence Imager (INTAS). 
When required, quantification of signal was performed by densitometric analysis, using the 
LabImage 1D software (Kapelan Bio-Imaging GmbH). 
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2.2.5.3 Determination of secreted Cytokines 
2.2.5.3.1 Enzyme Linked Immunosorbent assay (ELISA) 
The enzyme-linked immunosorbent assay (ELISA) is an analytic biochemistry assay that uses 
antibodies to identify the presence of substances (e.g. secreted cytokines) in a liquid samples 
(Engvall and Perlmann 1971). In this study ELISAs were performed to determine secreted 
CXCL8 in supernatants of control or L.p.-infected samples. Measurement was carried out with 
the DuoSet® ELISA Kit for human Interleukin-8 (CXCL-8) (BD Biosciences). The applied test uses 
HRP-conjugated antibodies and color changes to identify protein abundances. Analyses were 
performed according to manufacturer´s instructions. Supernatants were diluted depending on 
secretion levels. The measurement readings were performed in technical duplicates with the 
Tecan Infinite M200 PRO plate reader (Thermo Fisher Scientific). 
2.2.5.3.2 MILLIPLEX® Multiplex Assays Using Luminex® 
This technology allows measuring multiple cytokines in a single reaction with high sensitivity. 
The method is a magnetic bead-based assay that determines concentration of up to 50 
analytes in one sample. Therefore, this assay was used to determine the concentration of 
IL-1β, IL-6, GM-CSF, TNF-α and IL-10 in cell-free supernatants of L.p.-infected and uninfected 
macrophages. For THP-1 cells cytokine secretion was measured in samples infected with L.p. at 
an MOI of 0.25 and 0.5 at 24 and 48 h post infection. Since the well number on one plate was 
limited, the determination of secreted cytokines of BDMs was only performed at 48 h post 
infection. Samples were diluted accordingly. The MILLIPLEX MAP Human High Sensitivity T Cell 
Panel Premixed 13-plex - Immunology Multiplex Assay (Millipore) was used and performed 
according to the manufacturer’s instructions. Range of detection for each molecule was 
[pg/mL]: 21-406 (IL-1β), 23-384 (IL-6), 21-373 (GM-CSF), 23-391 (TNF-α), 24-422 (IL-10). The 
Infinite® M200 Pro microplate reader (Tecan) and MAGPIX System (Luminex) was used for 
measurements. 
 
2.2.5.4 Cytometric analysis of intracellular protein by indirect immunofluorescence 
staining 
THP-1 cells were transfected either with synthetic miRNA mimics or with an siRNA-pool against 
DDX58. As control a scramble mimic or siRNA was transfected. Subsequently, cells were 
differentiated and infected with L.p. at MOI 0.5 for 24 and 48 h or left untreated as control. 
After the infection time, THP-1 cells were detached with Trypsin/EDTA for 5 minutes at 37°C 
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and washed once with PBS. Cells were fixed with 4% PFA for 10 minutes in the dark and 
washed 3 times with PBS (centrifugation: 5 minutes, 2,000 x g). Then, THP-1 cells were 
permeabilized with 0.5% Tween in PBS for 15 minutes, followed by the blocking of non-specific 
binding sites for 30 minutes at room temperature in PBS with 0.5% (v/v) Tween and 10% FCS. 
Cells were centrifuged for 5 minutes at 5,000 x g and room temperature. The obtained cell 
pellet was solved in 100 µL PBS with 0.5% (v/v) Tween and 10% (v/v) FCS and Human BD Fc 
Block (BD Bioscience) was added for 10 minutes (2.5 µg for 1 x 106 cells) to block non-specifc 
binding of antibodies to Fc receptors. Primary antibody (α-MX1 antibody) was additionally 
added at a 1:500 dilution for 1 hour without any washing step in between. Since an indirect 
staining was performed, α-IgG antibody as control was necessary to assess the specific 
fluorescence signal for MX1. This antibody was given at a 1:1,000 dilution to obtain the 
corresponding antibody amount. For removal of excess antibody cells were washed 3 times 
with PBS (5% (v/v) FCS) (centrifugation: 5 minutes, 5,000 x g). Afterwards, all cell pellets were 
incubated with secondary antibody (anti-rabbit Alexa 555) at a 1:2,000 dilution in PBS with 
0.5% (v/v) Tween and 10% (v/v) FCS for 30 minutes at room temperature in the dark. After 
three washing steps with PBS (5% (v/v) FCS), pellets were resuspended in PBS containing 5% 
(v/v) FCS and analyzed on the Guava® easyCyte flow cytometer (Merck Millipore). The data 
were analyzed using FlowJo v. 7.6.5.. 
 
 Stable isotope labelling by amino acids in cell culture (SILAC) 2.2.6
2.2.6.1 Labelling of THP-1 cells and production of the heavy standard 
In order to allow relative quantification of protein abundance changes in response to miRNA 
and/or infection, a heavily labelled SILAC standard was prepared. Therefore, THP-1 cells were 
cultivated in SILAC-DMEM with 2% (v/v) FCS lacking arginine and lysine. The medium was 
additionally supplemented with heavy isotope labelled 13C arginine and lysine (Sigma Aldrich) 
and THP-1 cells were cultured over five passages. Then, 2.4 x 108 THP-1 cells were stimulated 
with 20 nM PMA and transferred into twenty 10 cm cell culture plates as previously described 
(section 2.2.1.3). In order to ensure high coverage of proteins in the subsequent internalization 
experiment, parts of the heavily labelled THP-1 cells were additionally infected with L.p. at an 
MOI of 0.5 for 24 h as described above (section 2.2.1.5.2). Before spiking the heavily labelled 
standard as quantification reference in all subsequent biological samples, non-infected and 
infected heavily labelled cells were tested for complete incorporation of heavy 13C arginine and 
lysine. To do so, supernatant was removed and cells were washed with PBS and removed from 
the culture plate by scratching in buffer consisting of 8 mol/L urea and 2 mol/L thiourea in 
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HPLC-grade water (UT-buffer). Cells were immediately frozen in liquid nitrogen and stored 
at -80°C until preparation for mass spectrometry. Afterwards, heavily labeled standard was 
sent to the lab of Prof. Dr. Uwe Völker for further analysis.  
 
In the following, the methods are described in detail performed by Dr. Kristin Surmann and 
Sascha Blankenburg. Mass spectrometry measurements were done by Manuela Gesell Salazar. 
 
2.2.6.2 Sample preparation for nanoHLPC–MS/MS 
Cells were disrupted applying five freezing (liquid nitrogen) and thawing (30°C, 500 rpm, 7 
minutes) steps supported with sonication on ice (3x3 s, 50% power, SonoPuls, Bandelin 
electronic). Supernatant from subsequent centrifugation (room temperature, 20,000 x g, 
1 hour) was collected in fresh vials and frozen at -80°C. Prior to tryptic digestion the 
abundances of protein in the samples was determined using a Bradford assay in technical 
triplicates.  
The heavily labelled THP-1 cells (infected and non-infected THP-1 cells separately) were 
digested first in gel-free manner for determination of the 13C arginine and lysine incorporation 
rate by mass spectrometry. Therefore, 4 µg of each sample were taken up in 20 mmol/L 
aqueous ammonium bicarbonate buffer to dilute the urea concentration to less than 
1 mmol/L. Proteins were reduced with 2.5 mmol/l dithiothreitol at 60°C for 1 hour, alkylated 
with 10 mmol/L iodoacetamide at 37°C for 30 minutes in the dark, and digested overnight at 
37°C using trypsin (Promega) in a protease to protein (m/m) ratio of 1:25. Digestion was 
stopped with a final concentration of 1% (v/v) acetic acid. By centrifugation (room 
temperature, 16,000 x g, 10 minutes) insoluble components were removed. The peptide-
containing supernatant was desalted and purified using C18 ZipTip columns. Purified peptide 
solution were dried by lyophilization and reconstituted in 20 µL buffer A [2% (v/v) acetonitrile 
and 0.1% (v/v) acetic acid in HPLC-grade water (J. T. Baker)]. Samples were stored short-term 
at -20°C before by nanoHLPC–MS/MS. Since the measurements and data analysis revealed 
heavy isotope labeling of more than 97% for all peptides and proteins, it was accepted as fully 
labeled. Finally, protein extracts of infected and non-infected heavily labeled THP-1 cells were 
mixed in equal protein amounts as global SILAC standard. The protein concentration of this 
mixed global SILAC standard was determined and aliquots were stored at -80°C to allow 
addition of the same standard to all future biological samples.  
Each 5 µg protein from the miRNA and L.p. infection experiment were mixed with 5 µg of the 
mixed global SILAC standard.  
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These combined samples (10 µg protein) were separated using one-dimensional gel (1D gel) 
electrophoresis with NuPAGE4-12% acrylamide Bis-Tris Midi Gels (Novex Life Technologies) 
according to the molecular weight in order to decrease the complexity of the samples. Samples 
were supplemented with 1 µL reducing agent and 2.5 µL sample buffer (Novex Life 
Technologies). The proteins were denatured at 70°C for 10 minutes. Gels were run at 200 mA 
for 5 minutes and afterwards at 160 mA until additional marker was visible at the bottom of 
the gel. Gels were stained with Coomassie Brilliant Blue to control separation. To do so, gels 
were fixed for 1 hour in 40% (v/v) ethanol and 20% (v/v) acetic acid in distilled water and 
washed twice for 15 minutes in distilled water. Gels were incubated overnight with colloidal 
Coomassie Silver Blue solution [consisting of 10% (m/v) (NH4)2SO4; 10% (v/v) phosphoric acid; 
0.12% (m/v) Coomassie G250 and 20% (v/v) methanol]. The gels were destained twice for 15 
minutes in methanol and washed twice for 15 minutes in distilled water. At this stage, images 
were acquired. Afterwards, each sample lane on the 1D gel was cut into 10 equal sized slices. 
Prior to tryptic digestion of the enclosed proteins, gel slices were incubated twice with 200 µL 
20 mmol/L aqueous ammonium bicarbonate (37°C, 150 rpm, 15 minutes) with removal of the 
supernatant between the repetitions of this step. The now fully discolored gel slices were then 
dehydrated with 100 µL acetonitrile (37°C, 150 rpm, 15 minutes). This step was also repeated 
one more time. Next, 20 µL of 5 ng/µL trypsin (Promega) in 20 nmol/L aqueous ammonium 
bicarbonate solution was added to the dehydrated gel together with 20 µL 20 nmol/L aqueous 
ammonium bicarbonate. After incubation at 37°C for 1 hour, the complete rehydration of the 
gel was controlled. If necessary 20 nmol/L aqueous ammonium bicarbonate was removed or 
added and tryptic digestion occured at 37°C for further 14 hours. Peptides were extracted 
from the gels first by incubation with 50 µL aqueous 0.1% (v/v) acetic acid for 30 minutes in an 
ultrasonic bath and then the supernatants of each two adjacent fractions were combined to 
reduce the final number of fractions per sample from ten to five. Extraction was repeated with 
50 µL 0.05% (v/v) acetic acid in 50% (v/v) acetonitrile for 30 minutes in an ultrasonic bath and 
the supernatants of the same two adjacent fractions were combined with the once from the 
acetic acid extraction step. Samples were dried by lyophilization, reconstituted in 40 µL 1% 
(v/v) acetic acid prior to purification using C18 ZipTip columns (Merck-Millipore). After one 
more lyophylization step, peptides were dissolved in 20 µL buffer A before nanoHLPC-MS/MS. 
 
2.2.6.3 Data acquisition by nanoHLPC–MS/MS 
Peptides were analyzed on a Q Exactive mass spectrometer (Thermo Fisher Scientific) after 
separation on a Dionex UltiMate 3000 nanoLC system (Dionex/Thermo Fisher Scientific) and 
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ionization with a TriVersa NanoMate source (Advion, Ltd.). Peptide separation was performed 
with a trap column (2 cm x 75 μm inner diameter, packed with 3 μm C18 particles, Acclaim 
PepMap 100, Thermo Fisher Scientific) and a 25 cm x 75 µm analytical column packed with 
2.6 μm C18 particles of 150 Å pore size (Acclaim PepMap RSLC). Peptides were separated by a 
linear gradient using a binary buffer system of buffer A and buffer B [0.1% (v/v) acetic acid in 
acetonitrile (Thermo Scientific)] at a flow rate of 300 nl/min from 5% to 25% in 60 minutes (0 
min-2% B, 2 min-5% B, 10 min-5% B, 70 min-25% B, 75 min-40% B, 77 min-90% B, 82 min-90% 
B, 85 min-2% B, 95 min-2% B). For mass analysis the Q Exactive was operated in DDA mode 
applying a full scan resolution of 70,000 in the range from 300 to 1,650 m/z. The ten most 
abundant isotope patterns (centroid data) with charge ≥2 from the survey scan were selected 
for MS/MS analysis and fragmented by higher energy collisional dissociation (HCD). 
 
2.2.6.4 Data analysis 
MS data were searched using MaxQuant (Cox and Mann 2008) against a database derived 
from Uniprot limited to human entries. Oxidation at methionine and 13C labeling (+6.02 Da) at 
arginine and lysine were set as dynamic modification, no missed cleavage of trypsin was 
performed. The false discovery rate of peptide identifications was set to < 1%. Only peptides 
which were detected with more than one peptide or with one peptide, if it contributed to at 
least 10% of the protein sequence coverage were allowed for further analysis. Furthermore, 
proteins had to be detected in at least three of the four biological replicates per condition for 
calculation of protein ratios between the conditions or had to be absent in at least three of the 
four replicates per condition for determination of so-called ON/OFF proteins depending on 
conditions. In the latter case, ratios were set manually to 1000 (ON) or 0.001 (OFF) to enable 
proceeding with data visualization. From the MaxQuant analysis, program specifically 
normalized SILAC ratios (light to heavy) of the peak areas in the experimental samples against 
the global SILAC standard were retrieved on protein level. These data were compared between 
infection and control depending on the presence of miRNA and the point in time of harvest. P- 
and q-values were calculated using the Genedata Analyst v8.0 software (Genedata AG, Basel, 
Switzerland). Proteins were defined as regulated if the absolute fold change exceeded 1.2 
respectively 1.5 and the q-value amounted < 0.05. Venn diagrams were created using JVenn 
(http://jvenn.toulouse.inra.fr/app/index.html) to visualize general differences on the 
proteome profiles of the THP-1 cells depending on the treatment.  
 
Materials and Methods 
69 
 
 Statistical analyses of conventional experimental data 2.2.7
Statistic evaluation was carried out with GraphPad Prism (Version 7). For data with multiple 
variables, a two-way ANOVA (Analysis of variance) was performed followed by either Sidak´s 
comparison test or Tukey´s. For comparison of two data columns, the paired t-test was 
employed on log2 transformed data. For all tests, a Gaussian distribution was assumed, and 
the confidence interval was set to 95%. Therefore, p-values ≤ 0.05 were considered significant. 
All performed statistical tests are specified in each figure legend. 
 
2.2.7.1 Statistical analysis of high-throughput data 
The data gained from Illumina RNA sequencing required extensive correlation studies and 
statistical correction for large sample sizes. Advanced analyses were carried out by Prof. Dr. 
Annalisa Marsico (Freie Universität Berlin, Germany) and Dr. Brian Caffrey (MPI MolGen Berlin, 
Germany).  
To analyse the dual RNA-Seq data, a workflow as Unix Shell script was implemented.  
Read Quality assessment was performed upon next generation sequencing and is the 
validation of sequence quality. Sequence quality was performed using the FastQC software. 
Illumina reads in FASTQ format were trimmed with an average Phred quality score cut-off of 
20 over every four base pair window by the program Trimmomatic. 3’ adapters were also 
trimmed using Trimmomatic. Reads shorter than 20 nt after adaptor trimming were discarded 
before mapping.  
RNA-Seq reads were aligned to the human genome assembly of hg19 by using the program 
STAR. Star conducts ultrafast mapping of RNA reads to a reference by use of uncompressed 
suffix arrays. This methodology allows for the creation of a joint genomic index for pathogen 
and host combined. A combined index allows for this simultaneous mapping but also for the 
removal of reads which map to both genomes. Star was used with default options with the 
allowance for split reads. Reads mapping to both genomes were not considered under the 
scope of this thesis.  
Differential expression analysis was performed using the DESeq2 R/bioconducter package. 
DESeq2 identifies genes which have significantly increased/decreased in expression by use of a 
negative binomial distribution fit as a generalised linear model. Finally, the p-values were 
adjusted using the procedure introduced by Benjamini and Hochberg. 
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2.2.7.2 Principal component analysis 
In order to visually represent the global sample variation within the RNA sequencing and 
proteomics experiments, a principal component analysis (PCA) was performed. 
PCA was done by Dr. Wilhelm Bertrams according to his doctoral thesis (Bertrams 2014). The 
DESeq2 normalized reads with an adjusted p-value ≤ 0.01 were used for the PCA of the dual 
RNA-Seq approach including 5,433 genes. For the proteomics experiments, only calculated 
ratios of heavy and light protein quantifications were used for creating the PCA (588 quantified 
proteins included).  





In  general,  this  study  aims  at  creating  a  comprehensive  knowledge  of  the  crosstalk  of 











immune  response  as  well  as  TLR‐signalling.  Therefore,  the  question  arose  whether miRNAs 
could  have  a  role  during  the  course  of  infection  of  human  macrophages  with  Legionella 
pneumophila (Sonkoly, Stahle et al. 2008; Lu and Liston 2009; Xiao and Rajewsky 2009; Nahid, 
Satoh et al. 2011b). 
In  humans,  Legionella  pneumophila  infects  alveolar  macrophages  (Chandler,  Hicklin  et  al. 
1977). Therefore, primary human monocytes were deemed more appropriate as a model for 
these  cells,  as  opposed  to  an  immortalised  cell  line.  Primary monocytes were  isolated  from 
buffy  coats  of  healthy  donors  by  positive  magnetic  selection  for  CD14.  CD14  is  a  surface 
marker  and  mainly  expressed  by  monocytes  (Ziegler‐Heitbrock,  Ancuta  et  al.  2010).  After 




The  most  important  initial  investigation  for  characterizing  the  miRNA‐mediated  regulatory 
network in Legionella infection was the optimization of infection dose and time points. To this 
end, human BDMs were  infected with  increasing multiplicities of  infection (MOIs)  for 24 and 
48 h.  A  key  requirement  for  the  identification  of  differentially  expressed  miRNAs  in 
L.p.‐infected macrophages was  low  cytotoxicity with  a  substantial  inflammatory  response  to 
rule  out  apoptosis‐related  miRNA  regulation.  Therefore,  CXCL8  secretion  (Fig. 3.1  A)  and 
cytotoxicity (Fig. 3.1 B) were examined. An MOI of 0.25 showed a significant increase in CXCL8 
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secretion  and  cytotoxicity  below  30%  as  determined  by  LDH.  An MOI  of  0.25  and  0.5 were 
used for further analysis in this study. To investigate another macrophage‐like cell model, THP‐
1  cells  were  used  and  compared  to  the  primary  BDMs.  This  monocytic  cell  line  was 
differentiated  into  macrophages  by  the  addition  of  20 nM  of  PMA  as  previously  described 
(section 2.2.1.3). After 24 h of differentiation, cells were infected with L.p. at an MOI of 0.25 


























0.25 and 0.5  for 24 and 48 h. Afterwards,  secretion of  IL‐1ß  (Fig. 3.2A, B),  IL‐6  (Fig. 3.2C, D), 
GM‐CSF  (Fig. 3.2E,  F),  TNF‐α  (Fig. 3.2G,  H)  and  IL‐10  (Fig. 3.2I,  J)  were  measured  using  the 
Multiple  Luminex  assay  (section  2.2.5.3.2).  Cytokine  secretion  analyses  demonstrated  a 
significant  induction of  IL‐1ß,  IL‐6, GM‐CSF, TNF‐α and  IL‐10  release at 48 h post  infection  in 














































































































 Figure  3.2:  Pro‐inflammatory  cytokine  release  of  macrophages  upon  infection  with  L.p..  BDMs  or 
PMA‐differentiated  THP‐1  cells  were  infected  with  L.p.  at  an  MOI  of  0.25  or  0.5  for  24  or  48  h, 
respectively.  Secretion  of  IL‐1β  (A,  B),  IL‐6  (C,  D),  GM‐CSF  (E,  F),  TNF‐α  (G,  H)  and  IL‐10  (I,  J)  was 
measured  using  Multiplex  Luminex  Assay.  Data  are  shown  as  mean  + SEM  of  three  independent 
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This  pipeline  integrates  existing  tools  for  quality  control,  mapping  of  sequencing  reads, 
identification of putative novel miRNAs as well  as  several  statistical packages  for differential 
expression  analysis  of miRNAs  and  validation.  The  results  are  depicted  in  a  heatmap which 
shows 54 statistically significantly dysregulated miRNAs following L.p. infection with an MOI of 
0.25 at 24 and 48 h, respectively (Fig. 3.3A). The 24 upregulated miRNAs are displayed in red, 
while  the  30  downregulated  miRNAs  are  shown  in  blue.  miR‐146a  and  miR‐155  were 
upregulated  following  Legionella  infection  and  are  known  to  play  a  crucial  role  in  the 
inflammatory response following bacterial infection (O'Connell, Taganov et al. 2007; O'Connell, 
Rao  et  al.  2010;  Nahid,  Satoh  et  al.  2011a).  Other  miRNAs  were  also  upregulated  upon 
infection  with  L.p.  and  have  not  yet  been  characterized  in  the  context  with  infection,  e.g. 
miR‐3196 or miR‐4284. miR‐221 and miR‐125b showed a downregulation, as well as miR‐1228 
and  miR‐1180  which  are  not  described  to  be  associated  with  bacterial  infections  yet. 
Furthermore, a time‐dependent regulation of several miRNAs upon infection was observed.  
Differentially  expressed  miRNAs  which  were  relevant  to  the  biological  context  and  well 
described in the literature were further validated via qPCR experiments in BDMs. The miRNAs 
miR‐146a, miR‐155, miR‐27a  and miR‐125a  showed  a  significant  upregulation  in  BDMs  48 h 
post  infection  with  L.p.  (Fig. 3.3B),  while  the  miR‐221,  miR‐222,  miR‐125b,  miR‐26a  and 
miR‐29b were  significantly  downregulated  (Fig. 3.3D).  Validation  experiments  confirmed  the 
results of the sequencing which was indicated by the increasingly significant regulation of the 
miRNAs over infection time. 
To demonstrate  that not only  the cytokine  release  is  comparable between BDMs and THP‐1 
cells,  the  regulation  of  selected  miRNAs  was  verified  and  validated  in  both  cell  types.  The 
expression of miR‐146a, miR‐155, miR‐221 and miR‐125b were analyzed in THP‐1 cells infected 
with  L.p.  at  an MOI  of  0.25  and  0.5  (Fig. 3.3C,  E). miR‐146a was  induced  to  a  higher  extent 
upon  L.p.  infection  in  THP‐1  cells  than  in  BDMs,  while  miR‐155  was  only  significantly 
upregulated in BDMs infected with an MOI of 0.25. In THP‐1 cells a higher infection rate was 
required to achieve a significant regulation of miR‐155. The downregulation of miR‐125b and 











important  to  understand  how  they  are  regulated  following  an  infection  with  L.p..  The 
promoter  regions  of  four  selected  miRNAs  (miR‐155,  miR‐146a,  miR‐221,  miR‐125b)  were 
investigated using the chromatin‐immunoprecipitation (ChIP) sequencing data from DuBois et 
al. (Du Bois, Marsico et al. 2016), where BDMs were infected for 1 h with L.p. at an MOI of 10 
and  ChIP  was  performed  using  a  pan‐ac‐H4‐antibody.  Infected  and  control  samples  were 
normalized  to  input  DNA  samples.  Acetylation  of  the  Histone  H4  is  a  chromatin  mark 
associated with active  transcription.  The analysis of  the promoter  region of  the upregulated 
miR‐155 and miR‐146a revealed an  increase  in pan‐H4 acetylation  in  the  infected sample vs. 
uninfected  control.  For  the  downregulated  miR‐221  and  miR‐125b  a  decrease  in  pan‐H4 
acetylation was detected (Fig. 3.4A).  
This  observation  led  to  the  assumption  that  rather  transcriptional  regulation  than  increased 
miRNA  processing  causes  the  significant  regulation  in miRNA  expression  in  response  to  L.p. 
infection.  
To  test  this  hypothesis,  the  pri‐miRNA  expression  levels  of  the  four  selected  miRNAs 
(miR‐146a,  miR‐155,  miR‐125b  and  miR‐221)  were  analysed  by  the  use  of  specific  qPCR 
detection  assays.  Pri‐mir‐16  served  as  an  endogenous  normalization  control,  which  is 
constitutively  transcribed under  a  large  variety of  conditions  (Schwarzenbach,  da  Silva  et  al. 
2015;  Lange,  Stracke  et  al.  2017).  The  qPCR  analysis  showed  indeed  an  upregulation  of  the 






















































Figure  3.4:  Infection‐related  chromatin  changes  on  miRNA‐promoters.  The  alterations  of  the 





browser are  shown. Boxes  indicate promoter  regions, while circles  show the mature  transcript of  the 
miRNA. The expression of the pri‐mirs (B, C, D, E) or Dicer and Drosha (F, G) in BDMs after L.p. infection 
was examined by qPCR and displayed as log2‐fold changes. BDMs from different donors were infected 
with L.p. at an MOI of 0.25 and 0.5  for 24 and 48 h. Data are shown as mean + SEM of  three  to  four 
independent  biological  replicates.  Paired  t‐tests  were  performed:  *p ≤ 0.05,  **p ≤ 0.01,  ***p ≤ 0.001 
compared to the corresponding control. 
 




Given  the  known  and  important  effects  miRNAs  can  have  upon  cells  under  infection  or 
inflammation, we endeavoured to  find a  function  for  those miRNAs which were  found to be 
differentially expressed following L.p. infection in macrophages.  
Upregulation  of  miR‐125b  and  miR‐221,  together  with  miR‐579,  have  been  shown  to  be 
important in endotoxin tolerance in macrophages leading to prevention of translation of TNF‐α 
mRNA  and  therefore  to  a  diminished  immune  response  (El  Gazzar  and McCall  2010; Quinn, 
Wang  et  al.  2012).  To  assess  if  dysregulation  of  miR‐125b,  miR‐221,  and  miR‐579  have  an 




verified  with  qPCR  experiments  (Fig. 3.5A,  B  and  C).  The  overexpression  of  the  individual 
precursors  as  well  as  the  transfection  of  all  three  miRNAs  (10 nM  of  each  precursor)  was 
successful und did not influence the following infection with L.p. as tested by qPCR. The high 
abundance of miR‐125b and miR‐579 after transfection is due to low expression levels of the 
miRNAs  in untransfected  cells. Additionally,  the moderate  increase of  the miR‐221  following 
transfection  can  be  explained  by  the  high  native  expression  level  of  this  miRNA  in 
macrophages.  While  knockdown  of  miR‐125b,  miR‐221,  and  miR‐579  resulted  in  reduced 
intracellular  replication  compared  to  scrambled  control  (scr),  an  overexpression  of  all  three 
miRNAs (miRNA pool) simultaneously resulted  in a strong  increase of  intracellular replication 
in  comparison  to  scramble  control  (Fig. 3.5D).  A  single  transfection  of  each  miRNA  did  not 
change replication of L.p. compared to scramble transfected cells. Therefore, it is assumed that 
all three miRNAs are necessary to mediate the observed replication effect in macrophages.  
In short,  the results  indicate  that manipulation of miRNA expression  levels can  influence  the 
replication process of L.p. in macrophages. 
Since miRNA targets can be suppressed on the protein level without being affected on mRNA 
level,  SILAC  was  performed  to  unravel  the  molecular  mechanisms  responsible  for  this 
phenotype.  THP‐1  cells were  transfected with  scrambled  sequences  or  the miRNA  pool  and 
additionally  infected with  L.p.  at  an MOI of  0.5  for  24  and 48 h  to  induce  the expression of 
infection‐related proteins  or  left  untreated as  control.  Subsequently,  the proteome of  these 
samples was analyzed using SILAC control cells labelled with heavy isotopes.  
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Differentiated  macrophages  were  infected  with  L.p.  at  an  MOI  of  0.5  or  left  untreated  as  control. 
Overexpression of the transfected miRNAs was validated with qPCR using TaqMan assays and displayed 
as  log2‐fold  change  (A, B, C). Bacterial  replication was determined by CFU assay  (D). Cells were  lysed 
after 24, 48 and 72 h post  infection. Data are depicted as percent  relative  to CFU count of  scramble‐
transfected (scr) cells at every time point. Data are shown as mean + SEM of three to four independent 
biological  replicates.  To  test  significance,  a  2‐way  ANOVA  with  Tukey  correction  was  performed: 
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dependent.  To  identify  the  target  which  led  to  the  replication  effect  we  focused  on  the 
comparison  of  scramble  transfected  cells  to  their  corresponding  overexpression  sample  to 
quantify miRNA‐induced  changes  in  protein  expression.  The  Venn‐diagram  (Fig. 3.5E)  shows 
proteins  which  were  downregulated  in  cells  transfected  with  the miRNA‐pool  compared  to 
scramble  transfected  cells  after  infection  of  24  and  48 h  (24 h  + L.p.  and  48 h  + L.p.)  or 
uninfected cells (24 h ‐ L.p.). In total, 113 proteins were downregulated following simultaneous 
overexpression  of  all  three miRNAs.  Especially, MX  dynamin  like  GTPase  1  (MX1)  and  three 
other proteins (RPL13A, RPL14, KRT2) were downregulated in all triple overexpression samples 
(irrespective of  infection). MX1  is  associated with  the  smooth ER and  is  regulated by  type 1 
and  type 2  interferons. Since MX1  is known to have broad antiviral activities,  it  is of  further 
interest for this study (Sadler and Williams 2008; Haller and Kochs 2011). Another protein that 






To  validate  the  regulation  of  MX1  protein  upon  miRNA‐overexpression  and  Legionella 
infection, the mRNA levels of MX1 were analysed by qPCR experiments. No reduction of MX1 
on mRNA level in THP‐1 cells was observed and an upregulation was only detected at 48 h post 
infection  with  Legionella  (Fig. 3.6A).  To  determine  the  MX1  expression  on  protein  level, 
intracellular  MX1  protein  was  investigated  via  indirect  immunofluorescence  staining  and 
subsequent  cytometric  analysis.  A  shift  of  the  population  away  from  the  IgG  peak  (isotype 
control) in the yellow fluorescence indicates cells positive for MX1. A reduced number of MX1‐
positive  cells  following  transfection  of  the  miRNA  pool  were  determined  (Fig. 3.6B).  The 
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Figure  3.7:  Downregulation  of MX1  enhances  L.p.  replication  in macrophages.  THP‐1  cells  or  BDMs 
were  transfected  with  a  small  interfering  RNA  targeting MX1  (siMX1)  or  with  a  scrambled  siRNA  as 
control  (scr).  24  h  post  transfection,  THP‐1  cells  were  stimulated  with  PMA  (20  nM)  for  24  h. 
Differentiated  THP‐1  cells  or  BDMs  were  infected  with  L.p.  at  an  MOI  of  0.5  for  24,  48  and  72  h. 
Knockdown of MX1 protein in THP‐1 cells (A) and BDMs (B) was verified and quantified by Western Blot. 










protein  mediated  by  siRNAs  was  more  efficient  in  BDMs  than  in  THP‐1  cells  (Fig. 3.7B). 




to monitor the  influence of MX1 on the L.p.  replication  in macrophages. Knockdown of MX1 
resulted in an increased replication of L.p.  in THP‐1 cells, similar to the effect observed upon 
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miRNA  overexpression  (Fig. 3.7E).  Aside  from  this,  the  downregulation  of  MX1  in  primary 
BDMs also yielded an increase in replication of Legionella but to a weaker extent (Fig. 3.7F). 




As  the  miRNA‐mediated  downregulation  of  MX1  on  protein  level  was  validated  by  FACS‐
staining,  the  3’UTR of MX1 was  investigated  for binding  sites of  the miRNA‐pool  (miR‐125b, 
miR‐221 and miR‐579). The in silico analysis of the 3’UTR by several prediction programs (e.g. 
TargetScan7.1,  microRNA.org)  predicted  no  binding  sites  for  either  miRNA  in  the  3’UTR  of 
MX1. Manual  investigation of  the 3’UTR  for  seed  regions of  these miRNAs  in  the 3’UTR was 
equally unsuccessful. Therefore, an Ingenuity pathway analysis (IPA) was performed to find the 
link between  the miRNA‐pool and  the downregulated MX1‐protein. Predicted and published 
targets  of  each miRNA were  visualized  (Fig. 3.8).  In  the  target  screening,  Filters were  set  to 
only  include  experimentally  observed  or  high‐confidence  predicted  microRNA/mRNA 
interaction  partners.  The  newly  found  microRNA  targets  were  interconnected  using  all 
available  data  sources  in  IPA with  restriction  to  experimentally  validated or  high‐confidence 
predicted  interactions  in humans.  In  the network all  targets of  the miRNAs  influencing MX1, 
are displayed.  
miRNAs downregulate their target mRNAs either by the repression of the translational process 
via  inhibition  of  the  translation  machinery  or  alternatively  through  the  degradation  of  the 
mRNA  (Winter,  Jung  et  al.  2009).  Since  overexpression  of  the  miRNA‐pool  resulted  in  a 
downregulation  of MX1 protein,  only  candidates  positively  regulating MX1  (marked  in  blue) 
were  of  interest  for  further  analyses.  Targets  contributing  to  a  negative  regulation  of MX1 
were unlikely to be the link between MX1 and the miRNAs (indicated in red).This filter strategy 
revealed four out of 13 possible candidates. Interferon gamma (IFNG) and Interferon Alpha 2 
(IFNA2)  showed  very  low  level  expression  in  THP‐1  cells  and were  not  detectable  via  qPCR 
(data  not  shown).  Therefore,  only  two  likely  candidates  remained  for  further  analyses: 
DExD/H‐Box Helicase 58 (DDX58), also known as RIG‐I, and Tumor protein p53 (TP53). DDX58 
encodes  for  the  RIG‐I‐like  receptor  dsRNA  helicase  enzyme.  It  functions  as  a  pattern 
recognition receptor that is a sensor for uncapped double or single stranded RNA (Yoneyama, 
Kikuchi et al. 2004; Pichlmair, Schulz et al. 2006). The gene TP53, also known as p53 (cellular 
tumour  antigen  p53),  encodes  for  a  protein  that  is  crucial  in  multicellular  organisms  and 
functions as a tumour suppressor (Bourdon, Fernandes et al. 2005; Surget, Khoury et al. 2013). 
 
















Figure  3.8:  MX1  is  not  directly  targeted  by  the  miRNA‐pool.  Igenuity  Pathway  Analysis  (IPA)  was 
performed  to  investigate  the  connection between  the miRNA‐pool  (miR‐125b, miR‐221  and miR‐579) 
and the MX1‐protein. In the target screening, Filters were set to only include experimentally observed 
or  high‐confidence  predicted  microRNA/mRNA  interaction  partners.  Output  was  limited  to  13  total 
candidates. The newly found microRNA targets were interconnected using all available data sources in 
IPA  with  restriction  to  experimentally  validated  or  high‐confidence  predicted  interactions.  Direct  or 
indirect  relationships  between  molecules  are  indicated  by  solid  or  dashed  lines,  respectively.  Blue 










Both  miRNAs  were  tested  via  qPCR  and  luciferase‐based  reporter  assays  to  evaluate  their 
influence on DDX58.  Transfection of  the  individual miR‐221  and  the miRNA‐pool  resulted  in 
decreased mRNA expression of DDX58  (Fig. 3.9B).  In  comparison, overexpression of miR‐579 
did not result in a reduced DDX58 expression (Fig 3.9B). 
To further analyze the miRNA binding of miR‐221 and miR‐579 to the DDX58 3’UTR, the 3’UTR 
fragment  of  DDX58  (length  of  813 nt)  was  cloned  into  the  psiCHECK2  vector.  This  vector 
construct (DDX58 wt) and the miRNA mimics were transfected into HEK293T cells. After 72 h, 
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the  luminescence  was  determined  as  an  indicator  of  an  interaction  between  miRNA  and 
mRNA.  A  decrease  of  luminescence  reflects  a  decrease  of  the  enzyme  which  indicates  a 
functional binding of  the miRNA to  the 3’UTR. Relative  luciferase activity was calculated and 
data  were  normalized  to  cells  transfected  with  the  empty  vector  and  the  corresponding 
miRNA‐mimic  (Fig. 3.9C).  The  relative  luciferase  activity  for  each  transfected  miRNA‐mimic 
(miR‐125b, miR‐221, miR‐579 or miR‐pool) was compared to cells co‐transfected with a non‐
specific miRNA scramble sequence (scr) to unveil the specific  interaction. The co‐transfection 




the  3’UTR of  the  vector  construct were mutated  (DDX58 mut).  Transfection of  the mutated 
version of the DDX58 3’UTR vector returned a significant increase of the relative luminescence 
compared to the wildtype 3’UTR. Therefore, the decreased luminescence was associated with 
the  loss  of  binding  of miR‐221  to  the  3’UTR  of  DDX58.  The  transfection  of  the miRNA‐pool 
together  with  the  mutated  version  also  provoked  a  significant  decrease  in  relative 
luminescence, but less significantly than the wildtype version of the 3’UTR. The co‐transfection 
of  the  miR‐579  precursor  with  either  the  wildtype  3’UTR  or  the  mutated  version  led  to  a 







To  analyze  the  direct  interaction  between  DDX58  and  MX1,  DDX58  knockdown  with 
subsequent analysis of the protein expression of MX1 was performed. As previously described, 
intracellular  MX1  was  stained  using  immunofluorescence  and  monitored  via  cytometric 
analysis,  following  downregulation  of  DDX58.  Knockdown  of  DDX58  resulted  in  a  decreased 
number of MX1‐positive cells compared to scramble transfected cells. The relative number of 
MX1‐positive cells was reduced to 75%.  
Overall,  the  luciferase assay corroborates  the observations made on the regulation of native 
transcript expression and the influence of DDX58 on MX1 protein expression was confirmed. 
 
































3’UTR DDX58 mut           5´..AGUUUGUACUAUAUUAUAUAUGCAAAGCAGUAUUCAGUGAAUCACAGCAC..	
3´UTR DDX58 wt (Postion 128 - 177) 5´..AGUUUGUACUAUAUUAUAUAUGCAAAGCACAAAUGAGUGAAUCACAGCAC.. 
                                                ||||||| 
hsa-miR-579-3p                      3’ UUAGCGCCAAAUAUGGUUUACUU 5’ 
 
3’UTR DDX58 mut           5´..AAUGGUUAUAUGUACUCAUGUUCCUGGUCUACGAACGUGUGGUAUGGCUA..	
3´UTR DDX58 wt (Postion 658 - 707) 5´..AAUGGUUAUAUGUACUCAUGUUCCUGGUGUAGCAACGUGUGGUAUGGCUA.. 
                                              |||||| 
hsa-miR-221-3p                   3’ CUUUGGGUCGUCUGUUACAUCGA 5’ 
 
3’UTR DDX58 mut           5´..AAGCUGUCCACUGUAGAGUUGCUGUAUCUACGAAUGUGUAUCCACUCUAC.. 
3´UTR DDX58 wt (Postion 754 - 803) 5´..AAGCUGUCCACUGUAGAGUUGCUGUAUGUAGCAAUGUGUAUCCACUCUAC.. 
                                            ||||||| 









+ L.p. [MOI 0.5] 48 h

























24 h 48 h
** ** **
 
Figure 3.9: miRNA‐221 and miRNA579 bind  to  the 3’UTR of DDX58. There are  two potential miRNA 
binding  sites  for miRNA‐221  and  one  for  the miRNA‐579  in  the  3’  UTR  of  DDX58  (A).  Vertical  bars 
represent  canonical  base  pairing  (C‐G;  A‐U), while  horizontal  lines  indicate  the  seed  regions  of  the 
miRNAs. The mutated bases are depicted  in  red. THP‐1 cells were  transfected either with miRNA‐221 
mimic,  miR‐579  mimic  or  the  miRNA  mimic  pool  (miR‐125b,  miR‐221  and  miR‐579)  at  a  final 
concentration of 30 nM. As a  control, a  scrambled  LNA  (scr) was  transfected. 24 h post  transfection, 
THP‐1 cells were stimulated with 20 nM PMA for 24 h. Differentiated macrophages were  infected with 
L.p. at an MOI of 0.5 for 48 h or left untreated as control. DDX58 expression was determined with qPCR 
and  displayed  as  log2‐fold  change  (B).  Luciferase  reporter  assay  analyses were  performed with  co‐




performed.  Transfected  cells were  fixed with  4%  PFA  and  stained with  an  anti‐MX1  antibody  or  an 
unspecific  IgG  antibody  as  control.  Finally,  cells were  stained  by  a  secondary  antibody  labelled with 
Alexa Fluor 555. The percentages of MX1‐positive cells were determined with FlowJo 7.6.5. The relative 
number  of MX1‐positive  cells was  calculated.  Data  are  shown  as mean  + SEM  of  three,  six  or  four 
independent biological  replicates. A  two‐way ANOVA with Sidak correction was performed: *p ≤ 0.05, 
**p ≤ 0.01, ***p ≤ 0.001 compared to scramble, # compared to wildtype. 





replication,  CFU‐assays  following  DDX58  knockdown  were  performed.  The  knockdown  was 
performed with an siRNA‐pool targeting DDX58 (siDDX58) or with a scrambled siRNA as control 
in THP‐1 cells (Fig. 3.10A) and BDMs (Fig. 3.10B). Transfected cells were subsequently infected 
with  L.p.  at  MOI  0.5  to  assess  replication  at  24,  48  and  72 h  post  infection.  Successful 
knockdown was verified via qPCR.  
BDMTHP-1
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independent  biological  experiments  are  depicted.  For  the  CFU‐Assays  a  2‐way  ANOVA  with  Sidak 
correction was performed: *p  ≤ 0.05; **p  ≤ 0.01, ***p  ≤ 0.001 compared to the corresponding control.  
 
The expression of DDX58 mRNA was reduced  in both cell  types  following transfection of  the 
siRNA‐pool  for DDX58. DDX58 downregulation was not affected by L.p.  infection. Proceeding 
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The  knockdown  of  DDX58  in  BDMs  resulted  in  an  increased  count  of  L.p.  up  to  150% 
(Fig. 3.10D). 





validated as a  target of miRNA‐125b by  several  studies  (Le, Teh et al. 2009; Qin, Zhao et al. 
2014;  Ahuja,  Goyal  et  al.  2016).  Bioinformatics  analysis  identified  one  binding  site  for 
miR‐125b  at  position  733  to  739  in  the  3’UTR  of  TP53  (in  isoform  NM_001126112.2) 
(Fig. 3.11A).  
In order  to analyze  the  influence of  the miR‐125b on TP53 mRNA expression, miR‐125b was 
overexpressed  in  THP‐1  cells.  The  transfection of  the  individual miR‐125b precursor  and  the 
miRNA‐pool showed a reduction of TP53 expression (Fig. 3.11B).  
To analyze of the influence of miR‐125b on TP53 3’UTR, the 3’UTR fragment (length of 254 nt) 
was  cloned  into  the  psiCKECK2  vector  for  luciferase  assays.  Relative  luciferase  activity  was 
calculated  and  the  data  were  normalized  as  previously  described.  The  co‐transfection  of 
miR‐125b and the miRNA‐pool with the wildtype version of the 3’UTR fragment of TP53 (TP53 
wt)  resulted  in  a  significant  decrease  of  relative  luciferase  activity  compared  to  scramble 
transfected cells (Fig. 3.11C). To identify specific binding of the miRNA to the indicated site, the 
seed  region  in  the  vector  construct was mutated  (TP53 mut)  as  shown  in  figure  3.11A.  The 
transfection  of  the  mutated  version  of  TP53  yielded  a  significant  increase  of  the  relative 
luminescence  compared  to  the  wildtype  3’UTR.  Furthermore,  lower  levels  of  transfected 
miRNA mimic also reduced the luciferase activity compared to scramble transfected cells. 
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Figure 3.12: TP53 knockdown enhances L.p. replication. BDMs were transfected with small interfering 
RNA  targeting  TP53  (siTP53)  or  with  a  scrambled  siRNA  as  control  (scr).  24  h  post  transfection, 
macrophages were  infected using L.p.  at  an MOI of 0.5  for 24, 48 and 72 h. Downregulation of TP53 
expression was verified by qPCR and displayed as log2‐fold change (A). Mean values + SEM of three to 
seven independent biological experiments are displayed. Colony forming units (CFU) were determined 






macrophages. Of  note,  binding  of miR‐579  to  the  3’UTR  of DDX58 was  not  reversed  by  the 
mutation  of  the  seed  region,  making  direct  targeting  unlikely.  Therefore,  another  target  of 
miR‐579  should  be  important  for  the  observed  replication  effect.  Since  LGALS8  protein was 
downregulated  in  cells  transfected with  the miRNA‐pool  compared  to  scramble  transfected 
cells  (Fig. 3.5E)  and  has  two  binding  sites  in  its  3’UTR  for miR‐579  (Fig. 3.13A),  LGALS8  was 
further  investigated.  Firstly,  the  influence  of  miR‐579  on  LGALS8  mRNA  was  investigated 
(Fig. 3.13B).  The  individual  overexpression  of  miR‐579  yielded  a  significantly  reduced 
expression of LGALS8, while transfection of the miRNA‐pool showed no influence.  
Secondly,  the  influence  of  miR‐579  binding  to  the  3’UTR  of  LGALS8  was  investigated  using 
luciferase assay (Fig. 3.13C). The 3’UTR fragment (length of 1634 nt) with two binding sites at 
position  2406  to  2414  and  3616  to  3622  was  cloned  into  the  psiCKECK‐2  vector  and 
transfected  in  HEK293‐T  cells  together with  the  different miRNA mimics.  Relative  luciferase 




a  significantly  reduced  luciferase  signal,  but  less  efficiently when  compared  to  the miR‐579 
transfection. In order to identify specific binding of the miRNA to the indicated sites, the seed 
regions of both binding sites in the vector construct were mutated (LGALS8 mut) as shown in 
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3’UTR LGALS8 mut                    5´..AGAAGAGTTAAGGCTTACAGTGGATATCAGGCGTCAGCTTTGGGTGCTAA.. 
3´UTR LGALS8 wt (Postion 2384 - 2433) 5´..AGAAGAGTTAAGGCTTACAGTGCAAATGAGGCGTCAGCTTTGGGTGCTAA.. 
                                         ||||||| 
hsa-miR-579-3p            3’ TTAGCGCCAAATATGGTTTACTT 5’ 
 
3’UTR LGALS8 mut                    5´..ACACTGTAAACGGACTCTGATATCATCAGGAGGTGGTCACTTCGCAACTT.. 
3´UTR LGALS8 wt (Postion 3598 - 3647) 5´..ACACTGTAAACGGACTCTCAAATGATCAGGAGGTGGTCACTTCGCAACTT.. 
                                     ||||||| 











































3’UTR  of  LGALS8  (A).  Vertical  bars  represent  canonical  base  pairing  (C‐G;  A‐U), while  horizontal  lines 
indicate  the  seed  regions  of  the  miRNAs.  The  mutated  bases  are  depicted  in  red.  THP‐1  cells  were 
transfected either with miRNA‐579 mimic or the miRNA mimic pool (miR‐125b, miR‐221 and miR‐579) at 
a  final  concentration  of  30  nM.  For  control,  a  scrambled  LNA  (scr)  was  transfected.  24  h  post 
transfection, THP‐1 cells were stimulated with 20 nM PMA for 24 h. Differentiated macrophages were 
infected  with  L.p.  at  an  MOI  of  0.5  for  48 h  or  left  untreated  as  control.  LGALS8  expression  was 
examined with  qPCR  and displayed  as  log2‐fold  change  (B). Data  are  shown  as mean  + SEM of  three 













In  order  to  elaborate  on  the  impact  of  LGALS8  on  the  infection  process,  a  knockdown  of 
LGALS8 with  subsequent CFU‐assay was performed. The knockdown was performed with an 
siRNA‐pool  targeting  LGALS8  (siLGALS8)  or with  a  scrambled  siRNA  as  control  in  THP‐1  cells 
(Fig. 3.14A) and BDMs (Fig. 3.14B). Transfected cells were subsequently infected with L.p. at an 
MOI 0.5 for 24, 48 and 72 h. Successful knockdown was verified via qPCR. The knockdown in 
both  cell  types  was  successfully  achieved  and  constant  over  time  (Fig. 3.14C,  D).  SiRNA‐
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were  infected  using  L.p.  at  an  MOI  of  0.5  or  left  untreated  as  control.  Downregulation  of  LGALS8 
expression with siRNA in THP‐1 cells (A) and BDMs (B) was verified by qPCR and displayed as log2‐fold 
changes. Mean values + SEM of three to five independent biological experiments are displayed. Colony 
forming  units  (CFU)  of  Legionella  were  determined  24,  48  and  72 h  post  infection  following  a 
knockdown of LGALS8 in THP‐1 cells (C) or in BDMs (D). Mean values + SEM of four or five independent 




infection.  In THP‐1 cells, Legionella  replication was significantly  increased  in cells  transfected 
with  siLGALS8  (up  to  152%)  compared  to  scramble  transfected  cells.  The  same  effect  was 
confirmed  in BDMs, where  the  greatest  difference  in  L.p.  replication between  scramble  and 
siLGALS8  transfected  cells was  observed  at  72 h  post  infection with  an  increase of  150%.  In 
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3.2 Identification  of  the  gene  expression  profile  during  the  course  of  Legionella 
infection by Dual RNA‐Seq 
 
The  second  part  of  this  thesis  was  set  out  to  uncover  the  most  important  transcriptional 
events  in  both  human  host  cells  and  bacteria  during  infection  with  the  lung  pathogen 
L. pneumophila.  The  dual  RNA‐Seq  method  grants  the  opportunity  to  define  the  RNA 
landscape,  including  coding  and non‐coding RNAs of  pathogen and host,  in  great depth and 
with  high  accuracy.  The  procedure  has  already  been  established  for  Salmonella  infection  of 
human  epithelial  cells  (Westermann,  Gorski  et  al.  2012; Westermann,  Forstner  et  al.  2016). 
Therefore,  one  aim  of  this  study was  the  establishment  and  adaptation  of  this method  for 





In order  to  study  the  transcriptional profile of both, host  and pathogen via dual RNA‐Seq,  a 
macrophage model needed to be selected. In humans, Legionella pneumophila infects alveolar 
macrophages in the lung. However, only relatively small numbers of alveolar macrophages can 
be  isolated  from bronchoalveolar  lavage  (BAL)  fluids  of  healthy  donors. Moreover,  the  dual 
RNA‐Seq approach includes several steps such as infection and sorting, where higher amounts 
of cells are  required  to gain enough RNA material  for  sequencing depths of both organisms. 
Therefore, THP‐1 cells were used as model for human alveolar macrophages. 
One of the most important steps for identifying transcriptional profiles of host and pathogen 
simultaneously  via  dual  RNA‐Seq was  the optimization of  infection dose  and  time points.  In 




for  sequencing.  The  time points  needed  to  characterize  different  growth  phases  of  L.p.  and 
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response  to  minimize  apoptosis‐related  transcriptional  regulation.  Thus,  cytotoxicity 
(Fig. 3.15A)  and  CXCL8  secretion  (Fig. 3.15B)  was  examined.  Compared  to  the  other  MOIs, 
MOI 15  showed  a  significant  increase  (up  to  45%)  of  cytotoxicity  at  24 h  post  infection  as 
determined by LDH‐Assay. Furthermore, all chosen MOIs triggered an inflammatory response 
to infection at both time points as displayed by the significantly increased secretion of CXCL8. 
An  MOI  10  at  16 h  post  infection  showed  a  substantial  inflammatory  response  and  low 
cytotoxicity.  Therefore,  an  MOI  of  10  and  the  infection  duration  of  16 h  were  chosen  for 





By  way  of  synthetic  control  for  TLR2‐activating  Legionella  LPS,  THP‐1  cells  were  stimulated 
with  the  TLR2  agonist  Pam3CSK4  (Pam3).  In  order  to  determine  the  concentration  for 
stimulation, PMA‐differentiated THP‐1 cells were treated with 10, 50, 100, 200 and 300 ng/mL 
of Pam3 for 8 and 16 h and CXCL8 expression was examined (Fig. 3.15D). A significant increase 
of  CXCL8  expression  was  detected  with  10 ng/mL  of  Pam3  at  8 h  and  with  100,  200  and 
300 ng/mL of Pam3 at 8 and 16 h post stimulation. Therefore, 100 ng/mL of Pam3 was used for 
subsequent experiments.  
To  separate  infected,  invaded  macrophages  from  non‐invaded  bystander  cells,  cytometric 
sorting was applied. Therefore, it was necessary to use a GFP‐expressing strain of Legionella to 
enable sorting. To guarantee that the wildtype strain and the GFP‐expressing strain trigger a 
comparable  inflammatory  response  in  macrophages,  PMA‐differentiated  THP‐1  cells  were 
infected with  the  two  strains of L.p.  at  an MOI of  10  for 8  and 16 h.  CXLC8  (Fig.  3.15E)  and 
miR‐146a expression (Fig. 3.15F) was investigated via qPCR. miR‐146a is a well‐studied miRNA 
and known to be induced during inflammation (O'Connell, Rao et al. 2012). As positive control 
for  the  inflammatory  response,  cells were  stimulated with  1 µg/mL  recombinant  IL‐1β  for  8 
and 16 h.  CXCL8 expression was  significantly  increased  in  all  three  conditions  at  8  and 16 h. 
The  expression  of  miR‐146a  was  only  significantly  induced  in  infected  THP‐1  cells.  The 
comparison between the two strains revealed only a significant difference in CXCL8 expression 
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Figure  3.15:  Establishment  of  macrophage  infection  with  Legionella  pneumophila  (L.p.)  for  dual 
RNA‐Seq. PMA‐differentiated THP‐1 cells were  infected with  increasing MOIs of GFP‐L.p.: 5; 10; 15 or 
left  untreated  as  control  (ctr).  At  2 h  post  infection,  cells  were  washed  three  times  with  PBS  and 
25 µg/mL gentamycin was added to the culture medium. Sampling was performed at 16 and 24 h post 





stimulation with  1 µg/mL  IL‐1β  at  8  and  16 h.  qPCR data  are  displayed  as  log2‐fold  change.  Data  are 
shown as mean + SEM of two to four independent biological replicates. Paired t‐tests were performed: 
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GFP‐intensity  were  considered  as  GFP‐positive  to  guarantee  the  purity  of  this  fraction.  The 
cells of three independent biological replicates were sorted and the sorting strategy as shown 
in  Figure 3.16B  was  applied  for  all  three  experiments.  To  obtain  an  appropriate  control, 
uninfected  cells  (ctr)  were  also  sorted.  At  8 h  post  infection,  approximately  16%  cells  were 
identified  as  GFP‐positive.  At  16 h  post  infection,  the  number  of  GFP‐positive  events  was 
17.7%, while the GFP intensity was higher at 16 h post infection compared to 8 h.  
In order  to verify  the applied sorting strategy, a  sub‐sample of each cell  fraction was sorted 
into PBS and subsequently  lysed with 1% saponin  for 10 min. Different dilutions of  the  lysed 
cells were plated on BCYE‐agar plates to quantify residual bacteria. Colonies were counted and 
CFU/mL  was  calculated  (Fig.  3.16C).  The  analysis  of  the  CFU/mL  in  the  different  fraction 
revealed a very low amount of bacteria in the GFP‐negative fraction whereas the GFP‐positive 
fraction  showed  an  enrichment  of  bacteria  within  the  cells.  Overall,  460  CFU/mL  were 
detected  in  the  GFP‐negative  fraction  and  over  80,000  CFU/mL  were  detected  in  the  GFP‐
positive samples. Furthermore, a 10‐fold  increase of CFU/mL was  identified when comparing 
8 h  to  16 h  post  infection  (8.07 x 104 CFU/mL  at  8 h  and  8.61 x 105 CFU/mL  at  16 h  post 






























































Figure 3.16:  FACS‐sort  settings  for  sequencing. Schematic  view of  the  infection protocol  for  the dual 
RNA‐Seq approach is displayed (A). THP‐1 cells were differentiated by the addition of PMA (20 nM) for 
24 h. After media change THP‐1 cells were  infected at an MOI of 10 with  the GFP‐L.p.  for 2 h, or  left 
untreated  as  control  (ctr).  Afterwards  cells  were  washed  three  times  with  PBS  and  gentamycin 
(25 µg/mL) was added to  the media  for  further cultivation. For  sorting and further analysis cells were 
detached at 8 or 16 h post infection. THP‐1 cells invaded by L.p. were identified via flow cytometry. GFP‐
positive  (gfp+) and GFP‐negative  (gfp‐) cells were detected via plotting PE versus Alexa Fluor 488 and 
subsequently  sorted.  One  representative  plot  of  the  sorting  strategy  is  shown  (B).  After  sorting, 







In  order  to  characterize  the  transcriptional  profile  of  both,  the  host  and  the  bacteria 
simultaneously, the dual RNA‐Seq procedure was applied as described before. The experiment 
was  performed  with  three  replicates  and  the  RNA  of  the  following  samples  was  prepared: 
Bacteria  from  inoculum  solution  (L.p.  T0),  mock  treated  cells  (ctr)  for  each  time  point, 
bystander  cells  (gfp‐)  and  the  L.p.  invaded  cells  (gfp+)  for  each  time  point.  The  RNA  was 
isolated  and  depleted  for  rRNA.  Random‐primed  libraries  were  prepared  and  sequenced 
commercially by Vertis Biotechnologie AG (Freising, Germany) without cut‐off above 50 bp on 
      Results 
99 
 




20  over  every  four  base  pair  window  by  the  program  Trimmomatic.  3’  adapters  were  also 
trimmed using Trimmomatic. Reads shorter than 20 nt after adapter trimming were discarded 
before  mapping.  The  reads  were  aligned  to  the  Legionella  Corby  genome  (NCBI  accession 
number:  400673  and  to  the  human  genome  (hg19‐GRCh37)  simultaneously  using  the  read 
aligner  STAR with  default  options  and  allowing  for  split  reads.  Reads  that  mapped  to  both 
genomes (mostly tRNAs) were discarded before further analysis.  
In  total, an average of over 11 million  reads could be mapped at 8 and 16 h post Legionella 
infection,  respectively  (Fig. 3.17A).  In  the T0 sample, where bacteria  from  inoculum solution 
were  sequenced, over 4.5 million  reads  in  total were mapped. Of  these  reads, 2% and 4.5% 
corresponded to reads mapping to the Legionella genome (displayed  in green) at 8 and 16 h 
post infection, respectively (Fig. 3.17B). Roughly 99.8% of the reads of the sequenced sample 
T0  mapped  to  the  Legionella  genome.  A  negligible  number  of  reads  were  mapped  to  the 
Legionella  genome  in  the  non‐infected  (ctr,  Pam3)  and  bystander  cells  (gfp‐)  at  either  time 
point,  while  the  rest  of  the  reads  mapped  to  the  human  genome  (depicted  in  blue).  The 
mapping  to  the  Legionella  genome  of  a  control  sample  (ctr)  with  a  maximum  of  0.07% 
mapping was higher than that of a gfp‐ sample with 0.05%. 
In  short,  the  percentage  of  bacterial  reads  increased  over  time,  and  nearly  all  reads  were 
mapped  to  the  human  genome  in  the  non‐infected  cells  at  both  time  points.  More 
importantly, an extremely  low number of Legionella  reads were found  in the bystander cells 
(gfp‐) reflecting an inbuilt control of the cell sorting process. 















8 h 16 h0 h
A
B
Source organism Sample ID # human reads (Mean) # Legionella reads (Mean) Total reads (Mean)
Legionella L.p. T0 10,542 4,583,946 4,594,488
Human ctr 10,851,482 2,681 10,854,162
Human PAM3CSK4 8,443,769 1,609 8,445,378
Human gfp‐ 13,605,314 2,901 13,608,214
Human & Legionella gfp+ 11,584,581 328,912 11,913,492
 
Figure 3.17: Bioinformatics analysis of the dual RNA‐Sequencing data. PMA‐differentiated THP‐1 cells 
were  infected with GFP‐L.p.  (MOI 10),  stimulated with 100 ng/mL Pam3CSK4  (Pam3) or  left untreated 
(ctr). At 2 h post infection, cells were washed three times with PBS and 25 µg/mL gentamycin was added 
to  the  culture medium.  Sampling was  performed  at  8  and  16 h  post  treatment.  After  RNA  isolation, 
rRNA was depleted. Libraries were prepared  for sequencing of  three  independent experiments of  the 
following samples: Bacteria from inoculum solution (L.p. T0), mock treated cells (ctr) for each time point, 








Given  the  previous  results,  the  obtained  read  coverage  of  mapped  reads  was  sufficient  to 
detect reliable expression levels of both bacterial and human mRNAs, as well as bacterial and 
human  non‐coding  RNAs.  Further  expression  analysis  was  focused  on  the  human  or  the 
pathogen side.  
First,  the  transcriptional  profile  of  the  human  macrophages  was  investigated  and  the 
distribution of  the RNA species was analysed.  In  total, 73.8% of all  transcripts  to  the human 
genome were protein coding, 6.2% processed pseudogenes, 5.7% antisense transcripts, 4.75% 
lncRNAs  and  0.55% miRNAs  (Fig.  3.18A).  Furthermore,  differential  gene  expression  analysis 
was  performed  using  DESeq2,  resulting  in  a  total  of  4,144  differentially  expressed  human 
genes  (across multiple  conditions).  In  general, more upregulated  than downregulated  genes 
were  identified  (Fig.  3.18B).  Less  significantly  regulated  genes  were  detected  in  the  gfp‐ 
samples  than  in  the gfp+ or Pam3 samples across both time points.  In order  to examine  the 
quality  and  to  visually  represent  the  global  sample  variation  of  the  sequenced  samples,  a 
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principal  component  analysis  (PCA)  was  performed  (Fig. 3.18C).  PCA  was  performed  by  Dr. 
Wilhelm Bertrams (Institute for Lung Research in Marburg, Germany) and normalized reads of 
genes (5,433) with an adjusted p‐value ≤ 0.01 from the differentially expression analyses were 





Figure  3.18:  Bioinformatics  analysis  of  the  hosts  differentially  expressed  genes.  PMA‐differentiated 
THP‐1 cells were infected with GFP‐L.p. (MOI 10), stimulated with 100 ng/mL Pam3CSK4 (Pam3) or left 
untreated (ctr). At 2 h post infection, cells were washed three times with PBS and 25 µg/mL gentamycin 
was  added  to  the  culture medium.  Sampling was  performed  at  8  and 16 h  post  treatment.  RNA was 
isolated  and  rRNA  depletion  was  performed.  Samples  were  prepared  for  sequencing  of  three 
independent  experiments  of  the  following  samples:  mock  treated  cells  (ctr)  for  each  time  point, 
bystander  cells  (gfp‐),  L.p.  invaded  cells  (gfp+)  and  Pam3CSK4  stimulated  cells  for  each  time  point. 
Random‐primed  libraries  were  prepared  and  sequenced  without  cut‐off  above  50  bp  on  an  Illumina 
NextSeq  500  system  using  75  bp  read  length.  After  read  trimming  and  alignment,  significantly 
differentially expressed genes were  identified using DESeq2. Cut‐offs were  set p   ≤ 0.05, p  adjusted ≤ 
0.05  and  log2‐fold  change  > 1.5.  Percentage  distribution  of  the  RNA  species  of  all  significant 
differentially  expressed  genes  of  the  human  samples  is  displayed  (A).  The  numbers  of  the  human 
differentially expressed genes are indicated for the different samples (gfp‐, gfp+ or Pam3). The sum of 
all differentially up‐  (red) and downregulated  (blue) genes  is  shown  (B). Principal  component analysis 
(PCA) of all  significant differentially expressed genes was performed (C). A correlation analysis  for  the 
human  samples  based  on  the  similarity  of  the  differentially  expressed  genes  is  displayed  (D).  High 
correlation is indicated by dark and big circles, while low correlation is shown by bright small circles. 
 
In  order  to  visualize  the  correlation  between  the  different  conditions  and  time  points,  a 
correlation analyses was performed by Dr. Brian Caffrey.  In this plot, correlation coefficients, 




to  the degree of  association between  variables  (Fig.  3.18D). High  correlation  is  indicated  by 
dark and big circles, while low correlation is shown by bright small circles. The gfp+ cells at 8 h 








As  mentioned  above,  the  sequencing  data  were  normalized  to  the  non‐infected  control 
samples  and  differential  expression  analysis  was  performed  using  DESeq2.  The  analysis 
revealed  3,504  differentially  expressed mRNAs  during  the  course  of  L.p.  infection.  Data  are 
displayed in a heatmap, which shows upregulated mRNAs in red and downregulated mRNAs in 
blue  (Fig.  3.19A).  Above  the  heatmap  a  dendrogram  is  depicted.  A  dendrogram  is  a  tree 
diagram  that  is  used  to  visualize  the  arrangement  of  the  clusters  produced  by  hierarchical 
clustering  (Everitt  1998).  In  this  plot,  the dendrogram  shows  a  clustering  for  each  condition 
between  the  8  and  16 h  time  point.  Additionally,  gfp‐  cells  cluster  closely  to  the  Pam3 
stimulated cells than to the gfp+ cells. Therefore, the gfp+ cells show a distinct position besides 
gfp‐ and Pam3.  
Furthermore,  the  heatmap  of  differentially  expressed  mRNAs  shows  gene  clusters  which 
indicate  differential  gene  regulation  at  different  times  and  conditions.  It  allows  for  the 
recognition  of  clusters  indicating  genes  which  are  upregulated  or  downregulated  in  all 
conditions  (gfp+,  gfp‐,  Pam3)  or  mainly  upregulated  in  Pam3  samples.  To  validate  the 
transcription  of  genes  showing  an  upregulation  in  all  three  conditions,  a  qPCR  analysis was 
performed. The expression of the inflammatory cytokine IL‐1β (Fig. 3.19B) and the member of 
the superoxide dismutase SOD2 (Fig. 3.19C) was significantly increased in gfp‐, gfp+ and Pam3 
cells  compared  to  the  ctr  samples.  Additionally,  the  expression  of  IL‐1β  and  SOD2  was 
significantly  increased  in  gfp+  compared  to  gfp‐  cells.  Therefore,  an  increase  in  all  fractions 
(gfp‐, fgp+ and Pam3) was observed. Furthermore, clusters specific for the gfp+ sample were 
detected in the heatmap. One cluster displays genes only highly upregulated or downregulated 
in gfp+. Another cluster  shows genes upregulated  in gfp+ with a downregulation  in gfp‐ and 
Pam3, which displays an interesting section of genes.  
 










bystander  cells  (gfp‐),  L.p.  invaded  cells  (gfp+)  and  Pam3CSK4  stimulated  cells  (Pam3)  for  each  time 
point.  Random‐primed  libraries  were  prepared  and  sequenced  without  cut‐off  above  50  bp  on  an 
Illumina NextSeq 500  system using 75 bp  read  length. After  read  trimming and alignment,  significant 
differentially  expressed  genes  were  identified  using  DESeq2.  Results  are  shown  in  a  heatmap  (A). 
Expression of IL‐1β (B) and SOD2 (C) mRNAs in THP‐1 cells after L.p. infection was validated by qPCR and 
displayed as log2‐fold change. Data are shown as mean + SEM of four independent biological replicates. 
Paired  t‐tests  were  performed:  *p ≤ 0.05,  **p ≤ 0.01,  ***p ≤ 0.001,  ****p ≤ 0.0001  compared  to  the 
corresponding control, or #p ≤ 0.05, ##p ≤ 0.01 compared to gfp‐cells. 




specific  for  gfp+  samples  and  revealed  a  substantial  difference  between  gfp+  and  the  other 




The  DESeq2  analysis  of  the  lncRNAs  revealed  495  differentially  expressed  genes.  The 
sequencing data are visualized in a heatmap with a hierarchical clustering above (Fig. 3.20A).  




clustering.  In  total,  the  heatmap  shows  expression  clusters  with  transcripts  mainly  up‐  or 
downregulated  in  Pam3  cells  or  transcripts  up‐  or  downregulated  in  all  conditions. 
Additionally, two clusters of lncRNAs specifically upregulated in gfp+ cells were recorded. Two 
example  lncRNAs were  validated  using  qPCR.  The  expression  of  LINC00278  (Fig.  3.20B)  and 
LINC00346 (Fig. 3.20C) was analysed and showed a significant upregulation in gfp+ cells at 16 h 
post treatment. The expression of LINC00278 was even significantly downregulated at 8 h post 
treatment  in  gfp+  cells,  while  the  expression  of  LINC00346  was  significantly  increased.  No 
significant  expression  changes  were  detected  in  gfp‐  cells  at  8  and  16 h  post  infection 
indicating that those lncRNAs are specifically regulated in gfp+ cells.  
In  summary,  the  lncRNA  expression  profile  showed  a  different  clustering  compared  to  the 
mRNA  expression  profile.  In  addition,  lncRNAs  specific  for  gfp+  cells  were  identified  and 
validated via qPCR. 
 








rRNA  depletion  was  performed.  Samples  were  prepared  for  sequencing  of  three  independent 
experiments of the following samples: mock treated cells (ctr) for each time point, bystander cells (gfp‐), 
L.p.  invaded  cells  (gfp+)  and  Pam3CSK4  stimulated  cells  (Pam3)  for  each  time  point.  Random‐primed 
libraries were prepared and sequenced without cut‐off above 50 bp on an Illumina NextSeq 500 system 
using 75 bp read  length. After  read trimming and alignment,  significant differentially expressed genes 
were  identified  using  DESeq2.  Results  are  shown  in  a  heatmap  (A).  Expression  of  LINC00278  (B)  and 
LINC00346 (C) mRNAs in THP‐1 cells after L.p. infection was validated by qPCR and displayed as log2‐fold 
change. Data are shown as mean + SEM of  four  independent biological  replicates. Paired  t‐tests were 









expressed  miRNAs.  The  results  of  the  sequencing  are  displayed  in  a  heatmap  with  a 
dendrogram  above  (Fig.  3.21A).  It  shows  the  arrangement  of  the  clusters  produced  by 
hierarchical clustering. Based on the dendrogram, a clustering of the 8 and the 16 h time point 
of each condition  is observable  in gfp‐ and Pam3 cells. Additionally,  the gfp+ sample at 16 h 




specific  for  gfp+  at  16 h  post  treatment  were  detectable  and  showed  strong  regulation. 
Additionally,  genes  of  Pam3  cells  at  8  and  16 h  post  treatment  are  stronger  regulated  than 
genes  of  gfp‐  or  gfp+  cells.  In  general,  a  gradual  up  or  downregulation  over  time  can  be 
reported  for  all  three  conditions.  In  order  to  highlight  the  transcriptional  regulation  of  two 
miRNAs  investigated  before,  the  log2‐fold  expression  of  the  miR‐146a‐5p  (Fig.  3.21B)  and 
miR‐221‐3p  (Fig.  3.21C)  of  the  heatmap  are  depicted.  The  expression  of  miR‐146a  was 
increased  in all  conditions and both  time points, while miR‐221  showed a  slightly decreased 
expression in gfp+ cells.  
In short,  the clustering analysis of the miRNAs showed no clustering of the gfp+ cells at 16 h 
post  treatment  to  the  other  samples  and  only  few  clusters  specific  for  cells  invaded  by 
Legionella as observed for the lncRNAs or the mRNAs. 
 







with  25 µg/mL.  Sampling  was  performed  at  8  and  16 h  post  infection.  RNA  was  isolated  and  rRNA 
depletion was performed. Samples were prepared for sequencing of three independent experiments of 
the following samples: mock treated cells  (ctr) for each time point, bystander cells  (gfp‐), L.p.  invaded 
cells  (gfp+) and Pam3CSK4 stimulated cells  (Pam3) for each time point. Random‐primed  libraries were 
prepared and sequenced without cut‐off above 50 bp on an Illumina NextSeq 500 system using 75 bp 
read  length.  After  read  trimming  and  alignment,  significant  differentially  expressed  genes  were 





In  order  to  identify  significantly  regulated  genes  specific  for  gfp+  cells,  an  Edwards‐Venn 
diagram was created using  the  JavaScript  library  jvenn.  It processes  lists and produces Venn 





































































































































































































































(ZFAND2A)  and  Heat  Shock  Protein  Family  A  (Hsp70)  Member  1A  (HSPA1A).  The  genes 
ZFAND2A  and HSPA1A were  considered  to be  Legionella  specific, while  the other  validated 
genes were found to be exclusively regulated in Legionella invaded cells.  
All  examined  genes were  significantly  upregulated  in  invaded  cells  (gfp+)  compared  to  not 
infected control cells  (ctr) at both time points  (8 and 16 h).  In the bystander cells, the genes 
BCL10  (Fig. 3.23A),  CYR61  (Fig. 3.23D),  RND3  (Fig. 3.23F),  JUN  (Fig. 3.23G),  ZFAND2A 
(Fig. 3.23H)  and HSPA1  (Fig. 3.23I)  showed  significant  upregulation  either  at  8  or  16 h  post 
infection  compared  to  control  cells.  It  is  worth  noting  that  these  genes  were moderately 
upregulated  (log2‐fold  change  of  0.5  to  1.5) with  the  exception  of  ZFAND2A  and  HSPA1A 
(log2‐fold change of 1.9 to 5.4). These two genes were identified using jvenn to be regulated in 
gfp‐ as well as in gfp+ cells, which can be confirmed by the qPCR results. 
The  genes  SOD1  (Fig.  3.23B),  IRS1  (Fig.  3.23C)  and ATG5  (Fig. 3.23E)  showed  no  significant 
regulation  in gfp‐ cells, but a significant  increased upregulation  in gfp+ cells. For Pam3 cells, 






the  infected cells, and can be used as specific markers of Legionella  infection  in this  infection 
setting. 
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Figure  3.23:  Validation  of  genes  using  jvenn.  PMA‐differentiated  THP‐1  cells  were  infected  with 









The  analysis  of  the  dual  RNA‐seq  data  revealed  not  only  the  regulation  of  different  RNA 
species from the human side, but also the gene expression of the pathogen within the human 
macrophages was also analysed. The separation of host and pathogen reads was performed in 
silico. After  bioinformatics  analysis,  differentially  expressed mRNAs  of  Legionella  during  the 
course  of  infection  at  8  and  16 h  post  infection were  identified  using DESeq2.  As  reference 
control, bacteria from inoculum solution were used and sequencing data were normalized to 
them. After applying cut‐offs (adjusted p‐value needed to be lower than 0.05 and the log2‐fold 
change  higher  than  1.5  or  lower  than  ‐1.5),  DESeq2  analysis  revealed  2,707  differentially 
expressed Legionella genes across both time points (8 and 16 h post infection). Among them, 






sequencing  data  are  visualized  in  a  heatmap  and  all  differentially  expressed  mRNAs  of 










differentially  regulated  in  intracellular  vs.  control  bacteria.  They  are  first  upregulated  at  8 h 
and  downregulated  at  16 h  post  infection.  Furthermore,  the  genes  flgB  and  flgG  are  both 
upregulated  at  the  16 h  time  point  and  are  components  of  flagellum  and  necessary  for 
bacterial motility.  
In  short,  the  DESeq2  analysis  of  the  protein  coding  genes  of  Legionella  revealed  many 
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Figure  3.24:  Differentially  expressed mRNAs  of  Legionella  during  L.p.  infection.  PMA‐differentiated 
THP‐1 cells were infected with GFP‐L.p. (MOI 10), stimulated with 100 ng/mL Pam3CSK4 (Pam3) or left 
untreated (ctr). At 2 h post infection, cells were washed three times with PBS and 25 µg/mL gentamycin 




sequenced without  cut‐off  above 50 bp on  an  Illumina NextSeq 500  system using 75 bp  read  length. 
After  read  trimming  and  alignment,  significant  differentially  expressed  genes  were  identified  using 
DESeq2.  Cut‐offs  were  set  p ≤ 0.05,  p  adjusted  ≤ 0.05  and  log2‐fold  change  > 1.5.  The  numbers  of 
differentially expressed genes in Legionella compared to T0 are indicated for 8 and 16 h post infection in 
macrophages.  The  sum  of  all  differentially  up‐  (red)  and  downregulated  (blue)  genes  is  shown  (A). 
Differentially expressed genes  in Legionella  are displayed  in a heatmap. A  sub‐panel  indicates mRNAs 
contradictorily regulated between 8 and 16 h post infection.  
 




Legionella pneumophila is an intracellular pathogen accounting for 4% of ambulant pneumonia 
cases in Germany (Robert-Koch-Institut 2012). This gram-negative bacterium is highly adapted 
to intracellular replication. It manipulates vital host cell functions like vesicle trafficking and 
gene expression by secretion of specific virulence factors into the host cell cytosol. Thus, 
Legionella modifies host gene regulation for its own benefit. One main goal of this study was 
to characterize transcriptional expression changes of different RNA species in response to 
infection with Legionella in human macrophages.  
An unbiased and global analysis of the molecular changes and biological processes that are 
associated with bacterial infections of eukaryotic cells can provide new insights into host-
pathogen interactions. The increasing sensitivity of high-throughput RNA sequencing enables 
dual RNA-Seq which allows the parallel transcriptomic analysis of two different organisms 
interacting with each other. This procedure was used to quantify deregulated RNA species 
during the course of Legionella infection in macrophages and to further characterize host-
pathogen interactions in a complex network of coding and non-coding RNAs. Overall, this 
technique enables the identification of new virulence factors from the pathogen side, or new 
pathways in the host cell that respond to the exposure to specific pathogens (Westermann, 
Gorski et al. 2012). In this study, the first steps were done to identify the interaction network 
between Legionella and human macrophages.  
In the last decades, non-coding RNAs have been found to be important regulators of immune 
function. Especially miRNAs have been established as regulators of immune function. They are 
regulating immune responses of mammalian cells to a pathogenic threat at the post-
transcriptional level to prevent harmful consequences of immune mechanisms. Therefore, one 
specific goal of this study was to identify the miRNA profile of Legionella-infected macrophages 
and to determine the functional impact of selected miRNAs.  
 
 
4.1 L.p.-induced changes of miRNA expression and their importance for bacterial 
replication 
miRNAs are critical regulators of many biological processes including cell proliferation, 
metabolic pathways, immune response, and development (Bartel 2004; Kloosterman and 
Plasterk 2006; Taganov, Boldin et al. 2007; O'Connell, Rao et al. 2010; Deiuliis 2016). 
Furthermore, it is known that miRNAs are also key mediators of the host response to infection, 




signaling. One known strategy adopted by intracellular bacteria to survive in host cells is the 
modulation of miRNAs that regulate TLR pathways. Therefore, pathogens have evolved to 
interfere with miRNAs and alter the inflammatory response (Das, Garnica et al. 2016).  
Legionella pneumophila manipulates its host in a highly sophisticated way to promote its own 
replication. Thus, it is very likely, that miRNA regulation in L.p.-infected macrophages is not 
only due to host response, but may also be directly influenced by Legionella.  
In humans, L.p. infects alveolar macrophages (Chandler, Hicklin et al. 1977). Since the 
availability of human alveolar macrophages for experimental purposes is limited, primary 
human blood-derived macrophages were used in this study to mimic the infection with L.p. in 
the lung. As described before, BDMs can been cultured either in presence of M-CSF, GM-CSF or 
human serum in order to differentiate to macrophages. It has been shown that M-CSF 
circulates at high concentrations in the blood, while GM-CSF is predominant in the lung and 
regulates alveolar macrophage differentiation (Shibata, Berclaz et al. 2001). Additionally, 
cultivation in the presence of human serum gives rise to macrophages that resemble tissue 
macrophages that develop in the GM-CSF rich environment of the lung (Akagawa, Kamoshita 
et al. 1988; Waldo, Li et al. 2008). Thus, isolated monocytes from the blood of healthy donors 
were cultivated in human off-the-clot AB serum to generate blood-derived macrophages in 
vitro to resemble alveolar macrophages. These cells were considered suitable L.p.-hosts.  
 
 Infection of macrophages with L.p. for miRNA expression analysis 4.1.1
In order to identify differentially expressed miRNAs in response to infection, human BDMs 
were infected with different MOIs for 24 and 48 h. MOI 0.25 and MOI 0.5 were selected for 
further analysis, since the cells showed a substantial inflammatory response with low 
cytotoxicity (Fig. 3.1A,B).  
When higher amounts of cells were needed, PMA-differentiated THP-1 cells were chosen as an 
experimental model for primary human macrophages in this study. The availability of primary 
human monocytes is limited and accounts for only 3-9% of all blood leukocytes. Additionally, 
donor variability, accessibility, and contamination with other blood components can interfere 
or mask biologically significant results (Qin 2012). Some experiments were repeated in BDMs 
to rule out cell line specific effects. To compare the inflammatory response of L.p.-infected 
THP-1 cells and BDMs, the secretion levels of different cytokines, including CXCL-8, IL-1β, IL-6, 
GM-CSF, TNF-α and IL-10, were tested (Fig. 3.1C, D; 3.2A-J). According to our results, the 
secretion pattern of both cell types was very similar and comparable. Furthermore, a previous 




macrophages, compared to other human myeloid cell lines, such as HL-60, U937, KG-1, or HEL 
cell lines (Auwerx 1991). Thus, THP-1 cells seem to be a suitable cell line model for primary 
BDMs. Furthermore, both investigated cell types (THP-1 cells and BDMs) showed an increased 
secretion of pro-inflammatory cytokines in response to an infection with L.p.. This is not 
surprising, since the stimulation or the infection with L.p. triggers TLR signaling in macrophages 
leading to NF-κB activation and to active transcription of pro-inflammatory genes, such as 
CXCL8 (Massis and Zamboni 2011; Cunha and Zamboni 2014; Naujoks, Lippmann et al. 2017). 
Copenhaver and colleagues found that alveolar macrophages and neutrophils are the primary, 
intracellular reservoir for L.p. in mice and that these cell types are the major source of pro-
inflammatory cytokines, such as TNF-α and IL-1β which contribute to the host immune 
response (Copenhaver, Casson et al. 2014). In this study, similar results were obtained using 
primary macrophages or THP-1 cells instead of alveolar macrophages. The secretion of TNF-α 
and IL-1β was significantly increased in L.p.-infected BDMs and THP-1 cells compared to non-
infected control cells, which indicated the successful stimulation of the cells with L.p.. Thus, 
deep sequencing analysis of BDMs infected with L.p. at an MOI of 0.25 for 24 and 48 h was 
performed to identify differentially expressed.  
 
 Changes in the miRNA profile of human BDMs in response to infection 4.1.2
To date, miRNA studies have been performed for several other intracellular pathogens, such as 
Mycobacteria tuberculosis, Salmonella typhimurium, Listeria monocytogenes, and Francisella 
tularensis (Das, Garnica et al. 2016). For Legionella, the miRNA profile was only determined in 
murine macrophages via TaqMan Low Density Arrays (TLDA) where the expression of pre-
selected miRNAs was determined (Jentho, Bodden et al. 2017). The present study describes for 
the first time the total miRNA regulation in human blood-derived macrophages (primary 
BDMs) in response to L.p.-infection. DESeq2 analysis of the sequencing data revealed 54 
differentially expressed miRNAs in human BDMs infected with L.p. at an MOI of 0.25 for 24 and 
48 h. The results showed a time dependent upregulation or downregulation of the miRNAs in 
response to infection with L.p. (Fig. 3.3A). Thus, miRNA regulation seems to be stronger after 
48 h of infection. Studies investigating the miRNA response to other pathogens have also 
chosen longer infection time points (Schulte, Eulalio et al. 2011; Liu, Zhou et al. 2014). This was 
also confirmed by further experiments where the expression levels of selected miRNAs were 
tested via qPCR. The chosen miRNAs showed stronger or more frequently significant 
regulations at 48 h post infection. Exemplarily, the miRNAs miR-146a, miR-155, miR-27a and 




downregulated in response to L.p.-infection in BDMs at 48 h post infection (Fig. 3.3B, D). 
miR-146a and miR-155 are well known miRNAs that are involved in inflammatory responses to 
pathogens (O'Connell, Taganov et al. 2007; Nahid, Satoh et al. 2011a; O'Connell, Rao et al. 
2012). Other studies also described an upregulation of miR-146a and miR-155 in macrophages 
following infection with intracellular pathogens. For instance, miR-146a and miR-155 were 
upregulated in BCG-infected RAW264.7 macrophages (Li, Yue et al. 2013), in Salmonella-
infected RAW264.7 macrophages (Schulte, Eulalio et al. 2011) and in Listeria-infected murine 
bone marrow derived macrophages (Schnitger, Machova et al. 2011b). This upregulation is not 
surprising, since TLR4‐mediated sensing of bacterial lipopolysaccharide (LPS) and downstream 
NF-κB activity induces the expression of miR-146a and miR-155 and are known to accumulate 
following stimulation of macrophages with bacterial LPS (Taganov, Boldin et al. 2006; 
O'Connell, Taganov et al. 2007; Androulidaki, Iliopoulos et al. 2009; Ceppi, Pereira et al. 2009). 
Furthermore, upregulation of miR-125a was also observed in response to infection with 
M. tuberculosis and L. monocytogenes (Schnitger, Machova et al. 2011a; Kim, Yuk et al. 2015). 
Schnitger et al. found that miR-125a regulation was TLR2- and MyD88-dependent. Intriguingly, 
this MyD88-dependent upregulation of miR-125a-3p was also confirmed in murine BMMs 
infected with L.p. by another study (Jentho, Bodden et al. 2017). Thus, miR-125a regulation in 
this study may be due to TLR2 activation by Legionella-LPS and hints towards a mechanism 
that is conserved across species.  
Furthermore, the miRNAs miR-3196 and miR-4284 were highly upregulated in L.p.-infected 
BDMs and showed only high abundances in infected BDMs. miR-3196 is a promising miRNA for 
further investigation, since this miRNA is implicated in the regulation of apoptosis in lung 
cancer cells via targeting the p53 upregulated modulator of apoptosis (PUMA) pathway (Xu, 
Zhang et al. 2016). Additionally, this miRNA has been found to be upregulated in different 
types of cancer (Sand, Skrygan et al. 2012; Pena-Chilet, Martinez et al. 2014; Gao, Zhou et al. 
2016). Since it is known that L.p. secretes effector proteins to inhibit apoptosis, this miRNA 
may be upregulated by Legionella to prevent apoptosis of the host cell (Ge, Gong et al. 2012). 
Additionally, it has been demonstrated that downregulation of miR-4284 increased the 
phosphorylation and activity of the c-Jun N-terminal kinase (JNK)/stress-activated protein 
kinase (SAPK), resulting in an increased abundance of phosphorylated c-Jun and total c-Fos. 
Both are major components of the transcription factor AP-1 which plays an important role in 
regulation of apoptosis. Thus, the miR-4284 also seems to be a promising candidate for further 
investigations.  
Highly downregulated miRNAs following infection with L.p. in BDMs were miR-1180 and 




proliferation. Thus, downregulation of miR-1180 is associated with different types of cancer, 
including bladder cancer (Wang, Chen et al. 2014) and pancreatic cancer (Gu, Zhang et al. 
2017). Different studies claimed that overexpression of miR-1180 may exert anti-cancer effects 
(Ge, Wang et al. 2017). Downregulation of miR-1228 in A549 cells has been shown to be 
associated with cellular apoptosis through a mitochondria-dependent pathway. Another study 
found a reduction of miR-1228 expression in apoptotic cells. Induced miR-1228 expression 
attenuated the progression of cellular apoptosis via targeting MOAP1 signaling pathway. 
Furthermore, miR-1228 was shown to be upregulated in breast cancer cell lines and tissues 
and an increased expression provoked cell growth, invasion and migration. Since both 
described miRNA are involved in the regulation of apoptosis, they could have a role in 
L.p.-infections. Downregulation of miR-1228 could be a host response, since it is known that an 
infection with L.p. induces apoptosis (Mou and Leung 2018), whereas the reduced expression 
of miR-1180 could be actively achieved by Legionella, since L.p. can prevent host cell death to 
ensure multiplication within macrophages (Ge, Gong et al. 2012). Regulation of apoptosis by 
miRNAs could represent a battleground of host and pathogen during the course of infection. 
All four miRNAs have been described to be involved in regulating apoptosis and may be 
interesting candidates for further investigations, as their opposing functions might represent 
such a battleground of host and pathogen.  
In this study, the expression of miR-146a, miR-155, miR-27a, miR-125a, miR-221, miR-221, 
miR-125b, miR-26a and miR-29b was investigated in L.p.-infected BDMs via qPCR and 
confirmed the sequencing results. Some of the validated miRNAs, including miR-146a, 
miR-155, miR-125b and miR-221, were chosen to be tested in THP-1 cells. Indeed, the selected 
miRNAs showed the same expression profile in BDMs as in THP-1 cells after L.p.-infection 
(Fig. 3.3C, E). Other studies also confirmed this observation, since they reported that miRNA 
regulation of several miRNAs, such as miR-146a/b, miR-132, miR-155, miR-214, miR-195a and 
miR-16, was comparable in THP-1 and primary cells (Qin 2012). Thus, the miRNA profile in 
THP-1 cells seems to be largely comparable to that of primary BDMs, as observed in the 
present study. Furthermore, the correlation in global gene expression between THP-1 cells and 
primary cells in response to LPS stimulation was investigated by Sharif and colleagues. They 
found that the LPS-induced transcriptional response in THP-1 cells is very similar to primary 
monocyte-derived macrophages. Compared to that, the LPS response in U937 cells was 
dramatically different to both, THP-1 and monocyte-derived macrophages, suggesting that 
THP-1 cells represent a better model system for investigating the mechanisms of LPS and 
NF-κB dependent gene expression in macrophages (Sharif, Bolshakov et al. 2007). Another 




treated monocytes via microarray (Kohro, Tanaka et al. 2004). They found 75 and 104 
significantly changed genes in PMA-treated THP-1 cells and GM-CSF treated monocytes, 
respectively. The comparison between the two cell types revealed high similarity and only 
small differences in the transcriptome of PMA-differentiated THP-1 cells and primary 
macrophages. Nevertheless, Kohro et al. argued that the results of experiments done with 
THP-1 cells need to be carefully interpreted (Kohro, Tanaka et al. 2004). Furthermore, one 
study demonstrated that PMA-differentiated THP-1 cells contain elevated levels of MHC class I 
and class II mRNAs even in the absence of additional activating factors, which displays a 
critical, immunologically relevant macrophage function. This observation enhances the utility 
of PMA-differentiated THP-1 cells as a macrophage model for in vitro studies (Asseffa, Dickson 
et al. 1993). Taken together, under certain circumstances, the gene expression in THP-1 cells is 
comparable to that of primary cells, as observed in the present study for the miRNA regulation. 
Thus, THP-1 cells can be used as cell line model instead of BDMs when higher amounts of cells 
were necessary. 
Overall, 54 different miRNAs were differentially expressed in BDMs upon L.p.-infection. Some 
of them were validated in BDMs as well as in THP-1 cells, representing the comparability 
between the cell line and the primary cells. Given that each miRNA may affect the expression 
of hundreds of genes (Selbach, Schwanhausser et al. 2008), further investigation of the 54 
differentially expressed miRNAs can reveal interesting candidates that play an important role 
in Legionella infection in human macrophages.  
 
 miRNAs in macrophages are regulated on the transcriptional level in response 4.1.3
to Legionella-infection 
In order to understand the mechanism of miRNA regulation in response to L.p.-infection, the 
histone H4 acetylation of the promoter region of the four selected miRNAs (miR-146a, 
miR-155, miR-221 and miR-125b) was investigated (Fig. 3.4A). Acetylation of histones is one of 
the master regulators of gene expression in mammalian development and human disease 
(Egger, Liang et al. 2004) and can strongly impact inflammatory and host defence responses 
(Ribet and Cossart 2010). Acetylation is controlled by histone acetyltransferases (HATs) and 
histone deacetylases (HDACs) and often associated with active transcription by rendering 
chromosomal domains more accessible to the transcription machinery. Thus, it is plausible 
that the histone H4 acetylation grade of the miRNA-promoter regions correlated with the 
miRNA expression post infection (Fig. 4A-E). For instance, an open chromatin structure within 




mature miRNAs by processing with Drosha and Dicer. Thus, the pri-miR expression of the 
selected miRNAs and the expression of Dicer and Drosha upon infection with L.p. for 24 and 
48 h were investigated. The correlation of the pri-miR expression with the acetylation level of 
the promoter region following infection with L.p. in face of the unchanged expression of Dicer 
and Drosha, led to the conclusion that miRNAs are transcriptionally regulated in macrophages 
in response to a Legionella-infection. A transcriptional regulation of the promoter region of a 
miRNA has exemplarily been described for miR-127. This miRNA is also controlled by 
epigenetic alterations in its promoter region, including DNA methylation and active histone 
marks, as shown by inhibitors of HDACs and DNA methylation (Saito, Liang et al. 2006). 
It has been shown that some bacteria alter the acetylation of histones and thereby change 
gene transcription. For instance, the infection of endothelial cells with L. monocytogenes led to 
an activation of p38 and ERK/MAPK pathways which was linked to an increased acetylation of 
histone H3 and H4 and led thereby to transcriptional activation of MAPK induced genes 
(Schmeck, Beermann et al. 2005). A study focusing on Anaplasma phagocytophilum, which is a 
tick-transmitted Rickettsia and an intracellular pathogen, demonstrated that an infection of 
macrophages led to silencing of host defence gene expression which was correlated with an 
increase in HDAC1 activity and a decrease in histone H3 acetylation on the promoters of 
defence genes (Garcia-Garcia, Barat et al. 2009).  
Legionella can also influence the histone code of the host by secreting the effector RomA via 
T4SS, which localizes to the nucleus of the infected cell. There, it promotes a burst of H3K14 
methylation and consequently decreases H3K14 acetylation, an activating histone mark, to 
repress gene expression. Thus, L.p. is actively modifying host histones to promote efficient 
intracellular replication (Rolando, Sanulli et al. 2013). 
In summary, the acetylation levels of the miRNA promoters were altered in response to L.p. 
infection. Alterations of the acetylation levels can be caused by the host cell as response to the 
infection or histone acetylation on gene promoters can be actively manipulated by Legionella.  
 
 miRNAs can manipulate Legionella replication inside human macrophages 4.1.4
In the present study, miR-125b and miR-221 were significantly downregulated upon 
L.p.-infection in both, THP-1 cells and BDMs. It has been found that miR-125b, miR-221 and 
miR-579 are implicated in the process of endotoxin tolerance. These miRNAs were shown to 
be upregulated in tolerant macrophages to prevent the translation of TNF-α and therefore 
leading to a diminished immune response (El Gazzar and McCall 2010). This process required 




and miR-125b. The miRNAs were coupled to RNA-binding proteins TTP, AUF1, and TIAR at the 
3' untranslated region to arrest protein synthesis of TNF-α. TIAR was bound to miR-125b and 
miR-579, whereas miR-221 was linked to TTP and AUF1 proteins. They found that miR-221 led 
to TNF-α mRNA decay, while miR-125b and miR-579 mediated translational arrest. Thus, they 
found an implication of these miRNAs in diminishing the inflammatory response in 
macrophages (El Gazzar and McCall 2010). Based on these finding, the role of the three 
miRNAs during L.p. infection was investigated. In order to assess if manipulation of miR-125b, 
miR-221 and miR-579 provokes an influence on intracellular replication of L.p., CFU-assays 
were performed upon overexpression or inhibition of the three miRNAs. Indeed, an 
overexpression of all three miRNAs caused an increased replication of L.p., whereas a 
downregulation of all three miRNAs led to a decreased replication of Legionella (Fig. 3.5A-D). It 
is important to point out that a combination of all three miRNAs was necessary for this effect 
and an overexpression of each miRNA separately or pairwise did not alter L.p.-replication.  
miR-125b is a highly conserved miRNA that has multiple targets, including proteins regulating 
apoptosis, innate immunity, inflammation, and differentiation (Chaudhuri, So et al. 2011; Le, 
Shyh-Chang et al. 2011; Surdziel, Cabanski et al. 2011). miR-125b targets 20 genes that are 
involved in apoptosis and proliferation including TP53, BAK1, CDC25C and CDKN2C, which are 
part of the p53 network, and is therefore implicated in the regulation of oncogenesis (Le, Shyh-
Chang et al. 2011). Depending on the cellular context, miR-125b shows different patterns of 
regulation. For instance, in some tumor types, miR-125b is upregulated and displays oncogenic 
potential, while in other tumor entities, miR-125b is heavily downregulated and acting as 
tumor suppressor gene (Banzhaf-Strathmann and Edbauer 2014). Moreover, miR-125b has 
been found to be downregulated in macrophages upon TLR4 ligation (Tili, Michaille et al. 2007; 
Androulidaki, Iliopoulos et al. 2009; Murphy, Guyre et al. 2010), which is in accordance with 
the finding of this study. In contrast to that, one study reports that miR-125b promoted 
macrophage activation, IFN-γ response and immune function in macrophages (Chaudhuri, So 
et al. 2011): Overexpression of miR-125b led to reduced levels of IRF4, which is a negative 
regulator of pro-inflammatory pathways in macrophages. Thus, the study of Chaudhuri and 
colleagues argues against the observed replication effect in the present study, since an 
increased pro-inflammatory response seems not to be compatible with an increased Legionella 
replication within macrophages. Furthermore, Chaudhuri et al. claim that downregulation of 
miR-125b serves as natural mechanism to limit inflammatory response. However, it has been 
observed by El Gazzar and McCall that increased expression and not downregulation of 
miR-125b prevented an exaggerated inflammatory response. Furthermore, one study showed 




targeting CCNA2 and eEF2K. This observation is in accordance with the present study, since NO 
production in macrophages is important for killing pathogens (MacMicking, Xie et al. 1997). An 
impact of miR-125b on bacterial replication has been described before by Liu and colleagues. 
They showed that an infection of macrophages with Brucella abortus, an intracellular 
pathogen, downregulated the expression of miR-125b, which is in line with the observation of 
the present study (Liu, Wang et al. 2016). Furthermore Liu et al. and others found that 
miR-125b targets A20, an inhibitor of NF-κB (Kim, Ramasamy et al. 2012; Haemmig, 
Baumgartner et al. 2014; Liu, Wang et al. 2016). The inhibition of A20 mediated by miR-125b 
led to decreased intracellular replication of Brucella abortus (Liu, Wang et al. 2016). This 
observation is in contrast to the finding of the present study where an enhanced miR-125b 
expression led to an increased replication of L.p. within macrophages. However, another study 
showed the reversed effect with an influence on viral replication. An inhibition of miR-125b 
expression resulted in decreased hepatitis B virus (HBV) replication in hepatoma cells (Deng, 
Zhang et al. 2017), which is in accordance with the present study, since a downregulation of all 
three miRNAs led to a decreased L.p.-replication. The variability of the results that were 
obtained from different research groups implicate that the role of miR-125b is highly 
dependent on the cell type and the pathogen used.  
miR-221 und miR-222 belong to the same miRNA-family, share the same seed sequence and 
were both downregulated following Legionella-infection in the present study. They are 
encoded as a cluster located on chromosome X and have been reported to be overexpressed 
in many types of cancer (Sun, Yang et al. 2009). The oncogenic activity of miR-221 has been 
linked to the ability to regulate cell cycle progression by targeting CDKN1C/p57 and 
CDKN1B/p27 (Visone, Russo et al. 2007; Fornari, Gramantieri et al. 2008). The key cell cycle 
inhibitor, p27, influenced by miR-221, seems to be important during dendritic cell 
development and maturation of human monocytes (Lu, Huang et al. 2011). Moreover, it has 
been shown that miR-221 is important for the regulation of several cellular processes in 
human umbilical vascular endothelial cells (HUVECs). One study showed that miR-221/-222 
overexpression decreased p38/NF-κB and ICAM-1 expression leading to less pro-inflammatory 
responses (Liu, Sung et al. 2017). Chen et al. found that miR-221 represses adiponectin 
receptor protein 1 (AdipoR1) expression in HUVECs and thereby inhibits NO production (Chen, 
Huang et al. 2015). If NO production and both p38- and NF-κB-signalling pathways are 
repressed by miR-221 in macrophages, the increased replication of L.p. within macrophages 
following overexpression of miR-221 could be partly explained. Furthermore, miR-221 and 
miR-222 inhibit endothelial cell migration, proliferation, and angiogenesis in vitro by targeting 




expression in endothelial cells (Urbich, Kuehbacher et al. 2008). Additionally, it has been 
shown that miR-221 expression was selectively decreased in LPS-treated macrophages as well 
as in the lungs of LPS-challenged mice (Zhao, Zhuang et al. 2016). Although the experiments 
were performed in mice, this observation is in line with the finding of the present study, where 
a downregulation of miR-221 in response to a Legionella-infection was observed. On the other 
hand, in the same study, Zhao et al. found that overexpression of miR-221 in macrophages 
significantly increases NF-κB and MAPK activation which was associated with the production of 
pro-inflammatory cytokines. These findings do not support the observations of the present 
study, since an increased pro-inflammatory response would not provoke an enhanced 
Legionella-replication in macrophages. Moreover, one study describing regulated miRNAs in 
porcine Salmonella infections showed a suppressed expression of miR-221, miR-125b and 
miR-27b in peripheral blood at 2 days after Salmonella inoculation and confirmed the 
miRNA-downregulation in response to an intracellular bacterium (Yao, Gao et al. 2016). The 
study showed that FOS is a direct target of miR-221 and miR-125b can suppress MAPK14. 
Thereby, the involvement of miR-125b and miR-221 in Salmonella infections in pigs was 
demonstrated and supports the replicative effect observed in the present study (Yao, Gao et 
al. 2016). The controversial findings about miR-221 underline again the importance of the 
experimental setup.  
miR-579 is a poorly characterized miRNA. Besides its role during LPS tolerance in macrophages, 
it has been shown to act as master regulator of melanoma progression and drug resistance 
(Fattore, Mancini et al. 2016). However, an involvement in inflammatory responses to bacteria 
has not been described so far.  
Taken together, the three miRNAs are involved in LPS tolerance and influence Legionella 
replication in macrophages. Many targets of miR-125b and miR-221 are described which 
regulate several different cellular processes, including cell cycle control and apoptosis. Despite 
that, the mechanism responsible for the altered replication of Legionella in macrophages upon 
miRNA manipulation observed in the present study needed to be determined.  
 
 MX1 is an indirect target of the miR-125b, miR-221, miR-579 4.1.5
Having shown that the manipulation of the expression of miR-125b, miR-221 and miR-579 can 
affect intracellular replication, the direct or indirect target responsible for this effect was to be 
determined next. A miRNA can regulate many of its targets at the transcriptional level without 
affecting mRNA abundance (Grosshans and Filipowicz 2008). For instance, Leivonen et al. 




according to microarray gene expression data (Leivonen, Rokka et al. 2011). Thus, proteomics 
methods are best suited for revealing the full spectrum of miRNA targets. In order to unravel 
the molecular mechanism responsible for the observed replication effect of L.p., SILAC was 
performed. For this method, isotopically labeled amino acids (mostly arginine and lysine) are 
added to the THP-1 culture medium. Proteins of cells cultivated in medium containing either 
normal amino acids (light) or labeled amino acids (heavy) are quantified and analyzed by 
tandem MS. SILAC quantifies a great number of proteins and has the advantage of 
incorporating the labeled amino acids during cultivation and before preparation. This markedly 
reduces potential biases due to separate handling of the samples (Gruhler and Kratchmarova 
2008). One limitation of this method is that it cannot be used for autotrophic organisms, tissue 
and body fluid samples (Elliott, Smith et al. 2009). However, it is applicable to cultured cells 
and can be used for THP-1 cells. Additionally, for this study, secreted proteins were not 
measured since supernatants were removed and cells were lysed before sample preparation. 
As already shown, SILAC was used for the identification of miRNA targets for several studies. 
For instance, Lössner et al. identified 46 putative targets of miR-155 in HEK293-T cells (Lossner, 
Meier et al. 2011). Chou et al. showed that ERF is a direct target of miR-27 in lung cancer cells 
by the successful application of SILAC for miRNA target identification (Chou, Lin et al. 2010). 
However, miRNA-mediated regulation of proteins with long half-lives may not be detected by 
measuring steady-state protein level, since proteins have different turnover times and miRNAs 
mostly cause slight decreases in protein translation. Thus, the proteome of different conditions 
and time points (not infected 24 h, infected with L.p. MOI 0.5 for 24 h, infected with L.p. 
MOI 0.5 for 48 h) was analyzed to identify protein expression changes mediated by the three 
miRNAs (miR-125b, miR-221, miR-579). MX1 protein was found to be downregulated following 
overexpression of all three miRNAs in all tested conditions (Fig. 3.5E). Since it was shown to be 
implicated in restricting viral replication, it was further investigated (Haller and Kochs 2011).  
The human gene MX1 encodes a 78 kDa protein called MX1 or MxA (Aebi, Fah et al. 1989; 
Horisberger, McMaster et al. 1990) and belongs to and shares many properties of the dynamin 
superfamily of large GTPases (Haller, Gao et al. 2010). It consists of 3 domains, an N-terminal 
GTPase domain that binds and hydrolyses GTP, a middle domain mediating self-assembly, and 
a carboxy-terminal GTPase effector domain which is also involved in self-assembly, but 
additionally mediates viral target recognition (Haller and Kochs 2011). MX1 proteins appear to 
assemble into long filamentous structures at physiological salt concentration which are 
detectable by electron microscopy. In the presence of guanosine nucleotides the filaments 
rearrange into rings that tubulate negatively charged liposomes, and associate with the 




membrane binding for MX1 protein is still poorly understood. It may have some general 
function in intracellular protein transport and sorting (Haller, Staeheli et al. 2015).  
MX1 downregulation following overexpression of all three miRNAs was validated via 
immunofluorescence with subsequent cytometric analysis (Fig. 3.6B, C). MX1 is induced 
predominantly by type I and II IFNs and its non-constitutive expression is tightly regulated by 
these IFNs (Holzinger, Jorns et al. 2007). Although it has been previously described that 
interferon-related genes, including MX1, are upregulated following transfection of 23-mer 
miRNA mimics - independently of their sequence - triggered by double-stranded RNA 
(Goldgraben, Russell et al. 2016), MX1 expression was reduced following overexpression of the 
miRNA pool in the present study. Compared with the nuclear rodent Mx1, human MX1 protein 
is located in the cytoplasm. Human MX1 protein exhibits about 70% amino acid sequence 
similarity to rodent Mx2 proteins, while it shares only 63% amino acid sequence similarity to 
human MX2 (Haller, Staeheli et al. 2015). Furthermore, human MX1 is more closely related to 
bovine, porcine, canine, feline, and bat Mx1 than to the human MX2 protein that in turn 
shares more sequence similarity to Mx2 proteins of these species (Haller, Staeheli et al. 2015). 
While it has been newly identified that human MX2 is a restriction factor for HIV-1 and other 
primate lentiviruses, human MX1 is able to inhibit a broad set of DNA and RNA viruses that 
replicate in the cytoplasm or in the nucleus, such as vesicular stomatitis virus (VSV) (Staeheli 
and Pavlovic 1991), human parainfluenza virus-3 (hPIV3) (Zhao, De et al. 1996), hepatitis B 
virus (HBV) (Yu, Wang et al. 2008; Li, Zhang et al. 2012), La Crosse virus (LACV) (Kochs, Janzen 
et al. 2002), Influenza A virus (IAV) (Xiao, Killip et al. 2013), African swine fever virus (ASFV) 
(Netherton, Simpson et al. 2009) and avian influenza A viruses (FLUAV) (Deeg, Mutz et al. 
2013). The antiviral activities of human MX1 are mediated by the direct interaction with crucial 
viral components. For instance, the nucleocapisd of FLUAV and THOV consists of genomic RNA 
segments associated with viral nucleoprotein and RNA polymerase (vRNPs). The nuclear 
translocation of these vRNPs is blocked by MX1 which leads to the inhibition of transcription 
and replication of the virus genomes. Thus, MX1 interferes with synthesis and/or nuclear 
import of newly synthesized viral components (Kochs and Haller 1999). Furthermore, it is 
known that VSV replicates in the cytoplasm. There, MX1 inhibits primary transcription of 
incoming viral nucleocapsids (Staeheli and Pavlovic 1991). In the case of Bunyaviruses, such as 
LACV, MX1 sequesters viral N protein into perinuclear complexes. The viral N protein is 
crucially needed for viral genome replication by the viral polymerase and synthesized in the 
early viral transcription. Thus MX1 blocks the viral replication (Reichelt, Stertz et al. 2004).  
Based on these findings, it was tested if knockdown of MX1 interferes with Legionella 




lead to an enhanced intracellular replication (Fig. 3.7A-F). It is known that L.p. manipulates 
various key host regulatory pathways in order to establish a LCV. The LCV is decorated with 
many bacterial and host factors to prevent bacterial degradation and enable intracellular 
replication. Proteomics screens identified that several small and large GTPases are associated 
with the LCV. It was demonstrated that these GTPases are functionally involved in the LCV 
formation as well as in the replication process (Hilbi, Rothmeier et al. 2014; Hilbi and Kortholt 
2017). The ER membrane is associated with many large GTPases that mediate membrane 
fusion and remodel the shape of the entire ER (Hu and Rapoport 2016). Since MX1 belongs to 
the dynamin superfamily of large GTPases, it seems likely that it also influences Legionella 
replication. For instance, it has been observed that the large GTPase dynamin-related protein 1 
(Drp1 or Dnm1l) is involved in Legionella replication (Arasaki, Mikami et al. 2017). Together 
with syntaxin 17, Drp1 regulates mitochondrial dynamics and autophagy. The secreted effector 
protein Lpg1137 binds and cleaves syntaxin 17 during intracellular replication leading to an 
altered activity of the large GTPase Drp1 and changed Legionella replication. Thus, modulation 
of ER by hijacking, either directly or indirectly, large GTPases can impact Legionella replication 
(Arasaki, Mikami et al. 2017).  
In contrast to this hypothesis, MX1 cannot be found in the proteome of LCVs within human 
macrophages as shown by Bruckert and Kwaik (Bruckert and Abu Kwaik 2015). Bruckert and 
Kwaik infected U937 macrophages with L.p. strain AA100/130b which is a different cell line 
and bacterial strain as used in this study. As discussed before, it has been shown that the LPS 
response in U937 cells was dramatically different to both THP-1 and blood-derived 
macrophages. Therefore, their response to a Legionella-infection could also differ compared to 
THP-1 cells and BDMs. Furthermore, it is possible that MX1 mediates its effects on Legionella 
replication without being associated to the LCV. One possibility could be that MX1 binds 
liposomes which are important for LCV formation leading to the diminished replication. Its 
ability to restrict Legionella replication could also be mediated by trap of ER tubules which 
normally promote the organelle remodeling and LCV formation.  
Overall, MX1 protein expression was downregulated following overexpression of all three 
miRNAs (miR-125b, miR-221, miR-579). SiRNA-mediated knockdown of MX1 protein led to an 
increased intracellular replication of L.p., as observed following overexpression of the three 
miRNAs. Thus, MX1 protein expression is influenced by the three miRNAs. Since it possesses 
no binding sites for the three miRNAs in its 3’UTR, MX1 seems to be indirectly targeted. In 
order to determine the targets of the miRNAs that influence MX1 protein expression, Ingenuity 
pathway analysis (IPA) was performed and revealed possible targets (DDX58 and TP53) 




 DDX58 as target of miR-221 with impact on replication 4.1.6
Luciferase reporter assays revealed the binding of miR-221 to the 3’UTR of DDX58, as 
predicted by computational analysis (IPA) (Fig. 3.9C). An interaction and co-expression (i.e. 
controlled by the same transcriptional regulatory program, functionally related, or members of 
the same pathway or protein complex) of MX1 and DDX58 was also suggested by the String 
Database (Szklarczyk, Morris et al. 2017) and additionally confirmed by the DDX58 knockdown 
experiments with subsequent staining and cytometric analysis of intracellular MX1 protein 
performed in the present study (Fig. 3.9D). Furthermore, the targeting of DDX58 by miR-221 
seems to be specific, as mutation of the seed region abrogated the reduction of the relative 
luminescence activity. For miR-579, a reduction of the relative luminescence activity was 
detected, but targeting does not seem to be specific as indicated by luciferase assay, where 
the seed region for miR-579 was mutated. Thus, this study describes for the first time the 
direct targeting of DDX58 by miR-221. It has been only reported that miR-545 (Song, Ji et al. 
2014; Liu, Dou et al. 2016), miR-34a (Wang, Zhang et al. 2016) and miR-485 (Ingle, Kumar et al. 
2015) target DDX58 and thereby influence viral replication or apoptosis in cancer cells.  
The gene DDX58 encodes the cytosolic RIG-I-like receptor (RLR) RIG-I. RLRs, including MDA5 
and RIG-I, recognize cytosolic double-stranded RNA or single-stranded RNA containing 5'-
triphosphate (5'-ppp). An activation of RIG-I or MDA5 activates MAVS to trigger a large-scale 
amplification of a signaling cascade. This cascade involves the recruitment of cytosolic adaptor 
molecules, followed by the activation of the canonical IKKs, the MAPK and the non-canonical 
IKK-related kinase. Ultimately, specific transcription factors, such as IRF3 and NF-κB are 
activated and translocated to the nucleus. Within the nucleus, expression of type I IFN-
dependent genes and pro-inflammatory cytokines are induced (Vabret and Blander 2013). It 
has been demonstrated by several groups that type I IFNs restrict Legionella replication in 
macrophages and epithelial-like cell lines (Schiavoni, Mauri et al. 2004; Opitz, Vinzing et al. 
2006; Stetson and Medzhitov 2006). Opitz and colleagues claimed that the translocation of 
IRF3 and NF-κB-p65 to the nucleus to induce type I IFN genes requires the IFN-β promoter 
stimulator 1 (IPS-1, also known as MAVS), but not RIG-I or MDA5. However, they used 
epithelial cells and not macrophages, but the type I IFN response accounted for bacterial 
growth restriction. An addition of exogenous type I IFN to macrophages inhibited the 
replication of L.p. in non-permissive macrophages (Schiavoni, Mauri et al. 2004; Plumlee, Lee 
et al. 2009).  
Although RIG-I and MDA5 were initially reported as sensors of viral infection, it has been 
shown that Legionella also activates the RIG-I/MDA5 pathway. Furthermore, the RIG-I pathway 




that L.p.-RNA is released to the cytosol of host cells and triggers the RIG-I/MDA5 pathway 
(Monroe, McWhirter et al. 2009). An active translocation of bacterial RNA to the cytoplasm has 
also been described for other bacteria, such as L. monocytogenes and H. pylori (Rad, Ballhorn 
et al. 2009). In both cases, the release of bacterial RNA led to the activation of RIG-I (Rad, 
Ballhorn et al. 2009; Abdullah, Schlee et al. 2012; Hagmann, Herzner et al. 2013).  
On the other hand, L.p.-DNA secreted into the host cytosol via the T4SS also stimulated the 
induction of type I IFN genes. Double-stranded DNA of L.p. was reported to be converted to 
intermediary double-stranded RNA via the DNA-dependent RNA-polymerase (Pol-III) which 
leads to the activation of the RIG-I/MDA5 pathway (Stetson and Medzhitov 2006; Chiu, 
Macmillan et al. 2009). This observation was confirmed by inhibition of Pol-III which leads to 
abrogation of IFN-β induction by L.p. and promotes bacterial growth (Chiu, Macmillan et al. 
2009). Additionally, in vitro resistance to an infection with L.p. in macrophages is dependent on 
STING- and IRF3-mediated production of type I IFNs. An upregulation of type I IFN genes 
suppressed replicating and non-replicating L.p. within their LCVs, and protected against 
Legionella lung infections in vivo (Lippmann, Muller et al. 2011). Furthermore, RNA Pol-III, 
which transcribes foreign cytosolic DNA into the RIG-I ligand 5'-triphosphate RNA, seems to be 
involved in the restriction of S. flexeneri infection. Thus, RIG-I is able to sense DNA and RNA. 
Furthermore, it has been shown, that Legionella secretes a bacterial protein, SdhA, which 
suppresses the RIG-I/MDA5 pathway (Monroe, McWhirter et al. 2009) suggesting the 
importance of this pathway to influence Legionella replication.  
All described observations hint to a role of this pathway in Legionella infections. A knockdown 
of RIG-I mediated by siRNA (Fig. 3.10A, B) increased the replication of Legionella in BDMs and 
THP-1 cells (Fig. 3.10C, D). It is possible that both, the direct inhibition of RIG-I as well as the 
inhibited activation of MX1 by RIG-I, are contributing to the replication effect observed in this 
study.  
 
 TP53 as target of miR-125b with impact on replication 4.1.7
Ingenuity pathway analysis showed that TP53 is a direct target of miR-125b, which was already 
demonstrated by others (Le, Teh et al. 2009; Qin, Zhao et al. 2014; Ahuja, Goyal et al. 2016). In 
this study, the direct binding of miR-125b to the 3’UTR of TP53 was also validated by the 
mutation of the binding sites via luciferase assay (Fig. 3.11C).  
TP53 or p53 is a master regulator of the cellular mechanisms controlling responses to cellular 
stress such as DNA damage, aberrant oncogene activation, loss of normal cell-cell contacts, 




provokes an activation of TP53. TP53 acts as a transcriptional regulator, which controls the 
expression of effector proteins and miRNAs, leading to the regulation of apoptosis, cellular 
proliferation, and autophagy (Sullivan, Galbraith et al. 2018). Thus, inactivation of TP53 is a 
hallmark of cancer development. The TP53 gene is the most frequently mutated gene in 
human cancer, highlighting the crucial role of this gene in regulating cellular proliferation and 
apoptosis (Kandoth, McLellan et al. 2013; Soussi and Wiman 2015). Since regulation of the 
cellular stress response is tightly connected with metabolic regulation, p53 is also involved in 
the cellular energy metabolism and the redox balance regulating glycolysis. It dampens 
glycolysis and promotes oxidative phosphorylation (Itahana and Itahana 2018).  
Furthermore, p53 also seems to be important in viral infections. Mice deficient in p53 are 
more permissive to viral infection (Munoz-Fontela, Garcia et al. 2005). It is induced in response 
to viral infections as a downstream transcriptional target of type I IFN signaling (Takaoka, 
Hayakawa et al. 2003). Furthermore, p53 is also activated indirectly by type I IFN through other 
IFN-inducible proteins, such as promyelocytic leukemia protein (PML), STAT1, or IFIXα-1 
(Townsend, Scarabelli et al. 2004; Ding, Lee et al. 2006; Pampin, Simonin et al. 2006). In 
addition, one study showed the association between TP53 and MX1 in IFN signaling. An 
increased expression of p53 was accompanied by enhanced expression of MX1, as well as RIG-I 
and IRF7 which strengthens its implication in the type I IFN signaling (Munoz-Fontela, Macip et 
al. 2008).  
Many viruses, including SV40, Influenza A virus, human papillomavirus, Kaposi's sarcoma 
herpesvirus, adenoviruses, and even RNA viruses such as polioviruses, have evolved 
mechanisms to affect p53 expression and abrogate p53-dependent responses to enable viral 
replication. Furthermore, it was shown that the interferon-stimulated gene ISG15 is induced by 
p53 and that p53 is required for optimal gene induction by double-stranded RNA (dsRNA) 
(Hummer, Li et al. 2001). For instance, the small DNA tumor polyomavirus SV40 binds p53 and 
inhibits p53-dependent transcription, resulting in accumulation of inactivated p53 protein and 
cellular transformation (Bargonetti, Reynisdottir et al. 1992; Jiang, Srinivasan et al. 1993). Thus, 
p53 inhibition is beneficial for viral replication.  
Since L.p. also activates a type I IFN response, the influence of TP53 knockdown on intracellular 
replication was tested. Indeed, the knockdown of TP53 (Fig. 3.12A) led to an increased 
replication of Legionella(Fig. 3.12B).  
Several studies showed that TP53 has a role in controlling bacterial infection and that 
inhibition of p53 may confer certain selective advantages to bacteria (Zaika, Wei et al. 2015). 
The first described bacterium, which inhibits p53 and induces its degradation, is H. pylori. This 




of H. pylori, 75% of gastric cancers would not occur. Typically, infections with H. pylori induce 
cellular stress because the bacteria induce DNA damage and disturb normal cellular 
homeostasis leading to p53 activation (Baik, Youn et al. 1996; Toller, Neelsen et al. 2011). 
However, H. pylori dampens the activity of p53 protein by inducing its degradation (Wei, Nagy 
et al. 2010; Buti, Spooner et al. 2011). Additionally, H. pylori alters the expression profile of 
p53 isoforms to change the cellular stress response (Wei, Noto et al. 2012). An inhibition of 
p53 activity was also observed for infection with Mycoplasma bacteria (Logunov, Scheblyakov 
et al. 2008). Furthermore, it was shown that Chlamydia trachomatis (C. trachomatis) also 
induces degradation of p53. The downregulation of p53 provide the bacteria with necessary 
metabolites and protects against oxidative stress (Siegl, Prusty et al. 2014). As Chlamydiae, 
Legionella are intracellular bacteria, which strictly rely on host resources. Since metabolic 
control of p53 provides antibacterial protection, inhibition of p53 seems to be important for 
bacterial survival and growth, as seen in this study.  
In the present study, the knockdown of TP53 by an siRNA-pool was not successful in THP-1 
cells. Several studies argue that TP53 is not expressed or not functional in THP-1 cells (Traore, 
Trush et al. 2005). One study claimed that p53 mRNA from THP-1, U937, and UT-7 had partial 
deletions of 26, 46, and 136 bases, respectively (Sugimoto, Toyoshima et al. 1992). 
Furthermore, Akashi and colleagues showed that THP-1 cells and U937 do not express p53 
mRNA. Also treatment of THP-1 cells with PMA showed no induction. However, they 
stimulated the cells only for 4 h with different concentrations of PMA (0.2, 2 or 20 nM) (Akashi, 
Osawa et al. 1999). In the present study, THP-1 cells were stimulated for at least 24 h with 
20 nM PMA, which may induce differences in the expression profile. Furthermore, THP-1 cells 
used in the present study were expressing p53 mRNA, which was proven via qPCR. The 
sequencing data, performed in this study supporting the observation that the used THP-1 cells 
express p53 mRNA. Furthermore, the data of the human protein atlas also indicating an 
expression of p53 in THP-1 cells, with a Transcripts per Kilobase Million (TPM) of 4.9. The RNA-
Sequencing data of the human protein atlas (HPA) project can give detailed information about 
a specific cell line and a TPM value of 1.0 is defined as a threshold for expression of the 
corresponding protein.(www.proteinatlas.org ; Uhlen, Fagerberg et al. 2015). Other studies 
also showed an expression of p53 on mRNA and even on protein level in THP-1 cells after 
diverse treatments (de Kreutzenberg, Ceolotto et al. 2010; Suzuki, Sasaki et al. 2010; Chen, Lin 
et al. 2011). Furthermore, Khatri et al showed that p53 mRNA level was also induced when 
PMA-differentiated THP-1 cells were treated with nanoparticles (Khatri, Bello et al. 2013), 




In contrast to the progenitor cell populations, the non-proliferating, mature cell populations, 
identified by CD20 (B-lymphocytes), CD3 (T-lymphocytes), CD15 (granulocytes), and CD 14 
(monocytes), express low, but detectable levels of p53. The expression of p53 in CD14-positive 
monocytes was examined via flow cytometric analysis (Kastan, Radin et al. 1991). Additionally, 
they showed that the expression of p53 can be induced upon cell differentiation. This was 
confirmed by the present study, since differentiated BDMs expressed p53 on mRNA and 
protein level. A study showed that ML-1 cells, a myeloid, leukemia cell line, such as THP-1 cells, 
were stimulated with PMA leading to increased protein levels of p53, differentiation into 
macrophages and cell replication stop. Thus, this study hints also towards a stable induction of 
p53 protein following PMA stimulation. Therefore, the p53 protein expression of the THP-1 
cells, used in the present study, was analysed. Indeed, p53 is expressed in THP-1 cells as shown 
by the Western Blot (supplement 1B). Additionally, PMA stimulation lead to an induced 
expression of p53 protein and was reduced by an infection with Legionella. Furthermore, a 
partial knockdown of p53 by the siRNA pool was achieved as indicated by the western Blot 
(reduction to 80%) (supplement 1C). This change of p53 protein was not significant and there 
was no difference in mRNA level detectable. Thus, further experiments are important to make 
a conclusion about the influence of p53 on L.p.-replication in THP-1 cells.  
However, the results of the present study, performed in BDMs, indicate a role of p53 in 
Legionella replication, which was also shown for other bacteria.  
 
 LGALS8 as target for miR-579 with impact on replication 4.1.8
Ingenuity pathway analysis revealed only two putative targets for miR-579 that might be 
involved in MX1 regulation: DDX58 and IFNA2. IFNA2 was expressed at low levels in THP-1 
cells, thus it is not considered to be the primary target of miR-579 that leads to the regulation 
of bacterial replication. Binding of miR-579 to the 3’UTR of DDX58 was demonstrated, but the 
mutation of the seed region did not reverse the reduction. Thus, direct binding of miR-579 was 
unlikely. Another target of miR-579 appears to be important for the replication effect, since all 
three miRNAs were necessary for the effect on Legionella replication. LGALS8 was detected by 
SILAC to be downregulated following overexpression of all three miRNAs (Fig. 3.5E). 
Furthermore, LGALS8 expression was significantly reduced following miR-579 overexpression 
and its 3’UTR possesses two binding sites for miR-579 (Fig. 3.13A, B). Thus, luciferase assays 
were performed to confirm the binding of miR-579 to the 3’UTR. Indeed, a binding of miR-579 
was validated. A mutation of the seed region led to a slight restoration of relative luciferase 




completely prevent the binding of miR-579, a deletion of the whole miRNA binding site may be 
useful. Nevertheless, binding of miR-579 was confirmed and mutation of the seed region led to 
a significant increase in relative luciferase activity. A miRNA regulation of LGALS8 has not been 
described before. Thus, this study describes for the first time a targeting of LGALS8 by 
miR-579.  
The gene LGALS8 encodes the protein galectin-8 which belongs to the galectin family. 
Galectins are glycan-binding, evolutionary conserved proteins and have pleiotropic roles in 
innate and adaptive immune responses (Yang, Rabinovich et al. 2008; Rabinovich and Toscano 
2009). For the binding to carbohydrates, galectins contain one or more carbohydrate-
recognition domains (CRDs) (Yang, Rabinovich et al. 2008). Galectins are localized in the 
intracellular compartment and in the cell nuclei. Moreover, several galectins are secreted by 
cells through an unusual route that requires intact carbohydrate-binding activity of the 
secreted protein, where they bind glycans to modulate cellular behavior (Yang, Rabinovich et 
al. 2008). Within the cytosol, galectins prevent the formation of complex carbohydrates. Thus, 
they function as a kind of danger and pattern-recognition receptor. For instance, galectin-3 
accumulates on damaged bacteria-containing vesicles (Paz, Sachse et al. 2010). Galectin-3 as 
marker for vacuole integrity was used for different intracellular pathogens, such as S. enterica 
serovar Typhimurium, Shigella flexneri, and Trypanosoma cruzi (Paz, Sachse et al. 2010; 
Machado, Cruz et al. 2014). It was shown that the cytosolic lectin, galectin-8, also localizes to 
damaged vesicles and restricts Salmonella replication in HeLa cells (Thurston, Wandel et al. 
2012). In addition, the data of Thurston et al. are in line with the results of the present study, 
since an siRNA-mediated knockdown (Fig. 3.14A, B) of galectin-8 led to an increased replication 
of Legionella (Fig. 3.14C, D). Furthermore, Thurston and colleagues demonstrated that 
galectin-8 monitors endosomal and lysosomal integrity and detects bacterial invasion by 
binding host glycans exposed on damaged Salmonella-containing vacuoles. Additionally, they 
showed that galectin-8 activates antibacterial autophagy by recruiting the adaptor NDP52, a 
xenophagy-specific receptor. Since galectin-8 also detected sterile damage to endosomes or 
lysosomes they claimed that galectin-8 serves as a versatile receptor for vesicle-damaging 
pathogens. Thus, galectin-8 seems to be a danger receptor to combat infection by monitoring 
endosomal and lysosomal integrity and the absence of galectin-8 could explain the enhanced 
replication of Legionella (Thurston, Wandel et al. 2012). An association of galectin-8 within the 
LCV of infected human macrophages at 6 h post infection was already validated, hinting 




Overall, galectin-8 was validated as a target of miR-579. Furthermore, the role of galectin-8 as 
danger receptor to restrict the replication of intracellular bacteria was confirmed, since a 
knockdown of galectin-8 enhanced intracellular replication of Legionella.  
 
 Proposed model 4.1.9
In order to summarize the major findings of this study, a schematic model is displayed in 
Fig. 4.1. The results indicate that changes of miRNA expression influence bacterial replication, 
since overexpression of the miRNA-pool (miR-125b, miR-221 and miR-579) led to an increased 
Legionella replication. Moreover, miR-125b binds to the 3’UTR of TP53 and reduces its 
expression, while miR-221 targets DDX58 (RIG-I). Thereby, both miRNAs downregulate their 
targets, which co-occurs with downregulation of MX1 and altered Legionella replication. In 
addition to its known antiviral activities, MX1 possesses an antibacterial effect on Legionella. 
Furhtermore, miR-579 affects LGALS8 by reducing its expression which also influences 
Legionella replication. Thus, both, MX1 and LGALS8, are responsible for the restriction of 
L.p.-replication within human macrophages. 

Figure 4.1: Scheme of MX1 and LGALS8 regulation by overexpressed miRNAs to influence L.p. 
replication in macrophages. Overexpressed miRNA-125b reduces the expression of TP53, while DDX58 
(RIG-I) is targeted by miRNA-221. Both targets further regulate the protein expression of MX1, which 
possesses an antibacterial effect on Legionella. Furthermore, miRNA-579 further acts on LGALS8 to 
reduce its expression. Thus, reduction of MX1 and LGALS8 expression lead to an increased replication of 
Legionella in macrophages. In conclusion, these miRNAs are influencing the expression of their targets 




4.2 Identification of the gene expression profile during the course of Legionella 
infection in human macrophages by dual RNA-Seq 
In order to understand host-pathogen interactions, it is crucial to detect gene expression 
changes in both, the pathogen and the host. Since bacterial transcripts differ dramatically from 
eukaryotic transcripts in terms of quantity and composition of their RNA (Westermann, Gorski 
et al. 2012), it is necessary to separate the transcriptomes. Usually, probe-dependent 
approaches require the pathogen and host cells to be physically separated before gene 
expression analysis. For instance, in order to analyse bacterial gene expression during infection 
via microarray or sequencing, the dominating host material has to be depleted prior to analysis 
(Westermann, Barquist et al. 2017). Therefore, the majority of host-pathogen studies have 
focused on either the pathogen or the host at a given time post infection. The studies were 
limited in understanding the interaction between host and pathogen during the course of 
infection (Westermann, Gorski et al. 2012). To overcome this limitation, RNA-Seq is a helpful 
technique to analyze the transcriptome of both in parallel. Thus, the dual RNA-Seq method had 
been established in the lab of Prof. Jörg Vogel in Würzburg and applied for the first time for 
Salmonella infection of human epithelial cells (Westermann, Forstner et al. 2016).  
A challenging technical issue to overcome is the minute fraction of bacterial transcripts in a 
mixed RNA pool. Typically, a single mammalian cell contains 20 pg of total RNA, which is 
approximately 100 to 200 times more than a bacterial cell with ~0.1 pg RNA (Alberts 2002). 
Thus, assuming an infected host cell is associated with ten bacteria, the relative difference in 
total RNA content is still ~10 to 20-fold (Westermann, Gorski et al. 2012). Since the bacterial 
RNA pool consists predominantly of rRNA and only ~5% account for mRNAs and sRNAs, the 
number of bacterial transcripts is further limited. Therefore, different methods are used to 
enrich for bacterial transcripts: by sequencing cDNA libraries to high depth (Humphrys, Creasy 
et al. 2013), partially enriching bacterial transcripts prior to sequencing (Humphrys, Creasy et 
al. 2013; Mavromatis, Bokil et al. 2015), by enriching for invaded host cells by FACS (Avraham, 
Haseley et al. 2015; Westermann, Forstner et al. 2016) or laser capture microdissection 
(Vannucci, Foster et al. 2013), by depleting rRNA of the bacterium and host either in series or 
in parallel (Humphrys, Creasy et al. 2013; Baddal, Muzzi et al. 2015; Mavromatis, Bokil et al. 
2015; Rienksma, Suarez-Diez et al. 2015; Avraham, Haseley et al. 2016; Westermann, Forstner 
et al. 2016) or by combinations of different methods.  
To date, dual RNA-Seq was performed for the following bacteria: Chlamydia trachomatis 
serovar E (Humphrys, Creasy et al. 2013), Lawsonia intracellularis (Vannucci, Foster et al. 
2013), uropathogenic Escherichia coli (UPEC) (Mavromatis, Bokil et al. 2015), Mycobacterium 




influenza (Baddal, Muzzi et al. 2015), Salmonella Typhimurium (Avraham, Haseley et al. 2015; 
Westermann, Forstner et al. 2016) and Streptococcus pneumoniae (Aprianto, Slager et al. 
2016).  
In this study, the dual RNA-Seq method was adapted and applied for the first time to 
Legionella infection of human macrophages. Invaded host cells were separated from non-
infected bystander cells by FACS, and rRNA of L.p. and the macrophages was depleted to 
facilitate accurate quantification of bacterial gene expression.  
The full coverage of protein-coding and non-coding RNA from human macrophages (mRNA, 
miRNA, lncRNA, circRNA) and L.p. (mRNA, sRNA) during infection by a dual RNA-Seq approach 
was determined.  
 
 Adaption of the dual RNA-Seq procedure to detect the transcriptional profile 4.2.1
of L.p. and THP-1 cells during the course of infection 
One of the most important preparative steps was the adaptation and optimization of the 
infection protocol for the dual RNA-Seq procedure. Therefore, inflammatory response, 
cytotoxicity, infection rate and sort purity were tested (Fig. 3.15 and Fig. 3.16). Based on these 
findings, the dual RNA-Seq procedure in this study was performed in PMA-differentiated THP-1 
cells, which were first infected with GFP-L.p. Corby at an MOI of 10 for 2 h. Infection was 
performed for a total of 8 h and 16 h.  
The GFP-expressing strain was used for infection of macrophages to separate invaded cells 
from non-invaded-bystander-cells and the responsiveness of THP-1 cells infected with the GFP-
strain was compared to that of cells infected with the wildtype strain by controlling CXCL8 and 
miRNA-146a expression. Both strains triggered a comparable inflammatory response in THP-1 
cells (Fig. 3.15E, F). Variations in log2-fold changes can be explained by different realised MOIs, 
since the real MOI can differ from the expected MOI.  
To separate extracellular pathogen recognition from L.p.-specific effects, THP-1 cells were 
stimulated with the TLR2 agonist Pam3CSK4 (Pam3). For stimulation, a concentration of 
100 ng/mL was used for the sequencing approach, since it was the lowest concentration 
yielding a significantly increased CXCL8 expression for both time points (8 and 16 h). 
Pam3CSK4 is a synthetic tripalmitoylated lipopeptide that mimics the acylated amino terminus 
of bacterial lipoproteins. Bacterial lipoproteins are cell wall components of both gram-negative 
and gram-positive bacteria. The stimulatory activity of bacterial lipoproteins resides in their 
acylated amino terminus. Pam3CysSerLys4 (Pam3CSK4) is recognized by TLR2 which 




inflammatory transcription factor NF-kB (Aliprantis, Yang et al. 1999; Ozinsky, Underhill et al. 
2000). An infection of macrophages with L.p. triggers the activation of many different PRRs 
(Massis and Zamboni 2011; Cunha and Zamboni 2014; Naujoks, Lippmann et al. 2017). 
Lipopeptides and lipoproteins of L.p. activate TLR2. TLR2-signalling is critical for the outcome 
of L.p. infections in mice (Hawn, Smith et al. 2006). Furthermore, the LPS of Legionella is 
mainly recognized by TLR2 (Akamine, Higa et al. 2005; Shim, Kim et al. 2009). Therefore, 
Pam3CSK4 as TLR2 agonist can serve as a positive control for extracellular activation of 
macrophages, which should induce an inflammatory response due to NF-kB activation.  
For synchronisation of the infection cycle, cells were centrifuged for 10 minutes at 500 x g 
directly after administration of bacteria. After 2 h, cells were washed 3 times with PBS to 
remove all extracellular, not internalized bacteria. Gentamicin was added to the medium for 
further cultivation to prevent reinfection. Gentamicin is a bactericidal antibiotic, which 
interrupts protein synthesis of the bacteria by irreversibly binding the 30S subunit of the 
bacterial ribosome (Hahn 1969). Reinfection was successfully prevented since no increase of 
the infection rate was observed in the flow cytometric analyses at 8 and 16 h post infection 
(Fig. 3.116B). 
The 8 h time point was chosen, since infected host cells showed a peak in CXCL8 expression at 
that time point (Fig. 3.15C). The time points were chosen to characterize the infection process 
within the host cells and different growth stages of Legionella during the course of infection. 
L.p. exhibits a biphasic life-cycle and expresses different virulence factors during the course of 
infection and while it switches between an infectious, non-replicating form and an 
intracellular, replicative form (Rowbotham 1986; Byrne and Swanson 1998; Molofsky and 
Swanson 2004). In this study, L.p. of three different time points were sampled: (1) L.p. from 
the inoculum solution which resembles the highly virulent, transmissive form, (2) replicating 
L.p. inside the host cell from the 8 h time point, which represents the avirulent, non-motile and 
replicative form, and (3) L.p. inside the host cell from the 16 h time point, which should 
present the transition of the replicaitve form into the flagellated, transmissive form. L.p. 
differentiates into this form, when nutrients and living space become scarce. Since the 
vacuoles within the host cells at the 16 h time point are packed with a high amount of L.p., it is 
likely that the bacteria within the macrophages are promoting the transmission to a new host 
cell at this stage. Thus, different growth stages of L.p. were expected at the chosen time points 
to shed light on the expression pattern of genes, relevant for the infection process within 
macrophages.  
The replication of L.p. over the two time points (8 and 16 h) can be ascertained by the 




events) is not increasing (Fig. 3.16B). Furthermore, the verification of the applied sort strategy, 
where a part of each sorted cell fraction was lysed and plated on BCYE-agar plates to quantify 
bacterial growth, indicated a 10-fold increase of CFU/ml comparing the 8 h with the 16 h time 
point (Fig. 3.16C). This represents again the replication of L.p. within the host cells over time.  
During the FACS process, different external factors associated with cell sorting such as flow 
rate, pressure, and droplet charge, can cause modulations in cellular physiology including RNA 
transcript levels. Sorted cells can experience physiologic stress and even a decrease in viability 
which can lead to altered RNA expression patterns or to potential RNA degradation (Arbibe, 
Kim et al. 2007). Therefore, it is important to reduce cellular activation or perturbation during 
the FACS procedure for accurate RNA analyses (Nishimoto, Newkirk et al. 2007). Deviating 
from the provided protocol of Alexander Westermann, cells were not fixed in RNAlater prior 
sorting. Zaiton and colleagues found that RNAlater treatment reduces GFP and YFP 
fluorescence, making separation of fluorescent (infected with L.p.) and non-fluorescent cells 
(non-infected bystander cells) difficult or impossible. They found that the pH of RNAlater is 5.6 
(Zaitoun, Erickson et al. 2010). It has been reported that GFP and its variants is pH dependent 
(Saeed and Ashraf 2009). Since 80% of GFP fluorescence is lost at pH 6.5 and lower, RNAlater 
might have a quenching effect on GFP and YFP fluorescence of L.p..  
In order to minimize cellular perturbation or downstream physiologic responses, cells were 
sorted at 4°C into RNAprotectTM solution to recover high quality RNA from cells separated by 
FACS. According to manufacturer’s protocol, this reagent provides immediate stabilization of 
RNA in sorted or cultured cells. Cells are stabilized at room temperature and can be stored or 
transported at ambient temperature prior to RNA purification. A comparable approach to 
characterize host microbe interaction was chosen by Nishimoto and colleagues. They 
recommended to sort cells, isolated by FACS, into RNAlater solution to minimize RNA 
degradation and perturbation of mRNA expression or downstream physiologic responses in 
the presence of a foreign pathogen or microbe, since host cells can respond very quickly to 
interactions with microbes (Nishimoto, Newkirk et al. 2007). The difference between both 
reagents is that RNAlater is recommended for tissue, while RNAprotectTM solution is 
specifically suggested for cultured or sorted cells by the manufacturer.  
Overall, different protocols can be applied to investigate and quantify transcriptional changes 
in host-pathogen interactions. In this study, RNA was isolated using the mirVana™ miRNA 
Isolation Kit. Bacterial ribosomal RNA (rRNA), eukaryotic cytoplasmic rRNA and mitochondrial 
rRNA was removed. No polyA enrichment was performed to preserve circular RNAs and 
bacterial RNAs for sequencing. Random-primed libraries without cutoff above 50 bp were 




(Freising, Germany) on an Illumina Illumina NextSeq 500 system with a 75 bp read length. 
Compared to that, sequencing the miRNA fraction required additional steps. First, the small 
RNA fraction (<200 bp) was purified from the total RNA and concentrated using RNeasy 
MinElute Cleanup kit (Qiagen). Secondly, the miRNAs were isolated by nuclear acid 
fractionation (Caliper LabChip XT) by help of an internal size marker. Afterwards, the samples 
were processed and sequenced. In total, an average of over 11 million reads could be mapped 
at 8 and 16 h post infection (Fig. 3.17A), respectively after discarding of reads mapping to both 
genomes. This observation is comparable with the results of other dual RNA-Seq studies 
varying from 1 million to a maximum of 40 million detected reads (Westermann, Barquist et al. 
2017). Moreover, 2% of the mapped reads of invaded cells at 8 h post infection were from 
Legionella origin (Fig. 3.17B). The bacterial reads were increasing to 4.5% mapped reads at 
16 h post infection reflecting the intracellular replication of L.p.. The reads from Legionella (T0) 
or THP-1 cells alone mapped to their respective genomes with high stringency. Nearly no reads 
were mapped to the Legionella genome from the bystander cells, indicating that the gates for 
sorting (Fig. 3.16B) were kept conservative enough to prevent cross-contaminations of the two 
fractions, which is also observable in the high sort purity (Fig. 3.16C). Similar mapping results 
were achieved by Rienksma and colleagues. They infected THP-1 cells with M. bovis at an MOI 
of 10 for 4 h, centrifuged the cells, washed and sampled at 20 h post infection (Rienksma, 
Suarez-Diez et al. 2015). Thus, a different bacterium, but a similar protocol was used for the 
infection. 
Focusing on the host side, the distribution of the RNA species showed a comparable pattern to 
other sequencing data depleted for ribosomal RNA (Fig. 3.18A). In this study, the abundance of 
miRNAs (with 0.55% to 0.1%) was higher and the abundance of lncRNAs (with 4.75% compared 
to 15%) was lower than in the study of Westermann and colleagues (Westermann, Forstner et 
al. 2016). Differences can be attributed to different cell lines and bacteria used in the studies. 
After performing differential gene expression analysis using DESeq2, 4,144 differentially 
expressed genes were identified. Mostly, significantly expressed genes were detected in gfp+ 
cells across both time points. More genes are regulated in cells invaded by Legionella than in 
bystander cells or TLR2-activated cells (Fig. 3.18B). This observation hints towards a specific 
transcriptional change following Legionella invasion. It has been shown that the transcriptome 
of human monocyte-derived macrophages infected with Legionella was dominated by 
upregulation of inflammatory and anti-apoptotic pathways, as well as downregulation of 
protein synthesis pathways (Price and Abu Kwaik 2014). As intracellular pathogen, L.p. 
interferes with host gene transcription to manipulate the host for its own benefit, explaining 




explanation for the low amount of differentially expressed genes in the bystander cells could 
be that the extracellular stimulation with the bacteria was only performed for 2 h, since all 
non-internalized bacteria were washed away and inactivated by gentamicin. Thus, after 2 h, 
only stimulation of the bystander cells by secreted chemokines or cytokines of infected cells 
could take place.  
Furthermore, a PCA and a correlation analysis of all differentially expressed genes were 
performed to examine the quality of the data and the association between the samples. The 
PCA shows a clustering of samples according to their treatment, reflecting again the high sort 
purity and the good quality of the sequencing data. In general, the correlation plot showed a 
high similarity between gfp- and Pam3 cells, while the gfp+ cells are not correlated to the other 
two cell fractions. This observation can be explained by the high expression changes within 
Legionella-invaded host cells. Pam3 and gfp- cells are both stimulated extracellularly either by 
Legionella or by the TLR2-ligand or by cytokines from infected cells with the result of TLR-
dependent NF-κB activation (Archer and Roy 2006; Archer, Alexopoulou et al. 2009), while 
within gfp+ cells, several intracellular PRRs could be activated such as NOD1, NOD2, 
NAIP5/NLRC4 inflammasome or TLR9 (Naujoks, Lippmann et al. 2017).  
Overall, the dual RNA-Seq protocol performed in this study yielded high quality sequencing 
data and can be compared with other dual RNA-Seq protocols for diverse intracellular and 
extracellular bacteria. The data set is the first one for L.p.-infection in human macrophages.  
Especially for Legionella, several transcriptome analyses have been performed with just a one-
sided focus on the pathogen. One study compared the global transcriptional changes of L.p. 
grown in a rich medium to that of L.p. exposed to an artificial freshwater medium (Li, Mendis 
et al. 2015). Another study used RNA deep sequencing to analyse the transcriptional landscape 
of exponentially (replicative) and post-exponentially (virulent) grown L.p. in medium (Sahr, 
Rusniok et al. 2012). These growth phases should mimic the biphasic life cycle of L.p., where 
the non-virulent replicative phase (RP) of the bacterium is transitioned to a highly virulent, 
transmissive phase (TP) (Molofsky and Swanson 2004). The bacteria are grown in BYE broth 
and the exponential phase culture represents the RP, while the post-exponential stationary 
phase models TP of the bacteria after infection (Molofsky and Swanson 2003). Within those 
two studies, no internalized bacteria by host cells were analysed. A third publication 
monitored the transcriptional response of L.p. during exponential and post-exponential broth 
growth and compared it to the Legionella transcriptome during the replicative and 
transmissive phase of infection inside A. castellanii. Therefore, they analysed the 
transcriptional response of L.p. during an infection of host cells (Weissenmayer, Prendergast et 




exponential and post-exponential phase was also performed by Faucher and colleagues. The 
difference between those studies was that another host was used for infection (Faucher, 
Mueller et al. 2011). Faucher et al. infected PMA-differentiated THP-1 cells with the L.p. strain 
JR32 at an MOI of 1 for 6 and 18 h. In principle, they used a similar protocol for the infection, 
but the bacterial transcripts were separated from host cDNA by SCOTS, a selective 
hybridization to bacterial genomic DNA (gDNA). Thus, the focus was set again on the pathogen 
side and the transcripts of the host were not analysed.  
In contrast, two other publications concentrated their transcriptional analyses on the host side 
(Fortier, Faucher et al. 2011; Price and Abu Kwaik 2014). Fortier and colleagues investigated 
the transcriptional profile in macrophages from C57BL6J mice (B6), and from congenic mice 
(BcA75) carrying the partial loss-of-function A/J-derived allele (Naip5(A/J)) on a B6 background, 
infected or not with wild-type L.p. or flagellin-deficient mutant (Fortier, Faucher et al. 2011). 
Thus, they identified genes regulated by flagellin and by Naip5. Bone marrow derived 
macrophages (BMDMs) were infected with L.p. Philadelphia-1 strain Lp02 at an MOI of 10 for 
1 h and cells were harvested at 4 h following infection. The host transcriptome was analysed 
using microarrays. Therefore, host cells from another species, a different infection protocol, a 
different bacterial strain, as well as another transcriptome analysis platform was used 
compared to this study (Fortier, Faucher et al. 2011). Thus, comparative analyses between the 
studies can hardly be done.  
Much more similar to the experimental design of this study are the experiments done by Price 
and Kwaik. They infected human monocyte-derived macrophages with L.p. strain AA100/130b 
at an MOI of 20 for 1 h and treated the cells for 1 h with gentamycin to kill remaining 
extracellular bacteria. The infection was performed with either the wildtype or the ankB 
mutant strain of L.p. for a total of 8 h. Data were analysed using microarrays meaning not all 
existing transcripts of the host were analysed (Price and Abu Kwaik 2014). However, the gene 
expression profile of the macrophages infected with the wildtype strain can still be compared 
to the data generated in this study although another strain of L.p. was used for infection. This 
comparison is discussed in the section 4.1.5. 
Taken together, these described studies have focused on either the pathogen or the host at a 
given time (Westermann, Gorski et al. 2012), but this study investigates for the first time both, 





 Identification of differentially expressed host RNA species 4.2.2
After differential expression analysis using DESeq2, the mRNA, lncRNA and miRNA regulation 
was displayed in heatmaps. The mRNA heatmap enabled the identification of gene clusters 
specific for Legionella-invaded cells or genes upregulated in all fractions. The expression of 
SOD2 and IL-1β could be validated via qPCR, showing a significant upregulation in all fractions. 
Several studies have shown that L.p. stimulates the production of many pro-inflammatory 
cytokines such as IL-1α, IL-1β, IL-6, IL-8, TNF-α, IFN-γ, IL-12, IL-17 and IL-18 in mouse BMDMs, 
human macrophage cell lines, murine models of L.p. infection or in patients with Legionnaires' 
disease (Tateda, Matsumoto et al. 1998; McHugh, Yamamoto et al. 2000; Fernandez-Serrano, 
Dorca et al. 2003; Shin, Case et al. 2008; Barry, Fontana et al. 2013). For instance, IL-1β is an 
important mediator of the inflammatory response and member of the IL-1 family of cytokines. 
It is produced by activated macrophages as a pro-protein and cleaved to its active form by 
caspase-1. It is suggested that IL-1β is critical for neutrophil recruitment in response to L.p.. 
They showed that L.p. infected macrophages produce IL-β which signals through the IL-1 
receptor (IL-1R) expressed by airway epithelial cells (AECs). In response to IL-1β stimulation, 
AECs produce chemokines including CXCL1 and CXCL2 which stimulate the rapid recruitment of 
neutrophils to the lung to clear infection (LeibundGut-Landmann, Weidner et al. 2011). 
Furthermore, Copenhaver and colleagues showed that Legionella-infected macrophages in 
mice produce IL-1α and IL-1β for host protection. They measured the expression levels of 
sorted populations of T4SS-infected (invaded cells) and uninfected cells (bystander cells). They 
used a fluorescence-based reporter system that detects the translocated effector protein RalF 
of Legionella to discriminate between the two populations. Copenhaver and colleagues 
showed a marked increase in transcript levels in Il1α, Il1β, Tnf and Il6 relative to uninfected 
cells, but more in infected cells exhibiting significantly greater increase in cytokine transcript 
levels than uninfected cells (Copenhaver, Casson et al. 2015). Thus, this observation is 
consistent with the finding of the present study and others (Asrat, Dugan et al. 2014). 
Furthermore, it is comparable, since a separation of invaded and bystander cells was 
performed as done in the present study. Copenhaver et al. also analysed the secretion of IL-1α 
and IL-β and found that those cytokines were robustly produced by both T4SS-injected and 
uninjected cells (Copenhaver, Casson et al. 2015). In the present study, the secretion of 
cytokine was not measured, since the analysis here focusses on the expression profile of 
different RNA species.  
In summary, genes identified via sequencing were validated and primarily encode mediators of 





 Identification of differentially expressed host lncRNA 4.2.3
Overall, 495 differentially expressed lncRNAs were detected in bystander cells, in Legionella-
invaded cells and in cells stimulated with Pam3. Although the dendrogram of the lncRNA 
profile shows clustering of gfp- to gfp+ cells, a cluster of genes was identified where genes 
showed an upregulation specific for gfp+ cells, or even a downregulation in gfp- and pam3 
cells. Two lncRNAs LINC00278 and LINC00346 were validated using qPCR and confirmed the 
sequencing data. Regarding the sequencing data, LINC00278 was downregulated in Pam3 and 
gfp- cells, while LINC00346 was upregulated in gfp+ cells. 
LINC000346 showed a significant upregulation at 8 and 16 h post infection in Legionella 
invaded cells, arguing for an infection-relevant lncRNA. LINC00346 has been previously 
described to be implicated in different types of cancer including non-small cell lung cancer 
(NSCLC), bladder cancer, breast cancer and hepatocellular carcinoma (Zhang, Fan et al. 2015; 
Liu, Li et al. 2016; Wang, Chen et al. 2017; Ye, Ding et al. 2017). Liu and colleagues found 
LINC00346 to be upregulated in breast cancer and associated with poor overall survival (Liu, Li 
et al. 2016). Another study showed that LINC00346 was upregulated in bladder cancer tissues 
compared to normal tissues. They demonstrated that a knockdown of LINC00346 inhibited 
bladder cancer cell proliferation and migration, induced cell cycle arrest and cell apoptosis (Ye, 
Ding et al. 2017). Thus, they postulate a role of LINC00346 as potential oncogene and a 
therapeutic target in bladder cancer. Furthermore, Wang and colleagues showed that 
LINC00346 was upregulated in tissue of patients with NSCLC and promoted proliferation and 
inhibits apoptosis through regulating the JAK-STAT signaling pathway (Wang, Chen et al. 2017). 
Therefore, an involvement of LINC00346 in Legionella infection is very likely, since the 
JAK/STAT pathway is active in macrophages infected by Legionella, which was shown by the 
phosphorylation of STAT1 upon the uptake of the bacteria (Schiavano, Dominici et al. 2016). 
Furthermore, LINC00346 was exclusively upregulated in Legionella invaded cells and it has 
been shown to be implicated in cell survival and cell cycle control which is crucial to diminish 
infection.  
LINC00278 was downregulated in bystander cells, while in invaded cells it was downregulated 
at 8 h and upregulated at 16 h post infection. Until now, no studies were focusing on this 
lncRNA. One study found the expression of LINC00278 to be unique in males (Bybjerg-
Grauholm, Hagen et al. 2017). Implications of this lncRNA in inflammation or other biological 
processes are still missing. Thus, it could be an interesting target to further focus on, since 
60 - 70% of the reported cases of Legionnaires’ disease are male (WHO 2017).  
It is known that lncRNAs can be key regulators of innate immunity. For instance, NRAV was 




significantly promotes influenza A virus (IAV) replication and virulence by negatively regulating 
the initial transcription of multiple critical interferon-stimulated genes (ISGs), including IFITM3 
and MxA, by affecting histone modification of these genes (Ouyang, Zhu et al. 2014). Thus, it 
could be shown that lncRNAs can modulate the immune response to pathogens. Further 
significantly regulated lncRNAs of the sequencing data in Legionella invaded cells should be 
validated and analyzed by knockdown and overexpression experiments for the 
characterization of their function during the immune response or the infection process.  
Taken together, lncRNAs may serve as markers for Legionella infection and their implication in 
the infection process needs to be determined.  
 
 Identification of differentially expressed host miRNAs 4.2.4
Based on the hierarchical clustering of the miRNA profiles, no association of the Legionella-
invaded cells at 16 h post treatment to the other samples was found. Furthermore, strong 
miRNA regulations were only detectable in Legionella-invaded cells at 16 h and not at 8 h post 
infection. miRNA regulation in response to Legionella infection seems to require more time to 
show stronger effects. This observation agrees with the miRNA sequencing data from section 
3.1.3, where a time-dependent regulation of several miRNAs upon infection was observed. In 
this experiment, more miRNAs were significantly regulated at 48 h post infection, which 
coincides with the stronger regulation of miRNAs at 16 h post infection observed in the dual 
RNA-Seq data. Other studies investigating the altered host miRNA expression in response to 
bacterial infections have also chosen longer infection time points (at least 24 h) (Schulte, 
Eulalio et al. 2011; Liu, Zhou et al. 2014). Moreover, Pam3 stimulated cells showed strong 
miRNA regulation. Pam3 is a TLR2-agonist and many miRNAs are regulated in response to TLR 
signaling (Sonkoly, Stahle et al. 2008; Nahid, Satoh et al. 2011b). Thus, it is not surprising that 
many miRNAs are differentially expressed upon TLR2 activation, since the Pam3 stimulation 
was performed for 8 and 16 h.  
Furthermore, an upregulation of miR-146a and downregulation of miR-221 were detected in 
gfp+ cells at both time points. This observation also confirms the miRNA regulation observed in 
section 3.1.3, where miR-146a showed an upregulation, while miR-221 was downregulated 
following an infection with Legionella at an MOI of 0.25 for 24 h and 48 h. Thus, miRNA 
regulation of miR-146a and miR-221 in response to L.p. infection was confirmed by both 




Taken together, miRNA regulation requires more infection/stimulation time to show stronger 
regulations and differentially expressed miRNAs of L.p.-infected BDMs from section 3.1.3 were 
also dysregulated in L.p.-infected and sorted THP-1 cells.  
 
 Identification of mRNA as markers for Legionella infections 4.2.5
The hierarchical clustering revealed that especially mRNAs are contributing to the separation 
of the gfp+ cells from the other two fractions (Fig. 3.19A). Compared to the heatmap of 
miRNAs and lncRNAs, the mRNA heatmap showed several promising cluster with genes 
specifically upregulated in Legionella-invaded cells. Therefore, different mRNAs were selected 
to identify markers specific for Legionella-invaded host cells in this setting. In order to identify 
significantly regulated genes specific for gfp+ cells, an Edwards-Venn diagram was created 
using jvenn (Fig. 3.22). Notably, 1,128 differentially expressed genes which were exclusively 
regulated in invaded cells were detected. Seven gfp+ specific mRNAs (BCL10, SOD1, IRS2, 
CYR61, ATG5, RND3 and JUN) and two mRNAs regulated in gfp- and gfp+ cells (ZFAND2A and 
HSPA1) were validated via qPCR (Fig. 3.23).  
The protein encoded by the gene B-Cell CLL/Lymphoma 10 (BCL10) contains a caspase 
recruitment domain (CARD) at its amino-terminal region. The CARD domain is suggested to 
mediate the binding between adapter molecules and found in many proteins that regulate 
apoptosis (Bouchier-Hayes and Martin 2002). It was identified as a candidate gene responsible 
for low grade B cell lymphomas of mucosa-associated lymphoid tissue (Du, Peng et al. 2000). 
BCL10 knockout mouse exhibits few defects that can be attributed to dysregulation of 
apoptosis, but the primary defect is a profound deficiency in NF‐κB activation in the context of 
T‐ and B‐cell receptor stimulation (Ruland, Duncan et al. 2001). BCL10 binds several CARD 
proteins and forms a signaling complex, which induces NFκB activation (Bertin, Guo et al. 2000; 
Bertin, Wang et al. 2001; Wang, Guo et al. 2001). Additionally, it has been found that after PRR 
activation a complex consisting of caspase-associated recruitment domain 9 (CARD9), BCL10 
and mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) is formed. 
This CARD9/BCL10/MALT1 complex, called CBM complex, activates NF-κB and triggers an 
immune response against fungi, bacteria, and viruses (Gross, Gewies et al. 2006; Hsu, Zhang et 
al. 2007; Roth and Ruland 2013). Thus, it is likely that upregulation of BCL10 represents the 
host response to the infection with L.p..  
Superoxide dismutase 1 (SOD1) is antioxidant enzymes that protects cells from reactive oxygen 
species (ROS). Macrophages kill phagocytosed bacteria through oxygen-dependent and 




phagocytosed bacteria in the oxygen-dependent bactericidal system. ROS include superoxide 
anion (SOA) (O2
-), hydrogen peroxide (H2O2), hypochlorous acid (HOCl), and the hydroxyl 
radical (OH-). Thus, macrophages, which have phagocytosed bacteria, show an increased 
production of ROS. In macrophages, SOA is converted into hydrogen peroxide or the hydroxyl 
radical, which kills bacteria (Fang 2004). The protein SOD1 is a soluble cytoplasmic enzyme and 
acts as a homodimer to degrade SOAs that are generated endogenously either by 
oxidoreductases or as a byproduct of reactions with electron transfer to hydrogen peroxide 
and oxygen (Fridovich 1975; Forman and Torres 2001). One study of Harada and colleagues 
could show that wildtype L.p. could suppress ROS production in macrophages, while 
intracellular growth-deﬁcient strains could not (Harada, Miyake et al. 2007). However, they 
could not clarify the details of the mechanism of inhibition of host ROS production by wild type 
strains. Moreover, another study showed that SOD1 was required for caspase-1 activation 
(Meissner, Molawi et al. 2008). Thus, increased SOD1 expression led to the increased release 
of the caspase-1-dependent cytokines IL-1β and IL-18 and therefore to pyroptosis, which 
argues for a host defence mechanism to reduce bacterial replication.  
Another mRNA specifically upregulated in gfp+ cells was the insulin receptor substrate 1 (IRS1). 
It encodes a protein which plays a role in mediating signals from the insulin and insulin-like 
growth factor-1 (IGF-1) receptors to intracellular pathways PI3K/Akt and Erk MAP kinase 
pathways (Copps and White 2012). It is described that IRS-1 protein is involved in various types 
of cancer, including colorectal, lung and breast cancer (Gibson, Ma et al. 2007; Houghton, 
Rzymkiewicz et al. 2010; Esposito, Aru et al. 2012). Furthermore, it has been shown that IRS-1 
plays an important biological role in both metabolic and mitogenic (growth promoting) 
pathways, since mice deficient of IRS1 have a pronounced growth impairment and only mild 
diabetes. However, IRS-1 seems to be involved in Legionella infection of macrophages, but its 
role in bacterial infection has not been described, yet.  
The cysteine rich angiogenic inducer 61 (CYR61) is a secreted, extracellular matrix (ECM)-
associated signaling protein of the CCN family (CCN intercellular signaling protein) (Jun and Lau 
2011; Lau 2011). Several studies have shown that CYR61 cooperates with and modulates the 
activities of several inflammatory cytokines, including TNF-α, Fas ligand, and TRAIL, which 
indicates that it plays a role in the inflammatory response (Chen, Young et al. 2007; Franzen, 
Chen et al. 2009; Juric, Chen et al. 2009). CYR61 supports macrophage adhesion and activates 
NF-κB signaling in macrophages, leading to the expression of multiple pro-inflammatory 
cytokines and chemokines characteristic for M1 macrophages. Thus, CYR61 regulates the 
inflammatory response of macrophages through integrin signaling (Bai, Chen et al. 2010). 




infection has not been described, yet. It could be shown that the expression of CYR61 in 
epithelial cells is induced by many different bacteria, including Yersinia enterocolitica, 
Escherichia coli, Pseudomonas aeruginosa, Enterococcus faecalis, or Staphylococcus aureus. 
This observation suggests a common response mediated by identical or similar components of 
all these bacteria (Wiedmaier, Muller et al. 2008). However, CYR61 expression was not 
significantly induced in Pam3CSK4 stimulated cells in the present study, suggesting a TLR2-
independent activation mechanism at least in macrophages.  
The protein encoded by the gene autophagy related 5 (ATG5) is an essential molecule required 
for autophagy and functions as an essential mediator of LC3-I to LC3-II conversion (Mizushima, 
Yamamoto et al. 2001; Klionsky, Cregg et al. 2003). Autophagy is the selective engulfment of 
cytoplasm, which also promotes antibacterial immunity (Levine, Mizushima et al. 2011; Huang 
and Brumell 2014). Macrophages activate autophagy as a barrier to infection (Deretic, Saitoh 
et al. 2013). Thus, certain intracellular pathogens, including L.p., perturb autophagosome 
maturation to avoid or delay their delivery to toxic lysosomes (Baxt, Garza-Mayers et al. 2013). 
For instances, L.p. injects the effector RavZ to inactivate Atg8 proteins during infection, 
thereby dampening the autophagy processes (Choy, Dancourt et al. 2012). Furthermore, it has 
been shown that Atg5-/- cells are unable to execute autophagy as a result of a defect in 
autophagosome formation (Mizushima, Yamamoto et al. 2001). Moreover, it has been 
described that ATG5 influences Legionella replication in mice. An siRNA-mediated knockdown 
of ATG5 resulted in an enhanced replication of L.p. compared to the non-targeting siRNA-
transfected cells (Matsuda, Fuiji et al. 2009). Therefore, upregulation of ATG5 in Legionella-
invaded cells (gfp+) in this study might be a host response to limit Legionella replication.  
Rho family GTPase 3 (RND3), also known as RhoE, is a member of the small GTPase protein 
superfamily. Members of this family are important regulators of actin organization, as well as 
many other cellular processes, including cell adhesion and migration, vesicle trafficking, 
cytokinesis, and apoptosis (Hall 1998; Etienne-Manneville and Hall 2002). The protein 
constitutively binds GTP and its activity does not depend on a GDP/GTP switch, but is 
regulated by expression, localization and phosphorylation (Chardin 2006). Treffers and 
colleagues showed that RND3 protein expression was downregulated in 293/ACE2 cells upon 
chikungunya virus infection, promoting viral replication (Treffers, Tas et al. 2015). Since small 
GTPases are involved in many cellular processes, they represent an attractive target for 
Legionella effectors during establishment of the LCV (Ge and Shao 2011; Steiner, Weber et al. 
2017). However, L.p. effector proteins predominantly target Arf/Sar, Rab and Ran family 
GTPases, whereas the majority of effectors of other pathogens target the family of Rho 




RND3 seems to be an important factor for the host defence and could be upregulated in 
Legionella-invaded cells as kind of host response to limit bacterial replication.  
The protein encoded by the gene Jun proto-oncogene (JUN) forms the transcription factor 
AP-1 with c-Fos. It is activated through phosphorylation on serine 63 and serine 73 in the 
NH2-terminal activation domain by the c-Jun N-terminal kinases (JNK) pathway, but it can act 
also phosphorylation-independent (Adler, Polotskaya et al. 1992; Hibi, Lin et al. 1993; Wisdom, 
Johnson et al. 1999). It is regulated by peptide growth factors, pro-inflammatory cytokines and 
other forms of cellular stress. C-Jun protects cells from apoptosis and regulates cell cycle 
progression (Wisdom, Johnson et al. 1999). An involvement of the JNK pathway in bacterial 
infections has been shown, since an infection of epithelial cells with S. pneumoniae resulted in 
JNK phosphorylation and increased AP-1-DNA-binding, which led to increased CXCL8 
expression (Schmeck, Moog et al. 2006). In addition, Welsh et al. demonstrated the 
importance of the stress-activated protein kinase/c-Jun N-terminal kinase or p38 pathway for 
intracellular replication and survival of Legionella. They showed that Legionella infection led to 
increased activity of c-Jun N-terminal kinase and an inhibition of the activity decreased the 
ability of Legionella to replicate intracellularly (Welsh, Summersgill et al. 2004). Thus, the JNK 
pathway is involved in bacterial infections. Whether an increased expression of JUN following 
Legionella infection leads to an increased activation of AP-1, needs to be further investigated.  
Zinc Finger AN1-Type Containing 2A (ZFAND2A), also known as arsenite-inducible RNA-
associated protein (AIRAP), is highly conserved among mammals (Sok, Calfon et al. 2001). It 
was detected to be upregulated in gfp- and gfp+ cells in this study. ZFAND2A is suggested to be 
regulated by NF-κB (McElwee, Song et al. 2009). One study could show that it acts as a 
canonical heat shock gene. Its expression is temperature-dependent and strictly controlled by 
central regulator of heat-induced transcriptional responses Heat shock factor-1 (HSF1) (Rossi, 
Trotta et al. 2010). AIRAP function, as well as its role in infection or inflammation, is still not 
defined, but it seems to be involved in the TLR2-independent sensing of Legionella as indicated 
by the expression results of this study (induced in gfp- and gfp+ cells, no significant regulation 
in Pam3 stimulated cells).  
The protein encoded by the gene heat shock protein family A (Hsp70) member 1A (HSPA1A), 
also known as Hsp72, is a stress-inducible intracellular protein with functions in prevention of 
protein aggregation, facilitation of protein refolding, and chaperoning of proteins. HSP70 is 
one of the major HSPs and includes the constitutive Hsp73 and stress-induced Hsp72 family 
members (Kiang and Tsokos 1998). It has been shown that HSP70 expression is upregulated in 
various states of physiological and environmental stresses, including infections, inflammation, 




variety of stressful conditions by the suppression of a stress-induced apoptotic program 
(Gabai, Mabuchi et al. 2002). Hsp72 can be released from both, necrotic and viable cells, and 
acts as danger signal for the immune system (Basu, Binder et al. 2000; Guzhova, Kislyakova et 
al. 2001; Broquet, Thomas et al. 2003). Some studies report that Hsp70 activates monocytes, 
macrophages and dendritic cells through innate immune receptors (such as TLRs) (Asea, Kraeft 
et al. 2000), while others report that Hsp70 is a negative regulator of the inflammatory 
response. One study addressed this inconsistency and found that extracellular Hsp72 
negatively regulates the production of TLR-induced pro-inflammatory cytokines and 
contributes to dampen the inflammatory response (Ferat-Osorio, Sanchez-Anaya et al. 2014). 
No literature is known that hints towards a connection between Hsp70 and Legionella 
infection. Therefore, the role of Hsp72 during the course of Legionella infection needs to be 
determined, since the data of this study indicate an upregulation following stimulations with 
Legionella.  
In order to compare the sequencing data of this study with the transcriptomics data of other 
studies, the expression of the validated genes was compared to the publication of Price and 
Kwaik (Price and Abu Kwaik 2014). Regarding the experimental design, this study showed the 
greatest similarity to the present study. Only three (RND3, JUN, HSPA1A) of the nine herein 
described genes were identified to be upregulated in the microarray data of Price and Kwaik. 
As aforementioned, they identified the transcriptome of human MDMs infected with L.p. 
strain AA100/130b wt for 8 h and no separation of bystander and Legionella-invaded cells was 
performed. Thus, the microarray data can detect only the sum expression of genes from non-
infected bystander cells and Legionella-invaded cells. The genes BCL10, SOD1, IRS1, CYR61, 
ATG5 and ZFAND2A were not regulated in response to Legionella (wt) infection. The genes 
RND3 (FC of 1.99), JUN (FC of 2.28) and HSPA1A (1.85) showed an up to 2.3-fold upregulation 
compared to untreated cells. Differences of the expression data can be explained by the 
performed separation of infected and non-infected in this study and the different cell types 
and strains used for infection. Nevertheless, these genes showed the same tendencies of 
regulation, but not to the same extent as in the present study. 
Overall, the differential expression data emphasized that the mRNAs can be used as markers 
for Legionella infection in this setting, since the validation experiment via qPCR showed the 





 Identification of differentially expressed mRNAs of Legionella 4.2.6
2,707 differentially expressed Legionella genes were identified across both time points. A 
switch of genes between the 8 and 16 h time point was detected, meaning genes were 
inversely regulated across both time points.  
Bacterial survival and replication requires the acquisition of essential nutrients including iron 
and amino acids as energy and carbon sources (Tesh, Morse et al. 1983). Therefore, 
macrophages actively sequester essential nutrients from invading bacterial pathogens to 
combat infection (Becker and Skaar 2014). 
Iron is crucial for the replication and virulence of Legionella (James, Mauchline et al. 1995; 
Cianciotto 2015). For instance, IFN-γ-activated macrophages are non-permissive for L.p. 
replication due to decreased levels of intracellular iron (Nash, Libby et al. 1988). Thus, the 
intracellular growth of L.p. depends on its ability to sequester iron from the host cell. L.p. uses 
different strategies to acquire iron in culture, but it was not known until recently how L.p. 
obtains iron during intracellular growth in macrophages (Cianciotto 2015). Isaac et al. found 
that this acquisition is mediated by more regions allowing vacuolar co-localization N (MavN), 
which is a protein translocated by T4SS (Isaac, Laguna et al. 2015). This factor was necessary 
for intracellular growth and was highly upregulated during iron starvation, while it was not 
required for growth in media (Isaac, Laguna et al. 2015; Portier, Zheng et al. 2015).  
FeoA and feoB are ferrous iron transporters that have already been described for E. coli. A loss 
of feoA or feoB resulted in decreased ferrous iron uptake (Kammler, Schon et al. 1993). FeoAB 
of L.p. shares homology to E. coli feoAB, Salmonella enterica serovar Typhimurium feoAB and 
H. pylori feoB (Kammler, Schon et al. 1993; Tsolis, Baumler et al. 1996; Velayudhan, Hughes et 
al. 2000). In Legionella, both genes are known to be iron regulated (Robey and Cianciotto 
2002). In addition, it has been shown that feoB of L.p. is important for both, extracellular 
growth in artificial media and intracellular growth in macrophages and amoeba, especially in 
iron-limited environments (Robey and Cianciotto 2002). For feoA, no further investigations 
exist for characterization of its function. Overall, the ability to acquire iron from the host cells 
is a critical determinant in the outcome of L.p. infection (Cianciotto 2015) and therefore an 
interesting domain for further investigations.  
L.p. alternates between a replicating form and a transmissive/virulent form. Nutrient 
starvation and environmental stress induce the transition from the metabolically active, 
replicating bacteria to the virulent, motile and stress-resistant form (Molofsky and Swanson 
2004). Bacteria express the transmissive traits such as motility (flagella) and become cytotoxic 
and infectious (Molofsky and Swanson 2004). Thus, at 16 h post infection when nutrients 




detected to be upregulated (flgB and flgG). The flagellar basal-body rod protein flgB and flgG 
are components of the flagellum and crucial for motility. Is has been shown that flgB is induced 
upon iron depletion, which supports the observation of this study (Portier, Zheng et al. 2015). 
At 8 h post infection, when L.p. is in the replicative form, genes coding for flagellin are 
downregulated. In this study, heat shock proteins (hsp70, hsp90, hsp100) were found to be 
first downregulated at 8 h and upregulated at 16 h post infection. It is known that heat shock 
proteins participate in the induction of an immunological response to infections caused by 
Legionella. For instance, HSP60 is located in the periplasm on the surface of Legionella, but 
may localize to the bacterial cell surface when the bacteria are intracellular (Gabay and 
Horwitz 1985; Hoffman, Houston et al. 1990). It triggers cytokine production including TNF-α, 
IFN-α, IFN–β, IL-1, IL-6 and GM-CSF in a protein kinase C-dependent manner (Retzlaff, 
Yamamoto et al. 1994; Retzlaff, Yamamoto et al. 1996). Furthermore, T cells obtained from 
patients with confirmed legionellosis proliferate upon stimulation with Hsp60 of L.p.. This 
observation suggests that Hsp60 is targeted by the cellular immune system early in infection 
(Eisenstein, Tamada et al. 1984). Another study found that a virulent strain of L.p. 
preferentially synthesizes and secretes Hsp60 early in the course of infection which correlates 
with virulence and is only secreted in contact with host cells (Fernandez, Logan et al. 1996). 
Thus, the upregulation of genes coding for heat shock proteins could display the transition of 
the replicating form to the transmissive form, when the bacteria become virulent. 
Furthermore, there is a hint that heat shock proteins could interact with host heat shock 
proteins. Nasrallah et al. confirmed the binding of Hsp60 to the mammalian small Hsp10 using 
a yeast two-hybrid system. Since it is known that chaperonins are required to interact with co-
chaperonins to function properly in protein folding, they claimed that Legionella Hsp60 
recruits the host cell Hsp10 to appropriately interact with SAMDC, a cytoplasmic protein 
required for synthesis of host polyamines that are important for intracellular growth of L.p. 
(Nasrallah 2015). Nevertheless, the function of the heat shock proteins detected in this study 
still needs to be determined. 
Overall, genes upregulated at 16 h post infection can be interesting candidates, since they 
could be important virulence factors for Legionella infection. These genes showing a switch 
across both time points are involved in iron metabolism, stress response and motility. Their 






Despite the significant biological findings of this study, this work also poses a number of 
questions. It was shown that MX1 downregulation facilitates Legionella-replication within 
human macrophages. The role of MX1 in limiting viral replication is well studied, but this study 
describes for the first time an implication of MX1 in bacterial infections. In the present study, 
the mechanism MX1-mediated restriction of Legionella-replication was not clarified. The 
localization of the protein could shed light on its function. Immunofluorescence staining for 
MX1 protein could be performed to determine the localization of MX1 upon infection in 
macrophages. Additionally, co-immunoprecipitation (co-IP) assays could reveal MX1 
interaction partners, giving further information about its function and involvement in different 
pathways. Furthermore, the role of galectin-8 as danger receptor, monitoring endosomal and 
lysosomal integrity needs, to be confirmed in Legionella infection, since it has been only 
described in infections with Salmonella, Listeria or Shigella (Paz, Sachse et al. 2010; Thurston, 
Wandel et al. 2012; Machado, Cruz et al. 2014). Also here, immunofluorescence staining could 
be performed to test the co-localization of galectin-8 with e.g. LC3-positive autophagosomes. 
Knockout studies in mice for both, galectin-8 and MX1, might be of limited scientific use. 
Galectin-8 is not found within the LCV of infected murine macrophages (Truchan, Christman et 
al. 2017) and human MX1 is not functionally related to rodent MX1 and localized in different 
cellular compartments. Moreover, both murine Mx genes are defective in classical inbred 
mouse strains (Staeheli and Sutcliffe 1988). They are only intact in wild mice and in some 
laboratory strains derived from them (Jin, Yamashita et al. 1998). Thus, to characterize the 
detailed role of galectin-8 and MX1, human systems, like human lung tissue explants or 
organoid models should be used. Looking into databases from clinical cohorts of Legionella 
induced pneumonia, one could search for patients carrying mutations in MX1 or LGALS8, 
including mono- and bi-allelic variations, and correlate these findings with disease severity. 
Within the present study, many differentially expressed miRNAs have been identified upon 
Legionella infection. Besides the described role of miR-125b, miR-221 and miR-579, it remains 
to be studied whether also other miRNAs contribute to Legionella pathogenesis or replication. 
Given the fact that miRNAs are essential mediators of the host response to pathogens, miRNAs 
are possible targets for the development of therapeutics and biomarkers. A prominent 
example of a clinical application of miRNAs as therapeutic targets is miravirsen, which is an 
oligonucleotide inhibitor of miR-122. Since HCV depends on expression of host miR-122 (a liver 
specific miRNA) to survive and replicate, miravirsen restricts HCV replication (Jopling, Yi et al. 
2005). It was proved to be safe and well tolerated in HCV-infected patients in a phase IIa trial 




miRNAs upon Legionella infection, potential biomarkers or therapeutics for Legionella 
infection could be introduced.  
The dual RNA-Seq protocol applied in this study yielded high quality sequencing data. Thus, it 
is possible to study and further validate other critical RNA species. Additionally, the impact of 
some interesting identified RNA species on pathogen recognition and modulation of the 
immune response should be investigated with respect to therapeutic applications. The overall 
goal is to identify a complex network of coding and non-coding RNAs to gain a deep 
understanding of the infection process. In order to achieve a full understanding of RNA 
regulation during the course of infection, the expression changes of sRNAs of Legionella and 
circular RNAs (circRNAs) of the macrophages also needs to be identified. The dual RNA-Seq 
data combined with advanced bioinformatics could provide the necessary information to 
identify such changes.  
CircRNA are generated by non-sequential backsplicing of exons, introns or a combination of 
both (Starke, Jost et al. 2015). They form a covalently closed loop feature without 5' end caps 
or 3' Poly (A) tails and are highly stable due to their nuclease resistance properties (Liang and 
Wilusz 2014). It has been found that some circRNAs can act as miRNA sponges to absorb and 
sequester miRNAs and fulfill regulatory functions in gene expression (Zhao and Shen 2017). 
Therefore, circRNAs can influence the infection process by counteracting miRNA-mediated 
degradation of mRNA. The use of miR-sponges for therapeutic applications is of emerging 
interest. Thus, after determination of circRNA expression, sponges could be designed based on 
their model and tested for antibacterial activities in Legionella-infected macrophages.  
On the other hand, bacterial small non-coding RNAs have a length of about 50 - 300 
nucleotides and regulate gene expression by translational activation/inhibition or by affecting 
mRNA stability (Waters and Storz 2009). They play a crucial role in many biological processes 
including environmental sensing and stress adaptation, virulence and infectivity (Gottesman 
and Storz 2011). Besides the sRNAs RsmY, RsmZ and 6 S RNA, little is known about the role of 
sRNAs in Legionella, since the Legionella genome is not completely annotated (Rasis and Segal 
2009; Sahr, Bruggemann et al. 2009; Faucher, Friedlander et al. 2010). For instance, the 6 S 
RNA of Legionella regulates expression of genes encoding T4SS effectors, stress response 
genes, and genes involved in acquisition of nutrients. In addition, deletion of 6 S RNA in 
Legionella affected intracellular multiplication, while growth in rich medium was not 
influenced (Faucher, Friedlander et al. 2010). This observation highlights the potential gene 
regulation by sRNAs in response to host adaptation. Thus, interesting candidates for further 




infection. Mutant strains of L.p. deficient for a selected sRNA could be generated to identify 
sRNA function in order to determine their implication in virulence and pathogenesis.  
Given the fact that about 10% of the genome of L.p. code for effector proteins which harbour 
eukaryotic-like motifs for targeting host pathways, unknown effector proteins could be 
identified and studied (Al-Quadan, Price et al. 2012). Their importance for infection and 
multiplication could be investigated via knockout studies with subsequent infection assays.  
Since RNA expression does not always correlate with protein abundance, dual proteomics 
could be performed to complement the dual RNA-Seq data and the deep understanding of the 
infection process. One advantage of dual proteomics is the detection of post translational 
protein modifications, giving information about activation or inhibition of specific pathways. 
Thus, the comparison of the data could expand the knowledge how Legionella regulate its 
adaptation to the invaded host, allowing intracellular replication and how the host regulates 
its immune response to cope with the invading bacteria. Proteomic studies are technically 
more demanding than transcriptional profiling because of the small number of bacteria 
present in the invaded host cells. No in silico separation of bacterial and host proteins within 
invaded host cells, as performed for the dual RNA-Seq approach, is possible because the huge 
excess of host-derived proteins masks the expression of bacterial proteins. In order to bypass 
this problem, enrichment of bacterial proteins needs to be performed. Bacteria can be 
separated via sorting from lysed host cells to enable isolated quantification of bacterial 
proteins. Further experiments are necessary to establish this method for Legionella-infected 
macrophages.  
Overall, the data and tools from this study can be used as a repository to identify RNA species 
regulated upon L.p. infection. The high quality dual RNA-Seq data could be a useful tool for 
further characterization of promising RNA molecules. Furthermore, the three miRNAs 
identified to play significant role in L.p.-replication can potentially be used as therapeutic 
targets. Taken miravirsen as a pioneer in miRNA therapeutics, further novel drugs will follow. A 
miRNA sponge with binding sites for all three miRNA (miR-125b, miR-221 and miR-579) could 
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Supplements 1:  
A: PCA of the SILAC data. Principal component analysis (PCA) of all detected proteins (normalized ratios 
(heavy vs. light)) was performed.  
B: Detection of TP53 protein in THP-1 cells. THP-1 cells were stimulated with 20 nM PMA (+PMA) for 
24 h or left untreated (-PMA). Differentiated THP-1 cells were not infected (-L.p.) or infected with L.p. at 
an MOI of 0.5 for 24 h (+L.p.).  
C: Knockdown test of TP53 in THP-1 cells. THP-1 cells were transfected with a small interfering RNA 
targeting TP53 (siTP53) or with a scrambled siRNA as control (scr). 24 h post transfection, THP-1 cells 
were stimulated with PMA (20 nM) for 24 h. Knockdown of TP53 protein was verified and quantified by 







Differentially expressed genes of the RNA sequencing data or fold changes of detected 
proteins of the SILAC approach are listed in an excel file. 
 
Excel file (1) 
Data of Figure 3.3A: Differentially expressed miRNAs in BDMs following infection with L.p. at 
an MOI of 0.25 for 24 or 48 h. 
 
Excel file (2) 
Data of Figure 3.5E: Fold change of proteins detected in scramble or miRNA pool transfected 
and PMA-treated THP-1 cells. Cells were either infected with L.p. at an MOI of 0.5 for 24 or 
48 h or left untreated as control.  
 
Excel file (3) 
Data of figure 3.19A, 3.20A, 3.21A and 3.24B: List of all differentially expressed genes of the 
host (in sheet 1) or the pathogen (in sheet 2 for 8 h and sheet 3 for 16 h post infection) of the 
dual RNA-Seq approach in THP-1 cells. 
 
Excel file (4) 
Gene names of 3.22: Six different input lists were used to present the results in the Edwards-
Venn diagram. All differentially expressed genes with an adjusted p-value lower than 0.05 and 
a log2-fold change higher than 1.5 or lower than -1.5 for each condition are listed. 
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